
<html lang="en"     class="pb-page"  data-request-id="80982cca-d228-449f-9c4c-9a9587bc2526"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm200590k;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-19;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT2" /></meta><meta name="dc.Creator" content="Tero  Huhtiniemi" /></meta><meta name="dc.Creator" content="Heikki S.  Salo" /></meta><meta name="dc.Creator" content="Tiina  Suuronen" /></meta><meta name="dc.Creator" content="Antti  Poso" /></meta><meta name="dc.Creator" content="Antero  Salminen" /></meta><meta name="dc.Creator" content="Jukka  Leppänen" /></meta><meta name="dc.Creator" content="Elina  Jarho" /></meta><meta name="dc.Creator" content="Maija  Lahtela-Kakkonen" /></meta><meta name="dc.Description" content="The lack of substrate-bound crystal structures of SIRT1 and SIRT2 complicates the drug design for these targets. In this work, we aim to study whether SIRT3 could serve as a target structure in the..." /></meta><meta name="Description" content="The lack of substrate-bound crystal structures of SIRT1 and SIRT2 complicates the drug design for these targets. In this work, we aim to study whether SIRT3 could serve as a target structure in the..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 7, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200590k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200590k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200590k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200590k" /></link>
        
    
    

<title>Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200590k" /></meta><meta property="og:title" content="Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0007.jpeg" /></meta><meta property="og:description" content="The lack of substrate-bound crystal structures of SIRT1 and SIRT2 complicates the drug design for these targets. In this work, we aim to study whether SIRT3 could serve as a target structure in the design of substrate based pseudopeptidic inhibitors of SIRT1 and SIRT2. We created a binding hypothesis for pseudopeptidic inhibitors, synthesized a series of inhibitors, and studied how well the fulfillment of the binding criteria proposed by the hypothesis correlated with the in vitro inhibitory activities. The chosen approach was further validated by studying docking results between 12 different SIRT3, Sir2Tm, SIRT1 and SIRT2 X-ray structures and homology models in different conformational forms. It was concluded that the created binding hypothesis can be used in the design of the substrate based inhibitors of SIRT1 and SIRT2 although there are some reservations, and it is better to use the substrate-bound structure of SIRT3 instead of the available apo-SIRT2 as the target structure." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200590k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200590k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200590k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200590k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200590k&amp;href=/doi/10.1021/jm200590k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 6456-6468</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200768h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200830u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT2</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tero++Huhtiniemi">Tero Huhtiniemi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heikki+S.++Salo">Heikki S. Salo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tiina++Suuronen">Tiina Suuronen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antti++Poso">Antti Poso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antero++Salminen">Antero Salminen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jukka++Lepp%C3%A4nen">Jukka Leppänen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elina++Jarho">Elina Jarho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maija++Lahtela-Kakkonen">Maija Lahtela-Kakkonen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>School of Pharmacy and <sup>§</sup>Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span></div><div class="aff-info" id="aff3"><span class="aff-text">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span></div><div class="aff-info" id="aff4"><span class="aff-text">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div><div class="corresp-info">Tel: +358 40 3553693. Fax: +358 17 162424. E-mail: <a href="/cdn-cgi/l/email-protection#2e664b47454547007d4f42416e5b4b48004847"><span class="__cf_email__" data-cfemail="733b161a18181a5d20121f1c330616155d151a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200590k&amp;href=/doi/10.1021%2Fjm200590k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 6456–6468</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 7, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 December 2010</li><li><span class="item_label"><b>Published</b> online</span>7 September 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 October 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200590k" title="DOI URL">https://doi.org/10.1021/jm200590k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6456%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTero%2BHuhtiniemi%252C%2BHeikki%2BS.%2BSalo%252C%2BTiina%2BSuuronen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D19%26contentID%3Djm200590k%26title%3DStructure-Based%2BDesign%2Bof%2BPseudopeptidic%2BInhibitors%2Bfor%2BSIRT1%2Band%2BSIRT2%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6468%26publicationDate%3DOctober%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200590k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2802</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200590k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tero&quot;,&quot;last_name&quot;:&quot;Huhtiniemi&quot;},{&quot;first_name&quot;:&quot;Heikki&quot;,&quot;last_name&quot;:&quot;S. Salo&quot;},{&quot;first_name&quot;:&quot;Tiina&quot;,&quot;last_name&quot;:&quot;Suuronen&quot;},{&quot;first_name&quot;:&quot;Antti&quot;,&quot;last_name&quot;:&quot;Poso&quot;},{&quot;first_name&quot;:&quot;Antero&quot;,&quot;last_name&quot;:&quot;Salminen&quot;},{&quot;first_name&quot;:&quot;Jukka&quot;,&quot;last_name&quot;:&quot;Leppänen&quot;},{&quot;first_name&quot;:&quot;Elina&quot;,&quot;last_name&quot;:&quot;Jarho&quot;},{&quot;first_name&quot;:&quot;Maija&quot;,&quot;last_name&quot;:&quot;Lahtela-Kakkonen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;6456-6468&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200590k&quot;},&quot;abstract&quot;:&quot;The lack of substrate-bound crystal structures of SIRT1 and SIRT2 complicates the drug design for these targets. In this work, we aim to study whether SIRT3 could serve as a target structure in the design of substrate based pseudopeptidic inhibitors of SIRT1 and SIRT2. We created a binding hypothesis for pseudopeptidic inhibitors, synthesized a series of inhibitors, and studied how well the fulfillment of the binding criteria proposed by the hypothesis correlated with the in vitro inhibitory activities. The chosen approach was further validated by studying docking results between 12 different SIRT3, Sir2Tm, SIRT1 and SIRT2 X-ray structures and homology models in different conformational forms. It was concluded that the created binding hypothesis can be used in the design of the substrate based inhibitors of SIRT1 and SIRT2 although there are some reservations, and it is better to use the substrate-bound structure of SIRT3 instead of the available apo-SIRT2 as the target structure.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200590k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200590k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200590k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200590k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200590k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200590k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200590k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200590k&amp;href=/doi/10.1021/jm200590k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200590k" /></input><a href="/doi/pdf/10.1021/jm200590k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200590k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200590k%26sid%3Dliteratum%253Aachs%26pmid%3D21895016%26genre%3Darticle%26aulast%3DHuhtiniemi%26date%3D2011%26atitle%3DStructure-Based%2BDesign%2Bof%2BPseudopeptidic%2BInhibitors%2Bfor%2BSIRT1%2Band%2BSIRT2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D19%26spage%3D6456%26epage%3D6468%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jmcmar.2011.54.issue-19/production/jmcmar.2011.54.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The lack of substrate-bound crystal structures of SIRT1 and SIRT2 complicates the drug design for these targets. In this work, we aim to study whether SIRT3 could serve as a target structure in the design of substrate based pseudopeptidic inhibitors of SIRT1 and SIRT2. We created a binding hypothesis for pseudopeptidic inhibitors, synthesized a series of inhibitors, and studied how well the fulfillment of the binding criteria proposed by the hypothesis correlated with the in vitro inhibitory activities. The chosen approach was further validated by studying docking results between 12 different SIRT3, Sir2Tm, SIRT1 and SIRT2 X-ray structures and homology models in different conformational forms. It was concluded that the created binding hypothesis can be used in the design of the substrate based inhibitors of SIRT1 and SIRT2 although there are some reservations, and it is better to use the substrate-bound structure of SIRT3 instead of the available apo-SIRT2 as the target structure.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>‡</span> Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mammalian sirtuin family of class III deacetylases (SIRT1-SIRT7) catalyzes the nicotinamide adenine dinucleotide (NAD<sup>+</sup>) dependent deacetylation of <i>N</i><sup>ε</sup>-acetyllysine residues in multiple protein substrates to nicotinamide, <i>O</i>′-acetyl-ADP-ribose (<i>O</i>AADPR) and <i>N</i><sup>ε</sup>-deacetylated lysine. The reversibility of the acetylation state of sirtuin target proteins by acetylases and deacetylases regulates diverse biological processes which have implications in devastating age-related diseases, such as cancer and metabolic, cardiovascular and neurodegenerative diseases.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Thus, it is important to discover small molecular regulators and to study sirtuin functions in cells. The most relevant therapeutic prospects for SIRT1 and SIRT2 inhibitors are for the treatment of cancer, either by inducing cell death or by preventing angiogenesis.<a onclick="showRef(event, 'ref1 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref5 ref6 ref7 ref8 ref9">(1, 5-9)</a> SIRT2 inhibitors have also been demonstrated to rescue proteotoxicity in neurodegenerative diseases.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">Several substrate based peptides have been reported to inhibit sirtuins. The inhibition was gained by replacing the acetyllysine with <i>N</i><sup>ε</sup>-thioacetyl-,<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref18">(12-18)</a><i>N</i><sup>ε</sup>-selenoacetyl-,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><i>N</i><sup>ε</sup>-isovaleryl-,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><i>N</i><sup>ε</sup>-3,3-dimethylacryl-,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> or <i>N</i><sup>ε</sup>-trifluoroacetyllysine.<a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14, 19)</a> However, apart from the acetyllysine analogue, the peptidic inhibitors can have various sequences (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which reflects the fact that sirtuins can deacetylate various substrates.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Recently, we demonstrated that a tripeptide is sufficient length for peptidic SIRT1 inhibitors and that an <i>N</i><sup>α</sup>-acetylated tripeptide has sufficient length for SIRT2 inhibition.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <i>N</i><sup>ε</sup>-Thioacetyllysine containing sirtuin inhibitors with various peptide sequences.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In general, peptidic inhibitors may show advantages over small molecules in terms of specificity and affinity for different targets,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> but unmodified peptides do not possess druglike properties; they are poorly bioavailable and vulnerable to nonspecific enzymatic degradation, which drastically limits their use as pharmacological tools. To move from peptidic toward small molecule inhibitors Suzuki et al. have recently presented a pseudopeptide backbone Cbz-Lys-NH-Ph with <i>N</i><sup>ε</sup>-3-ethoxy-3-oxopropanoyl<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and the <i>N</i><sup>ε</sup>-thioacetyl<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> substitutions at the lysine side chain. Furthermore, the activity of the latter compound was demonstrated in cellular studies. Pseudopeptides have potential to overcome the aforementioned problems with peptides.</div><div class="NLM_p">In order to develop potent pseudopeptidic inhibitors it is important to validate essential substrate–enzyme interactions, which may also define affinity of inhibitors. The available crystal structures are still limited, and for SIRT1 only a comparative model has been reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> For SIRT2, the only reported crystal structure is in the apo form.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The fact that the substrate binding is associated with significant domain movements<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> compromises the value of the available SIRT2 and SIRT1 structures in the structure-based design of inhibitors.</div><div class="NLM_p last">In this work, we aim to study whether SIRT3 could serve as a target structure in design, and help to screen scaffolds for pseudopeptidic inhibitors of SIRT1 and SIRT2. Based on the SIRT3 crystal structure, we have created a binding hypothesis for pseudopeptidic inhibitors. We have synthesized a series of pseudopeptidic SIRT1 and SIRT2 inhibitors and studied how they fulfill the binding hypothesis. The best inhibitors have comparable potency to the peptidic ones.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis routes and reaction conditions are shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. To obtain compound <b>8</b>, the amino terminal of <i>N</i><sup>ε</sup>-Cbz-Lys-OH was protected with a 9-fluorenylmethoxycarbonyl (Fmoc) group to give <b>4</b>. Compound <b>4</b> was taken to solid phase peptide synthesis (SPPS) on Wang resin and cleavage as a methyl ester with a mixture of MeOH, <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) and <i>N</i>,<i>N</i>-dimethylformamide (DMF) gave <b>5</b>. The methyl ester was treated with methylamine (<b>6</b>), and the Cbz group was removed by hydrogenation on palladium (<b>7</b>). Finally, <i>N</i><sup>ε</sup>-thioacetylation of the free amine with ethyl dithioacetate gave compound <b>8</b>. Similarly, the <i>N</i><sup>ε</sup>-thioacetyl group was introduced to <i>N</i><sup>α</sup>-Fmoc-Lys-OH·HCl and <i>N</i><sup>α</sup>-Cbz-Lys-OH to gain compounds <b>12</b> and <b>26</b> respectively. Compounds <b>13</b>–<b>24</b> were synthesized with SPPS on Wang resin using appropriate carboxylic acids, <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (TBTU) and DIPEA in the coupling phase and piperidine for the deprotection. Cleavage from the resin with 1 M NaOH (aq) in dioxane gave a free carboxylic acid, and cleavage with a mixture of MeOH, DIPEA and DMF gave a methyl ester. Compounds <b>27</b>–<b>30</b> were synthesized in solution phase using appropriate amine and TBTU as a coupling reagent. Reference compounds <b>1</b>, <b>2</b>, <b>3</b> and <b>25</b> were synthesized as described previously.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 9-fluorenylmethyl chloroformate, 0 °C to rt, 4 h; (b) solid phase peptide synthesis with Fmoc strategy [(coupling) appropriate carboxylic acid, TBTU, DIPEA, DFM, rt, 1 h; (Fmoc deprotection) 20% piperidine/DMF; (cleavage as –COOH) 1 M NaOH (aq) /dioxane (2:6), rt, 1 h, filtration, 3 M HCl (aq) or (cleavage as –COOCH<sub>3</sub>) DIPEA/MeOH/DMF (1:5:5), heat at reflux, overnight]; (c) 8 M methylamine in EtOH, 100 °C, 20 min; (d) 10% Pd on charcoal, MeOH, rt, overnight; (e) ethyl dithioacetate, EtOH/10% (w/v) Na<sub>2</sub>CO<sub>3</sub> (aq) (3:1), rt, 12–48 h; (f) appropriate amine, TBTU, DMF/pyridine (1:1), 0 °C to rt, 1–2 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Peptidic Inhibitors</h3><div class="NLM_p">We have previously shown that pentapeptide HKK(thioAc)LM (<b>1</b>) and tripeptide KK(thioAc)L (<b>2</b>) give similar inhibitory activity against SIRT1 while compound <b>1</b> is a 24 times more potent SIRT2 inhibitor than compound <b>2</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We have also shown that <i>N</i><sup>α</sup>-acetylated tripeptide Ac-AK(thioAc)A (<b>3</b>) gives good SIRT1 and SIRT2 inhibition.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In order to get a complete picture about the structure activity relationship (SAR) of peptidic inhibitors before the design of pseudopeptidic ones, we synthesized compounds <b>8</b> and <b>13</b>–<b>17</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SIRT1 and SIRT2 Inhibitory Activities of the Peptidic Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="2" align="center">compd</th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"> </th><th class="colsep0 rowsep0" align="center">SIRT1</th><th class="colsep0 rowsep0" align="center">SIRT2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a onclick="showRef(event, 'ref13 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref16">(13, 16)</a></td><td class="colsep0 rowsep0" align="left">HKK(thioAc)LM</td><td class="colsep0 rowsep0" align="left">0.31 (0.27–0.36)</td><td class="colsep0 rowsep0" align="left">6.3 (5.5–7.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></td><td class="colsep0 rowsep0" align="left">KK(thioAc)L</td><td class="colsep0 rowsep0" align="left">0.57 (0.38–0.84)</td><td class="colsep0 rowsep0" align="left">151 (104–218)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></td><td class="colsep0 rowsep0" align="left">Ac-AK(thioAc)A</td><td class="colsep0 rowsep0" align="left">0.24 (0.20–0.28)</td><td class="colsep0 rowsep0" align="left">9.8 (8.7–11)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Ac-AK(thioAc)A-NHMe</td><td class="colsep0 rowsep0" align="left">0.40 (0.35–0.46)</td><td class="colsep0 rowsep0" align="left">2.9 (2.6–3.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Ac-AK(thioAc)A-OMe</td><td class="colsep0 rowsep0" align="left">1.0 (0.82–1.3)</td><td class="colsep0 rowsep0" align="left">13 (9.5–19)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">AK(thioAc)A</td><td class="colsep0 rowsep0" align="left">0.66 (0.60–0.74)</td><td class="colsep0 rowsep0" align="left">36 (29–46)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">K(thioAc)A</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Ac-K(thioAc)A-OMe</td><td class="colsep0 rowsep0" align="left">51 (37–68)</td><td class="colsep0 rowsep0" align="left">862 (417–1782)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ac-PK(thioAc)A</td><td class="colsep0 rowsep0" align="left">0.37 (0.35–0.39)</td><td class="colsep0 rowsep0" align="left">31 (28–33)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Fluor de Lys based assay (repeated at least three times, 95% confidence intervals in parentheses).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">IC<sub>50</sub> was not determined. Inhibition % at 200 μM ± standard deviation (<i>n</i> = 2–3) was 46.9 ± 3.0%.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">IC<sub>50</sub> was not determined. Inhibition % at 200 μM ± standard deviation (<i>n</i> = 2–3) was 2 ± 0.9%.</p></div></div></div><div class="NLM_p">The free carboxyl terminal of compound <b>3</b> was blocked as methyl amide (<b>8</b>) and as methyl ester (<b>13</b>). While SIRT1 slightly favored the free carboxyl terminal (<b>3</b>), SIRT2 inhibition was improved by the additional amide bond at the C-terminus (<b>8</b>). Methyl ester (<b>13</b>) with the least hydrogen bonding sites gave the weakest inhibition of SIRT1 and SIRT2.</div><div class="NLM_p">Because <i>N</i><sup>α</sup>-acetylated tripeptide Ac-AK(thioAc)A (<b>3</b>) had turned out to be a surprisingly good SIRT2 inhibitor compared to tripeptide KK(thioAc)L (<b>2</b>),<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> we examined the inhibitory activity of tripeptide AK(thioAc)A (<b>14</b>). As expected, it was significantly more potent than compound <b>2</b> against SIRT2. This further reinforces the picture that no specific side chains are required for binding but, quite the contrary, some side chains can disrupt it. However, the <i>N</i><sup>α</sup>-acetylated <b>3</b> was more potent than compound <b>14</b>.</div><div class="NLM_p">The K<sup>thioAc</sup>+1 residue is known to be important for inhibitory activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We synthesized compounds <b>15</b> and <b>16</b> in order to study the role of the K<sup>thioAc</sup>–1 residue in binding. Both compounds showed only weak or no inhibitory activity against SIRT1 and SIRT2 compared to compound <b>14</b>. It can be concluded that both residues flanking the thioacetyllysine are needed for binding.</div><div class="NLM_p">In the available X-ray structures cocrystallized with a substrate peptide, the peptide backbone has a change in the orientation at the K<sup>Ac</sup>–1 position (see for example Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a), which may help to stabilize the substrate–protein interaction at the K<sup>Ac</sup>–1 and K<sup>Ac</sup>–2 sites. Compound <b>17</b> with a conformationally restricted Ac-Pro moiety at the N-terminal was found to be nearly equipotent with pentapeptide <b>1</b> and compound <b>3</b> for SIRT1, but slightly less potent for SIRT2. The slight preference for SIRT1 over SIRT2 makes the usage of proline a valid way to restrict conformational orientation of SIRT1 inhibitors.</div><div class="NLM_p last">Based on the peptidic inhibitors, it was concluded that (1) the amide bonds at both sides of the thioacetyllysine need to be preserved to ensure hydrogen bonding and proper orientation of the thioacetyllysine, (2) no side chains of amino acids need to be mimicked, and (3) in order to obtain SIRT2 inhibition, the pseudopeptides should stretch over larger area than tripeptides cover.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Substrate Binding Area and the Creation of the Binding Hypothesis</h3><div class="NLM_p">Although there are no substrate-bound structures for SIRT1 or SIRT2, the key interactions of the substrate–enzyme complex in the vicinity of the acetylated lysine residue are well-defined for example in the crystal structures for SIRT3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and Sir2Tm (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d">2h2d</a>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b, respectively). In the SIRT3 structure the reactive acetyllysine of the substrate is located in a tunnel shaped groove formed between the Rossman fold and the zinc binding domains. The substrate binding has been claimed to induce movement of the two domains relative to each other, which significantly reduces the size of the cavity of the acetyllysine binding site.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The orientation of the substrate backbone is dictated by a hydrogen bond network between the substrate main chain and the backbone of protein residues Gly295, Glu296, Glu323 and Glu325 (SIRT3 numbering) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a). The reactive acetyllysine is oriented toward the NAD<sup>+</sup> binding site by a hydrogen bond of the acetyl carbonyl with Val292. In addition, at the K<sup>Ac</sup>–2 position, the substrate potentially has a water molecule mediated hydrogen bond with Leu298.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of (a) SIRT3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and (b) Sir2Tm (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d">2h2d</a>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> showing the substrate binding site around the acetylated lysine. (c) The sequence homology of SIRT1–3 and Sir2Tm in the binding site area.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Comparison of the SIRT3 structure to the crystal structure of the Sir2Tm substrate complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d">2h2d</a>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b) indicates that small differences in the binding site sequences (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c) do not lead to any significant changes in the substrate binding orientations. The interaction pattern between substrates and proteins is similar in SIRT3 and Sir2Tm structures, and consists mainly of main chain interactions. It is assumed that this can be generalized to the active sites of SIRT1 and SIRT2.</div><div class="NLM_p">Substrate-bound SIRT3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>) was used as a target structure to study the substrate binding area. Based on the peptide modifications and substrate-bound crystal structures, it was obvious that only main chain interactions were critical for the substrate binding. However, we wanted to get a more detailed insight on the substrate binding site in order to design potent pseudopeptidic inhibitors for sirtuins. Two virtual libraries of various possible pseudopeptides were created by attaching various chemical structures to the terminals of a thioacetyllysine amino acid. The libraries were docked in the crystal structure of SIRT3 to study the chemical space of molecules that can be docked to the substrate binding site allowing the thioacetyllysine to be placed similarly as the acetyllysine in the X-ray structure. A binding hypothesis for pseudopeptidic inhibitors was generated based on the docking results (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a–e).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The binding hypothesis represented with wire spheres for pseudopeptidic inhibitors. (a) The molecular structure (green carbon atoms) represents the binding mode of the peptide cocrystallized with SIRT3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>). (b) The key hydrogen bonds formed by the acetylated lysine in the SIRT3 (blue and magenta spheres). (c) N-Terminal modification from the virtual database screening that forms a hydrogen bond to Leu298 (blue sphere) and fills a cavity surrounded by residues Pro297, Leu298, Phe302 and Leu303 (green sphere). (d, e) Possibility for aromatic interactions found from the virtual database screening (orange spheres).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Interaction Criteria Proposed by the Binding Hypothesis</h3><div class="NLM_p last">Hydrogen bonds observed from the acetylated lysine in the SIRT3 crystal structure to Val292, Gly295, Glu296 and Glu325 were assumed to be vital for the proper orientation of the acetylated lysine (Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). A change in the substrate peptide backbone orientation is seen at the K<sup>Ac</sup>–1 glycine residue position (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a). This change in the orientation places the backbone to a crevice between residues Pro297 and Pro326. The crevice between residues Pro297 and Pro326 leads to a small cavity formed by residues Pro297, Leu298, Gln300, Phe302 and Leu303 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). It was hypothesized that binding affinity could possibly be increased by occupying the cavity with an appropriate structure and that Leu298 could offer an additional hydrogen bonding site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c), although the substrate peptide in the crystal structure did not form a direct hydrogen bond at this location. On the C-terminal side, it was noted that the location of the amino acid Phe294 could offer a possibility for aromatic interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>d,e). In addition, the backbone amine of Glu325 could serve as an additional hydrogen bonding partner.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Analysis of the in Vitro Results in Light of Molecular Docking</h3><div class="NLM_p">A series of pseudopeptides was designed (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The first group of compounds has <span class="smallcaps smallerCapital">l</span>-alanine at the C-terminal site of the thioacetyllysine residue and various N-terminal modifications. The second group has the benzyloxycarbonyl group at the N-terminal site of the thioacetyllysine residue and various C-terminal modifications. The N- and C-terminal modifications consist of non-natural peptidic fragments (<b>18</b>, <b>19</b>), known structures and their modifications (<b>20</b>, <b>21</b>, <b>25</b>, <b>27</b>), structures with different H-bonding properties (<b>22</b>, <b>23</b>, <b>28</b>, <b>29</b>) and structures from the virtual libraries selected based on the binding hypothesis (<b>24</b>, <b>30</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. The Studied N- and C-Terminal Fragments and in Vitro Inhibitory Activities of the Synthesized Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0006.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Fluor de Lys based assay (repeated at least three times, 95% confidence intervals in parentheses).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> was not determined. Inhibition % at 200 μM ± standard deviation (<i>n</i> = 2–3) was 22.4 ± 3.0.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> was not determined. Inhibition % at 200 μM ± standard deviation (<i>n</i> = 2–3) was 57.2 ± 1.4.</p></div></div><div></div></div><div class="NLM_p">The docking poses are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> (see Figure S1 in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for additional figures). The Glide scores (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) represent the overall docking score, while the per-residue scores are listed to present hydrogen bond patterns of the docking poses. The root-mean-square deviation (rmsd) value represents the similarity of the thioacetylated lysine poses of the docked compounds to the cocrystallized acetylated lysine (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>). The in vitro inhibitory activities are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The docking poses of the pseudopeptides. The interactions were predicted with the Ligand Interactions tool available in MOE.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (a) The docking poses of compounds <b>18</b> and <b>24</b> showed binding to the crevice between Pro297 and Pro326, positioning of the <i>tert</i>-butyl groups in a pocket surrounded by residues Pro297, Leu298, Gln300, Phe302 and Leu303 and hydrogen bonding to Leu298. (b) The docking poses of compounds <b>20</b> (cyan) and <b>21</b> (green). (c) The docking poses of compounds <b>22</b> (orange) and <b>23</b> (cyan) compared to compound <b>21</b> (green). Compound <b>23</b> was hydrogen bonded to Gly295. (d) The docking pose of compound <b>30</b> showing aromatic interactions with Phe294 and hydrogen bonding to Glu325. The best ranked pose (green) had the N-terminal amide in the <i>cis</i>-form while the second ranked pose (cyan) had the N-terminal amide in the <i>trans</i>-form. However, the poses of the C-terminal fragment were identical. (e) The docking poses of compounds <b>25</b> (green) and <b>27</b> (cyan) placed the cyclohexyl and phenyl moieties in the same location. (f) The docking poses of compounds <b>25</b> (green), <b>28</b> (cyan) and <b>29</b> (dark cyan) with the overlaid phenyl moieties. The hydrogen bond acceptors hydroxyl and fluorine are toward the backbone amine of Glu325.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. The Glide Docking Results of the Pseudopeptide Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Glide gscore</th><th class="colsep0 rowsep0" align="center" char=".">Glu325 hbond</th><th class="colsep0 rowsep0" align="center" char=".">Leu298 hbond</th><th class="colsep0 rowsep0" align="center" char=".">Glu296 hbond</th><th class="colsep0 rowsep0" align="center" char=".">Gly295 hbond</th><th class="colsep0 rowsep0" align="center" char=".">Val292 hbond</th><th class="colsep0 rowsep0" align="center" char=".">subset rmsd<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.85</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">–0.72</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–0.94</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.06</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–0.96</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.47</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.41</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–0.85</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.66</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–0.96</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.81</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–2.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">–9.71</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–0.96</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.28</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.60</td><td class="colsep0 rowsep0" align="char" char=".">–2.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.97</td><td class="colsep0 rowsep0" align="char" char=".">–2.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">–1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Rmsd calculated between the common core substructure of the compounds and the substrate peptide. The common core structure was defined by the SMARTS pattern C(═O)NC(CCCCNCC)(C(═O)N).</p></div></div></div><div class="NLM_p">Compounds <b>18</b> and <b>24</b> have the Boc-<span class="smallcaps smallerCapital">l</span>-alanine and Boc-piperidine-3-carbonyl fragments at the N-terminus, respectively. The Boc-piperidine-3-carbonyl fragment was chosen among the fragments in the previously created virtual libraries and was used in the formation of the binding hypothesis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). Compounds <b>18</b> and <b>24</b> were synthesized to test the hypothesis that the shape of the receptor surface on the N-terminal side allows the size of the N-terminal modification to be increased. The docking poses of these compounds showed the N-terminal fragment binding through the crevice, placing the <i>tert</i>-butyl moiety in the small cavity and the carbamate carbonyl H-bonded with Leu298 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Thus, these compounds fulfilled all the N-terminal binding criteria proposed by the binding hypothesis and are the two most potent compounds in the series of the N-terminal modifications. Compared to Ac-AK(thioAc)A peptide (<b>3</b>), compounds <b>18</b> and <b>24</b> showed equipotent SIRT2 inhibitory activity and slightly reduced SIRT1 inhibitory activity. For complementary binders, the increase in size usually increases the inhibitory activity; therefore, it may be that the binding conformation of compounds <b>18</b> and <b>24</b> is not optimal for SIRT1 and SIRT2.</div><div class="NLM_p">One <span class="smallcaps smallerCapital">d</span>-amino acid was chosen into the set of N-terminal modifications. <span class="smallcaps smallerCapital">d</span>-Phenylalanine in compound <b>19</b> has two atoms between the phenyl and carbonyl groups as has the Cbz group, a known N-terminal fragment.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In the docking calculations the free amino terminal of the <span class="smallcaps smallerCapital">d</span>-phenylalanine showed H-bonding to Gly295 but the phenyl group was not placed in the crevice between Pro297 and Pro326 and no hydrogen bonding to Leu298 was formed (see Figure S1 in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). This compound did not fulfill any of the criteria proposed by the binding hypothesis, and it is also the least active compound in the series of N-terminal modifications. The additional H-bond to Gly295 seen in the docking to SIRT3 does not correlate well with the inhibitory activity toward SIRT1 or SIRT2.</div><div class="NLM_p">In order to gain more insight into the effect of modifications in the N-terminal, docking studies were carried out for compounds <b>20</b>–<b>23</b>. The N-terminal Cbz group (<b>20</b>) has been presented by Suzuki et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In compound <b>21</b>, the Cbz group was replaced by the 3-phenylpropanoyl group. This modification was made in order to study whether the removal of the oxygen in the chain affects the activity. Docking calculations did not show any significant differences in the binding of these compounds, and the N-terminal structures were well superimposed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). Both compounds bind to the crevice but do not reach all the way to the cavity and do not form an H-bond to Leu298 thus fulfilling one of the three binding criteria. The rmsd values illustrating the similarity of the lysine orientation were small for both compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compared to compound <b>20</b>, compound <b>21</b> had equipotent SIRT1 but slightly decreased SIRT2 inhibitory activity. This decrease in the activity cannot be explained by docking to SIRT3.</div><div class="NLM_p">Compound <b>21</b> was further modified by additional hydrogen bonding groups (<b>22</b> and <b>23</b>). The position of the phenyl group of compound <b>22</b> is slightly different compared to compound <b>21</b> but is still positioned to the crevice (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c). The placement of fluorine could allow H-bonding to Leu298, but the GlideScore scoring function does not consider fluorine as a hydrogen bond acceptor. The SIRT1 in vitro results do not support Leu298 H-bonding, but in the case of SIRT2 it cannot be excluded. The docking pose of compound <b>23</b> to the SIRT3 is different compared to compound <b>21</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c). The phenyl group is not positioned to the crevice, and the hydroxyl group forms an H-bond to Gly295. However, the in vitro results are similar for these compounds and, again, the additional hydrogen bond to Gly295 found in the pose is not supported by the in vitro activities. It is possible that the docking pose of <b>23</b> to SIRT3 may not represent the binding to SIRT1 or SIRT2.</div><div class="NLM_p">The C-terminal modification in compound <b>30</b> was chosen among the fragments in the previously created virtual libraries and was used in the creation of the binding hypothesis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>e). The docking pose of compound <b>30</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d) positions the ketone carbonyl to form a hydrogen bond to Glu325. When the pose was analyzed with the Ligand Interaction tool of MOE (version 2009.10),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> the adjacent phenyl ring was predicted to have aromatic interactions with Phe294. This compound fulfills both binding criteria for the C-terminal binding proposed by the binding hypothesis and is the most potent compound in the series of C-terminal modifications.</div><div class="NLM_p">When the previously published compound <b>25</b><a onclick="showRef(event, 'ref15 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref17">(15, 17)</a> is compared to compound <b>30</b>, it is seen that the phenyl group is positioned differently (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>e). Compound <b>25</b> also lacks the H-bond to Glu325. The differences in the docking poses are reflected by the in vitro inhibitory activities; compound <b>30</b> was more potent than compound <b>25</b> against both enzymes. The Ligand Interaction tool of MOE did not detect aromatic interactions between the phenyl ring of <b>25</b> and Phe294. However, when the phenyl group was replaced by a cyclohexyl group (<b>27</b>), the inhibitory activity against SIRT1 and SIRT2 decreased. This proved the importance of the phenyl group even though the docking scores and the per-residue hydrogen bonding scores were nearly equal for these compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>e). It may be that the receptor flexibility allows aromatic interactions of the phenyl group with Phe294 although the interaction may not be as optimal as for compound <b>30</b>. However, compound <b>27</b> with the cyclohexyl group at the C-terminus does not fulfill the criteria of the aromatic interactions or the H-bond to Glu325 and is the least active compound in the series.</div><div class="NLM_p">Compounds <b>28</b> and <b>29</b> are derivatives of compound <b>25</b> with an additional hydrogen bonding group. The docking poses of compounds <b>25</b>, <b>28</b> and <b>29</b> were well superimposed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>f). The C-terminal phenyl group of all three compounds had similar position and orientation. The position of the hydroxyl oxygen of compound <b>29</b> allowed hydrogen bond formation to residue Glu325, and slight improvement is also seen in the inhibitory activities. The fluorine of compound <b>28</b> is also in a position that allows hydrogen bonding to the backbone amine of Glu325, but no effect on the inhibitory activities was observed. No hydrogen bonding scores were seen, either, in the per-residue scores (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), but this is because the GlideScore scoring function does not consider fluorine as a hydrogen bond acceptor.</div><div class="NLM_p">The binding hypothesis created by using SIRT3 structure seems to predict quite well binding to SIRT1 and SIRT2 although there are some reservations. The most active N- and C-terminal modifications (<b>18</b>, <b>24</b> and <b>30</b>) fulfilled all the binding criteria proposed by the hypothesis while the least active modifications (<b>19</b> and <b>27</b>) failed to fulfill them. On the N-terminal side, the occupation of the cavity seemed to be important for SIRT2 while SIRT1 can be inhibited with shorter compounds. This is well in line with the SAR of the peptidic inhibitors. Hydrogen bonding to Leu298 in the SIRT3 structure does not seem to correlate with SIRT1 in vitro activity, while some correlation in the case of SIRT2 was seen. The proposed hydrogen bonding of compounds <b>19</b> and <b>23</b> to Gly295 was not supported by the in vitro results. On the C-terminal side, both the hydrogen bonding to Glu325 and the aromatic interactions with Phe294 in the SIRT3 structure predicted good inhibitory activities for SIRT1 and SIRT2 inhibitors. The proposed binding hypothesis can be used in the design of SIRT1 and SIRT2 inhibitors although all affinity differences between these two targets cannot be explained. This would require detailed structural data on the SIRT1 and SIRT2 substrate binding sites in the substrate binding conformation, but because of the lack of crystal structures, this data is not available.</div><div class="NLM_p last">There are 11 globular isoforms of human histone deacetylases (HDACs) with conical pockets that fit acetylated lysine residues. The pseudopeptidic compounds were tested on a mixture of class I and class II HDACs to study inhibition among HDACs. The compounds did not show high inhibition activities in the HDAC assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>27</b> was the only compound that showed some response.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Sensitivity of the Modeling Approach To Target Protein Differences</h3><div class="NLM_p">In order to test how sensitive the used molecular docking approach is to sequence differences, the synthesized compounds (excluding compound <b>2</b>) were docked again to several sirtuin X-ray structures and two homology models representing different conformational forms. These structures included four different SIRT3 X-ray structures, one SIRT2 X-ray structure, one SIRT2 homology model, one SIRT1 homology model and five Sir2Tm structures. The homology models of SIRT1 and SIRT2 were based on the substrate binding X-ray structures of SIRT3. The target set included one apo structure from each protein.</div><div class="NLM_p">The resulting docking poses were visually analyzed to see whether the synthesized compounds fulfill the hydrogen bonding network of the thioacetyllysine (see Figures S2–S13 in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for the docking poses). The docking results are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The results of SIRT3, Sir2Tm and SIRT1 calculations indicated that the obtained docking poses are not sensitive to small sequence differences. The compounds could be docked into correct docking poses with a high success rate on all of these proteins. However, the protein conformation seemed to have a bigger effect on the docking results. Dependence of the success rate on the conformation variation was observed on SIRT3 and Sir2Tm proteins. When the apo conformations of SIRT3, SIRT2, and Sir2Tm were used as the docking targets, none of the docked compounds resulted in a correct pose. This can be explained by the significant conformation difference and enlargement of the binding site cavity, caused by the movement of the two large domains.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The success rate was increased on SIRT2 when the homology model was used. However, a lower success rate was obtained with the SIRT2 model than with the SIRT1 model. The results do not explain whether the lower success rate is caused by sequence differences or by not optimally placed side chains of the SIRT2 model.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. The Number of Successfully Docked Compounds on Various SIRT3, SIRT2 and Sir2Tm Crystal Structures and SIRT1 and SIRT2 Models<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PDB code</th><th class="colsep0 rowsep0" align="center">protein</th><th class="colsep0 rowsep0" align="center">cocrystallized substrate</th><th class="colsep0 rowsep0" align="center">no. of successfully docked compounds</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a></td><td class="colsep0 rowsep0" align="left">SIRT3</td><td class="colsep0 rowsep0" align="left">AceCS2-K<sup>Ac</sup></td><td class="colsep0 rowsep0" align="left">18/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gls">3gls</a></td><td class="colsep0 rowsep0" align="left">SIRT3</td><td class="colsep0 rowsep0" align="left">apo</td><td class="colsep0 rowsep0" align="left">0/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glt">3glt</a></td><td class="colsep0 rowsep0" align="left">SIRT3</td><td class="colsep0 rowsep0" align="left">AceCS2-K<sup>Ac</sup>-ADPR</td><td class="colsep0 rowsep0" align="left">13/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glu">3glu</a></td><td class="colsep0 rowsep0" align="left">SIRT3</td><td class="colsep0 rowsep0" align="left">AceCS2</td><td class="colsep0 rowsep0" align="left">18/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f">1j8f</a></td><td class="colsep0 rowsep0" align="left">SIRT2</td><td class="colsep0 rowsep0" align="left">apo</td><td class="colsep0 rowsep0" align="left">0/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d">2h2d</a></td><td class="colsep0 rowsep0" align="left">Sir2Tm</td><td class="colsep0 rowsep0" align="left">p53-K382<sup>Ac</sup></td><td class="colsep0 rowsep0" align="left">19/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2f">2h2f</a></td><td class="colsep0 rowsep0" align="left">Sir2Tm</td><td class="colsep0 rowsep0" align="left">p53-K382</td><td class="colsep0 rowsep0" align="left">19/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2g">2h2g</a></td><td class="colsep0 rowsep0" align="left">Sir2Tm</td><td class="colsep0 rowsep0" align="left">H3-K115<sup>Ac</sup></td><td class="colsep0 rowsep0" align="left">18/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2h">2h2h</a></td><td class="colsep0 rowsep0" align="left">Sir2Tm</td><td class="colsep0 rowsep0" align="left">H4-K79<sup>Ac</sup></td><td class="colsep0 rowsep0" align="left">18/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2i">2h2i</a></td><td class="colsep0 rowsep0" align="left">Sir2Tm</td><td class="colsep0 rowsep0" align="left">apo</td><td class="colsep0 rowsep0" align="left">0/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">model</td><td class="colsep0 rowsep0" align="left">SIRT1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">18/20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">model</td><td class="colsep0 rowsep0" align="left">SIRT2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8/20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">In order to be considered as a successful docking pose, the thioacetyllysine had to form the three hydrogen bonds seen in substrate-bound sirtuin structures (e.g. PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr.pdb">3glr</a>).</p></div></div></div><div class="NLM_p last">The results of this analysis gave further justification for our choice to use the SIRT3 crystal structure complexed with AceCS2-K<sup>Ac</sup> substrate. As the small sequence differences in the substrate binding site did not seem to affect significantly the docking poses, the results can be postulated to give a somewhat reasonable prediction on the binding poses also on SIRT1 and SIRT2. The in vitro results supported these assumptions as several new active inhibitors were discovered in the process.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Inhibition of SIRT1 Activity in Cell Culture Models</h3><div class="NLM_p">To examine if the compounds are also active at the cellular level, we used Western blot analysis to detect the changes in acetylation level of p53 after etoposide-induced DNA damage in three different cell types. SIRT1 is known to be involved in deacetylation of p53 at those conditions.<a onclick="showRef(event, 'ref15 ref27'); return false;" href="javascript:void(0);" class="ref ref15 ref27">(15, 27)</a> The effect of compounds <b>20</b>, <b>24</b> and <b>30</b> on p53 acetylation rate in cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) is in accordance with the in vitro inhibition profile of SIRT1. Those compounds were not toxic to cells at concentrations used (data not shown).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of SIRT1 activity increases p53 acetylation after DNA damage. (A) Effect of 10 μM compound <b>30</b> on p53 acetylation after 100 μM etoposide (eto) treatment for 5 h in three different cell lines. (B) Effect of 10 μM compound <b>20</b> and 10 or 100 μM compound <b>24</b> on p53 acetylation after 100 μM etoposide treatment for 5 h in SH-SY5Y cells. + present; – absent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Structure-based computational design approach was successfully applied in the design of <i>N</i><sup>ε</sup>-thioacetyllysine containing pseudopeptidic inhibitors of SIRT1 and SIRT2. Several designed pseudopeptidic inhibitors maintained the potency comparable to the peptidic inhibitors. Those N- and C-terminal fragments which gave the best inhibitory activities were the same fragments that fulfilled all the interaction criteria proposed by the binding hypothesis. On the other hand, those fragments which did not fulfill the set criteria gave the least active compounds. The pseudopeptides were shown to inhibit class III HDACs (SIRT1 and SIRT2), however no high inhibition responses were observed in an assay that contained a mixture of class I and class II HDACs. Compounds <b>20</b>, <b>24</b> and <b>30</b> demonstrated SIRT1 inhibition also in cultured cells. It was concluded that the homologous SIRT3 structure can be used for designing substrate based inhibitors of SIRT1 and SIRT2. On the other hand, the available experimental SIRT2 structure in the apo conformation is not suitable for the design of substrate based modulators as the sirtuins undergo significant conformational changes upon substrate binding.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> The Virtual Databases</h3><div class="NLM_p">The first virtual database was created using the RECAP synthesis tool of MOE (Molecular Operating Environment) version 2008.10.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The thioacetyllysine structure was used as a root structure in the RECAP synthesis process, and molecular fragments were attached to both terminals of the thioacetyllysine. The fragments were taken from a small-size fragment subset of the RECAP fragment database provided with MOE. The subset contained all fragments of size 12 or less heavy atoms from the MOE RECAP database. The RECAP synthesis process was run with default settings except the size limit was increased to 35 heavy atoms with default value of 11 for the standard deviation setting. The Leadlike filter was left on, and no exclusion for the reactive compounds was done. The RECAP synthesis was set to continue until 10000 compounds or 1000000 repeated attempts had been performed. The thioacetyllysine structure was set as a root structure by placing the structure in a MOE database and by forcing the root structure to be always selected from this database. The weight setting, which defines the probability that a fragment is selected from this database, was set to 0 for the root database and 1 for the small size fragment database, forcing the fragments to be selected from the latter. Overall 10000 structures were generated. Hydrogens were added to the created molecules using the Database Wash function in MOE. Prior to subjecting the ligands to docking, the compounds were preprocessed with Ligprep (version 2.3).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The molecules were imported to Ligprep in sdf format. The ionization and tautomeric states were determined with EPIK<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (version 2.0) in pH of 7 ± 2. OPLS2005 force field was used for the geometric optimization.</div><div class="NLM_p last">The second virtual database was created using CombiGlide (version 2.5).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The fragment ideas were obtained from a list of selected structure sets available from the chemical vendor Sigma-Aldrich. The carboxylic acid containing fragments were downloaded in sdf format from the Sigma-Aldrich web page (<a href="http://www.sigmaaldrich.com/chemistry/chemistry-services/selected-structure.html" class="extLink">http://www.sigmaaldrich.com/chemistry/chemistry-services/selected-structure.html</a>, accessed January 27th, 2010). The carboxylic acid fragments were prepared with the Reagent Preparation process of CombiGlide. The carboxylic acid group was defined as the reactive functional group. No changes to the ionization, tautomerization and steroisomer states of the fragments were made at this point. Thioacetyllysine–alanine structure, used as a core structure in the CombiGlide process, was built and energy minimized in MOE (version 2009.10)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and later prepared with Ligprep (version 2.3)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> using OPLS2005 forcefield for geometric optimization. The fragments were attached to the N-terminal of the core structure using the Combinatorial Library Enumeration tool of CombiGlide. Overall 6748 structures were generated. Prior to subjecting the structures to docking they were prepared with Ligprep. OPLS2005 force field was used for geometric optimization, all possible protonation and tautomeric states were generated with EPIK at pH 7 ± 2 and chiralities if defined were taken from the 3D structure.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> The Docking Calculations</h3><div class="NLM_p">The docking calculations were performed using Glide (version 5.5)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> molecular docking program. The X-ray crystal structure of human SIRT3 protein complexed with an acetylated lysine structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr.pdb">3glr</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> was used as a target in the docking calculations performed on the virtual databases. The protein structure was prepared using the Protein Preparation Wizard available in the Schrödinger Suite 2009.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The PDB structure was downloaded from <a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a> using the Import command of the Protein Preparation Wizard (PDB download date December 18th, 2009). In the preprocess phase of the Protein Preparation Wizard the bond orders were assigned, hydrogens were added, distant water molecules were removed, metals were treated and overlaps were detected. Later all water molecules and HET groups except the zinc were removed. Exhaustive sampling method was used to optimize the hydrogen bonding and determine the orientations of hydroxyl groups, amide groups of Asn and Gln amino acids, and the proper state and orientations of the histidine imidazole rings. Finally a restrained minimization was performed using OPLS2001 force field, with a 0.3 Å rmsd atom displacement limit.</div><div class="NLM_p">The prepared protein structure was used in the receptor grid generation process. The acetyllysine containing peptide was defined as a ligand to be excluded, and the peptide defined the grid box location and the size of the outer box. Default values were used for all the other available options and settings for the grid calculations.</div><div class="NLM_p">The same receptor grid files were used in the docking calculations of both virtual databases. The dockings were performed using the SP (standard precision) precision option. The compounds were docked flexibly using the options that allow the algorithm to sample ring conformations but penalize the nonplanar amide bond torsion angles. 50 poses of each docked compound were subjected to post docking minimization. The other options and settings were left at their default values.</div><div class="NLM_p">The synthesized and tested pseudopeptides were subjected to docking calculations. The molecular structures were exported in sdf format from a ChemBioOffice<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> database and prepared using Ligprep (version 2.3).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> OPLS2005 force field was used for geometric optimization, and all possible ionization and tautomeric forms were created at pH 7 ± 2 using EPIK.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The chiralities specified in the input structures were retained. The same grid files were used in the dockings as in the virtual library dockings. The dockings were performed using the SP precision settings treating the compounds as flexible. The ring conformations were allowed to be sampled and nonplanar amide bond torsions penalized to favor planar conformations. 50 poses of each ligand were subjected to postdocking minimization, and an option for adding a strain correction term if the strain crossed the default strain limit was set on. The best ranked pose of each docked ligand was included in the analysis.</div><div class="NLM_p last">In order to test whether the docking results can be somewhat generalized to other sirtuin structures with differences in the conformations and in the amino acid sequences, the 20 different tested compounds (<b>1</b>, <b>3</b>, <b>8</b>, <b>13</b>–<b>25</b> and <b>27</b>–<b>30</b>) were docked to 4 human SIRT3 X-ray structures (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gls">3gls</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glt">3glt</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glu">3glu</a>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> to 5 Sir2Tm X-ray structures (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d">2h2d</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2f">2h2f</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2g">2h2g</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2h">2h2h</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2i">2h2i</a>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to the only available SIRT2 X-ray crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f">1j8f</a>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (the PDB files were downloaded between June 1 and June 3, 2010) and to homology models of SIRT1 and SIRT2. The homology models were built using MODELER in Discover Studio.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The templates used for the homology models were the crystal structure of SIRT3 with substrate (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glt">3glt</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glu">3glu</a>). Several models were generated, and side chains were optimized. The model with the smallest rmsd compared to <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a> was chosen for dockings. The protein structures were prepared with Schrödinger Suite 2009 (Update 2) Protein Preparation Wizard<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in a similar automated fashion that was used for preparing the protein used in the virtual database dockings. The ligands were treated with Ligprep (version 2.3)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> as described earlier. The grid box center for SIRT3 proteins was defined based on the amino acids Pro297, Pro326 and Phe294 for SIRT3 structures. Also the dockings for the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a> crystal structure were repeated using the same grid box center in order to improve the comparability of the docking results. The corresponding amino acids were also used for defining the grid box center on the Sir2Tm, SIRT1 and SIRT2 proteins. The dockings were performed with the same Glide settings as the earlier dockings.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Result Analysis and Figure Preparation</h3><div class="NLM_p">The figures of the crystal structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr.pdb">3glr</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d.pdb">2h2d</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) were prepared using MOE (version 2009.10).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Prior to the figure preparation, the structures were treated using the Protein Preparation Wizard (Schrödinger Suite 2009 Update 2).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This included bond order assignment, addition of hydrogens, removal of water molecules and heteroatomic groups. For the SIRT3 structure a water molecule close to amino acid Leu298 was not removed, and the zinc atoms for both structures were left untouched. The Ligand Interactions tool in MOE was used for predicting the interactions between the substrate peptides and their protein counterparts. The protein sequences for the sequence alignment were obtained from the UniprotKB<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> database (access date July 8, 2010). The sequence alignment was made with the online Clustalw2 (version 2.0.12)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> alignment tool available at the UniprotKB web page. The alignment figure was prepared using Jalview (version 2.5.1).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The graphical effects on the final figure were prepared with Inkscape (version 0.47).</div><div class="NLM_p">The binding mode hypothesis figure (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) was prepared using MOE (version 2009.10).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The protein structure in the figure is the one used in the virtual database screening. MOE pharmacophore annotations were used for describing the hypothesized interactions. The graphical effects on the figure were prepared using Gimp version 2.2.13 and ImageMagick version 6.5.1–0.</div><div class="NLM_p">The figures describing the docking poses (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were prepared using MOE (version 2009.10).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The interactions in the figures including the hydrogen bond possibilities and aromatic interactions were analyzed and visualized using the Ligand Interaction module available in MOE. The score limit for presenting a hydrogen bond was set to 10%. The figure labels were added with ImageMagick version 6.5.1–0.</div><div class="NLM_p last">Hydrogen bond scoring of Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> is based on the per-residue interaction scoring output of Glide. The rmsd value of Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> is a rmsd between a common substructure of the peptide substrate of the crystal structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a> and the synthesized ligands, defined with a SMARTS pattern C(═O)NC(CCCCNCC)(C(═O)N). The rmsd calculation was performed with a Schrödinger script rmsd.py (version 1.14.2.6)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> downloaded from the Schrodinger Script Center Web site (<a href="http://www.schrodinger.com/scriptcenter" class="extLink">http://www.schrodinger.com/scriptcenter</a>, access date June 23th, 2010).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p last">All reagents and solvents were commercial high purity quality. Purification of products <b>8</b>, <b>13</b>, <b>16</b>–<b>18</b>, <b>20</b>–<b>24</b> and <b>27</b>–<b>30</b> was performed by CombiFlash column chromatography on normal phase silica (average particle size, 35 to 70 μm; mesh, 230 to 400; average pore size, 60 Å) or by crystallization methods. Compounds <b>14</b>, <b>15</b> and <b>19</b> were purified by preparative HPLC (Shimadzu LC-10Avp (Shimadzu, Kyoto, Japan)) on a reverse phase C18 column (Supelcogel ODP-50, 25 cm × 21.2 mm, 5 μm) with a linear gradient of 5–90% solvent B (0.05%acetic acid/acetonitrile) in solvent A (0.05 acetic acid/H<sub>2</sub>O) in 30 min with the flow rate 10 mL/min. The peptide was detected by UV at λ = 215 nm. NMR spectra were recorded on a Bruker Avance 500 AV (Bruker Biospin, Switzerland) 500.1 MHz for <sup>1</sup>H and 125.8 MHz for <sup>13</sup>C. The chemical shifts are expressed in ppm relative to the shift of used solvent as an internal standard (<sup>1</sup>H NMR, DMSO at 2.50 ppm, CH<sub>3</sub>OH at 3.31 ppm and CHCl<sub>3</sub> at 7.26 ppm; <sup>13</sup>C NMR, (CD<sub>3</sub>)<sub>2</sub>SO at 39.52 ppm, CD<sub>3</sub>OD at 49.00 ppm and CDCl<sub>3</sub> at 77.16 ppm). Positive ion mass spectra were acquired with a quadrupole ion trap mass spectrometer (Finnigan MAT, San Jose, CA) equipped with an electrospray ionization source (ESI-MS). The purity of compound <b>14</b> was determined using Agilent 1100 HPLC (Agilent Technologies Inc., Waldbronn, Karlsruhe, Germany) with diode array detection, using reversed phase column (Zorbax Eclipse XDB C 18, 4.6 × 50 mm, 1.8 μm, Agilent Technologies, Palo Alto, CA, USA), 5% solvent B (0.05% AcOH in CH<sub>3</sub>CN) in solvent A (0.05% AcOH in H<sub>2</sub>O) for 5 min, then linear gradient 5–80% B in A in 15 min with the flow rate 1 mL/min. The purity of compound <b>15</b> was determined using Shimadzu LC-10Avp (Shimadzu, Kyoto, Japan), using a reverse phase column (Supelcogel ODP-50 C 18, 4 × 150 mm, 5 μm), with an isocratic eluent (0.05% AcOH, 2.5% MeOH, 97.45% H<sub>2</sub>0) in 30 min with the flow rate 1 mL/min. The purity of the rest of the compounds was determined by combustion analysis for CHN by Thermo Quest CE Instruments EA 1110 CHNS-O elemental analyzer. Peptide <b>14</b> showed 93% purity, and all other compounds had purity of ≥95%.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Manual Solid Phase Peptide Synthesis (SPPS)</h3><div class="NLM_p last">Wang resin (polymer-bound <i>p</i>-alkoxybenzyl alcohol) was used as solid support for the peptide synthesis of compounds <b>5</b> and <b>13</b>–<b>24</b>. Solid phase synthesis was performed in a 10 mL syringe equipped with a frit. Fmoc-Ala-Wang resin (loading 0.4–0.8 mmol/g) was swelled for 1 h in 3 mL of DMF. In the deprotection phase, the <i>N</i><sup>α</sup>-Fmoc protection group was removed with 5 mL of 20% (V/V) piperidine in DMF for 15 min and the resin was rinsed 5 times with DMF. In the coupling phase, the following <i>N</i><sup>α</sup>-Fmoc-amino acid or acetic acid (2–4 equiv) was preactivated (1–3 min) with the coupling reagent TBTU (2–4 equiv) and DIPEA (5–10 equiv) in 3–5 mL of DMF. This solution was added on the resin, and the syringe was shaken at rt for 60 min. Then the resin was rinsed 5 times with DMF. The cycle of Fmoc-deprotection and coupling was repeated until the desired resin-bound peptide was completed. Before cleavage from the resin, the resin was washed once with AcOH, five times with dichloromethane (DCM), and once with MeOH to remove the excess solvents and then dried under vacuum.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Cleavage of Peptide-Resin as Carboxylic Acid</h3><div class="NLM_p last">The dried peptide-resin was preswelled in dioxane for 15 min. The excess of dioxane was removed, and 8 mL of cool (0 °C) cleavage mixture of 1 M NaOH (aq)/dioxane (2 and 6 mL) was added on the peptide-resin. The reaction mixture was shaken for 1 h at rt. The mixture was filtrated, the filtrate was collected and the resin was washed with H<sub>2</sub>O/dioxane (1:3), dioxane and H<sub>2</sub>O. The filtrate was neutralized with 3 M HCl (aq), and the solvents were evaporated. Acetone was added on the residue, and the mixture was filtrated to remove inorganic salts. The solvent of the filtrate was evaporated under reduced pressure to yield the crude product, which was purified by column chromatography or by crystallization.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cleavage of Peptide-Resin as Methyl Ester</h3><div class="NLM_p last">The dry peptide-resin was placed in a flask. Cleavage mixture DIPEA/MeOH/DMF (1:5:5, 11–22 mL) was added, and the reaction mixture was refluxed under argon atmosphere overnight. The mixture was filtrated, filtrate was collected and the resin was rinsed 5 times with MeOH/DMF (1:1). Solvent was evaporated from the combined filtrates under reduced pressure to yield the crude product, which was purified by column chromatography or by crystallization.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-2-((<i>S</i>)-2-Acetamidopropanamido)-6-ethanethioamido-<i>N</i>-((<i>S</i>)-1-(methylamino)-1-oxopropan-2-yl)hexanamide (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.15–1.21 (m, 6 H), 1.29 (m, 2 H), 1.45–1.73 (m, 4 H), 1.83 (s, 3 H), 2.37 (s, 3 H), 2.57 (d, 3 H), 3.43 (m, 2 H), 4.13–4.28 (m, 3 H), 7.73 (m, 1 H), 7.82 (d, 1 H), 7.92 (d, 1 H), 8.07 (d, 1 H), 9.93 (m, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.92, 18.29, 22.45, 22.81, 25.52, 26.81, 31.33, 32.77, 45.32, 48.08, 48.34, 52.36, 169.23, 170.98, 172.33, 172.55, 198.76. ESI-MS (<i>m</i>/<i>z</i>): 402.2 [M + H]<sup>+</sup>, 424.3 [M + Na]<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>S·0.3hexane·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-Methyl 2-((<i>S</i>)-2-((<i>S</i>)-2-Acetamidopropanamido)-6-ethanethioamidohexanamido)propanoate (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (MeOD): δ = 1.34 (d, 3 H), 1.39 (d, 3 H), 1.47 (m, 2 H), 1.62–1.92 (m, 4 H), 1.98 (s, 3 H), 2.45 (s, 3 H), 3.59 (m, 2 H), 3.71 (s, 3 H), 4.28–4.45 (m, 3 H). <sup>13</sup>C NMR (MeOD): δ = 17.28, 17.80, 22.39, 24.06, 28.27, 32.86, 33.12, 46.96, 49.46, 50.63, 52.76, 54.12, 173.28, 173.92, 174.52, 175.18, 201.57. ESI-MS (<i>m</i>/<i>z</i>): 403.2 [M + H]<sup>+</sup>, 425.3 [M + Na]<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub>S) C, H, N.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>S</i>)-2-((<i>S</i>)-2-((<i>S</i>)-2-Aminopropanamido)-6-ethanethioamidohexanamido)propanoic Acid (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.25 (d, 3 H), 1.28–1.41 (m, 2 H), 1.32 (d, 3 H), 1.48–1.74 (m, 4 H), 2.37 (s, 3 H), 3.42 (m, 2 H), 3.83 (m, 1 H), 4.09 (m, 1 H), 4.27 (m, 1 H), 8.12 (d, 1 H), 8.48 (d, 1 H), 9.99 (m, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.50, 17.55, 22.78, 26.95, 31.87, 32.81, 45.37, 47.95, 48.18, 52.51, 169.79, 170.62, 174.18, 198.83. ESI-MS (<i>m</i>/<i>z</i>): 347.14 [M + H]<sup>+</sup>. HPLC: <i>t</i><sub>R</sub> 9.31 min, area percent 93% at 260 nm.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>S</i>)-2-((<i>S</i>)-2-Amino-6-ethanethioamidohexanamido)propanoic Acid (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O): δ = 1.44 (d, 3 H), 1.50 (m, 2 H), 1.73 (m, 2 H), 1.96 (m, 2 H), 2.51 (s, 3 H), 3.63 (t, 2 H), 4.03 (t, 1 H), 4.36 (q, 1 H). <sup>13</sup>C NMR (D<sub>2</sub>O): δ = 17.82, 22.71, 27.86, 31.87, 33.71, 47.11, 50.92, 54.36, 170.49, 178.16, 201.83. ESI-MS (<i>m</i>/<i>z</i>): 276.19 [M + H]<sup>+</sup>. HPLC: <i>t</i><sub>R</sub> 3.18 min, area percent 99% at 260 nm.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>S</i>)-Methyl 2-((<i>S</i>)-2-Acetamido-6-ethanethioamidohexanamido)propanoate (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ = 1.43 (d, 3 H), 1.46 (m, 2 H), 1.66–1.88 (m, 4 H), 2.01 (s, 3 H), 2.56 (s, 3 H), 3.65 (m, 2 H), 3.76 (s, 3 H), 4.52 (m, 1 H), 4.57 (m, 1 H), 6.63 (m, 1 H), 7.12 (m, 1 H), 8.21 (m, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 17.47, 22.30, 23.13, 26.81, 32.62, 33.71, 45.84, 48.15, 52.30, 52.52, 170.45, 171.57, 173.31, 200.75. ESI-MS (<i>m</i>/<i>z</i>): 332.22 [M + H]<sup>+</sup>, 354.25 [M + Na]<sup>+</sup>. Anal. (C<sub>14</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>S·0.3Et<sub>2</sub>O) C, H, N.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-2-((<i>S</i>)-2-((<i>S</i>)-1-Acetylpyrrolidine-2-carboxamido)-6-ethanethioamidohexanamido)propanoic Acid (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.22–1.37 (m, 5 H), 1.46–1.79 (m, 5 H), 1.79–1.89 (m, 3 H), 1.96–2.22 (m, 3 H), 2.34–2.40 (m, 3 H), 3.37–3.59 (m, 4 H), 4.11–4.41 (m, 3 H), 7.85–7.94 (m, 1 H), 8.12–8.22 (m, 1 H), 9.86–9.97 (m, 1 H), 12.01–12.53 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 16.97, 17.05, 21.03, 22.01, 22.38, 22.50, 22.76, 22.86, 24.31, 26.77, 26.79, 29.44, 31.28, 31.58, 31.73, 32.78, 45.27, 45.36, 46.29, 47.41, 47.47, 47.65, 51.71, 51.94, 59.34, 60.19, 168.51, 168.93, 171.27, 171.55, 171.80, 171.97, 173.91, 173.96, 198.77, 217.03. ESI-MS (<i>m</i>/<i>z</i>): 415.23 [M + H]<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub>S·0.8AcOH) C, H, N.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (6<i>S</i>,9<i>S</i>,12<i>S</i>)-9-(4-Ethanethioamidobutyl)-2,2,6,12-tetramethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oic Acid (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.16 (d, 3 H), 1.26 (d, 3 H), 1.37 (s, 9 H), 1.22–1.41 (m, 2 H), 1.45–1.71 (m, 4 H), 2.37 (s, 3 H), 3.41 (m, 2 H), 3.96 (m, 1 H), 4.17 (m, 1 H), 4.28 (m, 1 H), 6.96 (d, 1 H), 7.69 (d, 1 H), 8.17 (d, 1 H), 9.90 (m, 1 H), 12.17 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.09, 17.99, 21.04, 26.89, 28.17, 32.11, 32.79, 45.38, 47.45, 49.73, 51.75, 78.10, 155.07, 171.16, 171.98, 173.89, 198.75. ESI-MS (<i>m</i>/<i>z</i>): 447.11 [M + H]<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub>S·0.6AcOH·0.15hexane) C, H, N.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-2-((<i>S</i>)-2-((<i>R</i>)-2-Amino-3-phenylpropanamido)-6-ethanethioamidohexanamido)propanoic Acid (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.15 (m, 2 H), 1.25 (d, 3 H), 1.38–1.61 (m, 4 H), 2.37 (s, 3 H), 2.66–3.00 (m, 2 H), 3.39 (m, 2 H), 3.68 (m, 1 H), 4.09 (m, 1 H), 4.25 (m, 1 H), 7.18–7.32 (m, 5 H), 8.19 (m, 2 H), 9.97 (m, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.43, 22.41, 26.86, 32.07, 32.76, 45.31, 47.82, 51.95, 55.15, 126.39, 128.18, 129.29, 137.49, 170.79, 171.88, 173.91, 198.74. ESI-MS (<i>m</i>/<i>z</i>): 423.27 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>S·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-2-((<i>S</i>)-2-(Benzyloxycarbonylamino)-6-ethanethioamidohexanamido)propanoic Acid (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.27 (d, 3 H), 1.34 (m, 2 H), 1.45–1.69 (m, 4 H), 2.37 (s, 3 H), 3.43 (m, 2 H), 4.00 (m, 1 H), 4.19 (m, 1 H), 5.02 (s, 2 H), 7.27–7.42 (m, 6 H), 8.15 (d, 1 H), 9.92 (m, 1 H), 12.47 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.11, 22.97, 26.89, 31.66, 32.79, 45.31, 47.38, 54.21, 65.31, 127.64, 127.74, 128.31, 137.05, 155.89, 171.67, 173.99, 198.74. ESI-MS (<i>m</i>/<i>z</i>): 410.26 [M + H]<sup>+</sup>, 432.27 [M + Na]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>27</sub>N<sub>3</sub>O<sub>5</sub>S·0.1hexane) C, H, N.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-2-((<i>S</i>)-6-Ethanethioamido-2-(3-phenylpropanamido)hexanamido)propanoic Acid (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.24 (m, 2 H), 1.27 (d, 3 H), 1.39–1.67 (m, 4 H), 2.37 (s, 3 H), 2.45 (m, 2 H), 2.80 (m, 2 H), 3.41 (m, 2 H), 4.18 (m, 1 H), 4.29 (m, 1 H), 7.13–7.29 (m, 5 H), 7.93 (d, 1 H), 8.17 (d, 1 H), 9.90 (m, 1 H), 12.47 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.03, 22.73, 26.92, 31.07, 31.93, 32.78, 36.68, 45.37, 47.35, 51.84, 125.81, 128.18, 128.19, 141.27, 171.21, 171.49, 173.96, 198.72. ESI-MS (<i>m</i>/<i>z</i>): 408.23 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub>S·0.1H<sub>2</sub>O·0.1hexane) C, H, N.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-2-((<i>S</i>)-6-Ethanethioamido-2-(3-(2-fluorophenyl)propanamido)hexanamido)propanoic Acid (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.19–1.31 (m, 2 H), 1.26 (d, 3 H), 1.41–1.67 (m, 4 H), 2.37 (s, 3 H), 2.44 (m, 2 H), 2.82 (dd, 2 H), 3.40 (m, 2 H), 4.18 (m, 1 H), 4.28 (m, 1 H), 7.06–7.16 (m, 2 H), 7.19–7.32 (m, 2 H), 7.97 (d, 1 H), 8.18 (d, 1 H), 9.90 (m, 1 H), 12.33 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.03, 22.74, 24.17 (<i>J</i><sub>CF</sub> = 2.49 Hz), 26.91, 31.90, 32.78, 35.06, 45.36, 47.36, 51.89, 114.98 (d, <i>J</i><sub>CF</sub> = 21.88 Hz), 124.24 (d, <i>J</i><sub>CF</sub> = 3.32 Hz), 127.77 (d, <i>J</i><sub>CF</sub> = 15.72 Hz), 127.96 (d, <i>J</i><sub>CF</sub> = 8.09 Hz), 130.58 (<i>J</i><sub>CF</sub> = 4.89 Hz), 160.43 (<i>J</i><sub>CF</sub> = 243.12 Hz), 170.87, 171.47, 173.98, 198.73. ESI-MS (<i>m</i>/<i>z</i>): 426.23 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>4</sub>S·0.4AcOH·0.05hexane) C, H, N.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-2-((<i>S</i>)-6-Ethanethioamido-2-(3-(2-hydroxyphenyl)propanamido)hexanamido)propanoic Acid (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.21–1.33 (m, 2 H), 1.27 (d, 3 H), 1.42–1.68 (m, 4 H), 2.37 (s, 3 H), 2.39 (m, 2 H), 2.72 (dd, 2 H), 3.41 (m, 2 H), 4.18 (m, 1 H), 4.29 (m, 1 H), 6.68 (m, 1 H), 6.76 (d, 1 H), 6.98 (m, 1 H), 7.04 (d, 1 H), 7.91 (d, 1 H), 8.17 (d, 1 H), 9.28 (br, 1 H), 9.91 (m, 1 H), 12.29 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.05, 22.79, 25.62, 26.92, 31.89, 32.79, 35.09, 45.36, 47.39, 51.91, 114.87, 118.83, 126.88, 127.41, 129.54, 155.02, 171.54, 171.75, 173.98, 198.73. ESI-MS (<i>m</i>/<i>z</i>): 424.20 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>29</sub>N<sub>3</sub>O<sub>5</sub>S·0.1H<sub>2</sub>O·0.7AcOH) C, H, N.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-2-((<i>S</i>)-2-((<i>R</i>)-1-(<i>tert</i>-Butoxycarbonyl)piperidine-3-carboxamido)-6-ethanethioamidohexanamido)propanoic Acid (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 1.26 (d, 3 H), 1.21–1.37 (m, 4 H), 1.39 (s, 9 H), 1.43–1.86 (m, 6 H), 2,32 (m, 1 H), 2.37 (s, 3 H), 2.59–2.85 (m, 2 H), 3.43 (m, 2 H), 3.78–3.97 (m, 2 H), 4.16 (m, 1 H), 4.24 (m, 1 H), 7.98 (d, 1 H), 8.09 (m, 1 H), 9.92 (m, 1 H), 12.36 (br, 1 H). <sup>13</sup>C NMR ((CD<sub>3</sub>)<sub>2</sub>SO): δ = 17.11, 21.03, 22.79, 22.84, 24.10 (br), 26.88, 27.44, 28.04, 31.73, 32.78, 41.86, 45.33, 47.38, 51.79, 78.65, 153.80, 171.39, 172.68, 173.99, 198.75. ESI-MS (<i>m</i>/<i>z</i>): 487.12 [M + H]<sup>+</sup>, 509.32 [M + Na]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>38</sub>N<sub>4</sub>O<sub>6</sub>S·0.4AcOH·0.2hexane) C, H, N.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-Benzyl 1-(Cyclohexylamino)-6-ethanethioamido-1-oxohexan-2-ylcarbamate (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ = 1.04–1.95 (m, 16 H), 2.54 (s, 3 H), 3.55–3.78 (m, 3 H), 4.09 (m, 1 H), 5.11 (s, 2 H), 5.45 (d, 1 H), 5.86 (d, 1 H), 7.29–7.39 (m, 5 H), 7.72 (m, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 22.67, 24.88, 25.54, 26.99, 32.56, 33.01, 33.12, 34.22, 45.89, 48.64, 54.51, 67.28, 128.15, 128.45, 128.74, 136.23, 156.59, 170.52, 201.08. ESI-MS (<i>m</i>/<i>z</i>): 420.30 [M + H]<sup>+</sup>, 442.32 [M + Na]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-Benzyl 6-Ethanethioamido-1-(2-fluorophenylamino)-1-oxohexan-2-ylcarbamate (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ = 1.50 (m, 2 H), 1.66–2.05 (m, 4 H), 2.53 (s, 3 H), 3.66 (m, 2 H), 4.36 (m, 1 H), 5.15 (s, 2 H), 5.43 (d, 1 H), 7.03–7.16 (m, 3 H), 7.28–7.40 (m, 5 H), 7.53 (br, 1 H), 8.11 (br, 1 H), 8.19 (dd, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 22.82, 27.23, 31.89, 34.30, 45.81, 55.42, 67.65, 115.18 (d, <i>J</i> = 19.17 Hz), 122.21, 124.70 (d, <i>J</i> = 3.65 Hz), 125.25 (d, <i>J</i> = 7.63 Hz), 125.77 (<i>J</i> = 10.05 Hz), 128.25, 128.54, 128.77, 135.98, 152.94 (<i>J</i> = 244.37), 156.77, 170.04, 201.24. ESI-MS (<i>m</i>/<i>z</i>): 432.26 [M + H]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>3</sub>S·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-Benzyl 6-Ethanethioamido-1-(2-hydroxyphenylamino)-1-oxohexan-2-ylcarbamate (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ = 1.47 (m, 2 H), 1.64–2.02 (m, 4 H), 2.51 (s, 3 H), 3.66 (s, 2 H), 4.41 (br, 1 H), 5.13 (s, 2 H), 5.52 (d, 1 H), 6.86 (dd, 1 H), 6.98 (d, 1 H), 7.11 (dd, 2 H), 7.28–7.40 (m, 5 H), 7.52 (br, 1 H), 8.33 (s, 1 H), 8.55 (br, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 22.71, 27.23, 31.84, 34.31, 45.67, 55.12, 67.78, 119.45, 120.85, 122.74, 125.19, 127.47, 128.28, 128.61, 128.81, 135.88, 148.52, 156.83, 171.58, 201.38. ESI-MS (<i>m</i>/<i>z</i>): 430.23 [M + H]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>S) C, H, N.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>)-Benzyl 6-Ethanethioamido-1-oxo-1-(2-oxo-2-phenylethylamino)hexan-2-ylcarbamate (<b>30</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ = 1.50 (m, 2 H), 1.65–1.98 (m, 4 H), 2.53 (s, 3 H), 3.64 (m, 2 H), 4.35 (m, 1 H), 4.76 (m, 2 H), 5.14 (s, 2 H), 5.54 (d, 1 H), 6.95 (br, 1 H), 7.28–7.39 (m, 5 H), 7.51 (dd, 2 H), 7.64 (dd, 1 H), 7.74 (br, 1 H), 7.96 (d, 2 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 22.72, 27.11, 32.83, 34.21, 46.07, 46.45, 54.49, 67.37, 128.09, 128.18, 128.45, 128.75, 129.16, 134.39, 134.48, 136.18, 156.55, 171.86, 194.05, 201.13. ESI-MS (<i>m</i>/<i>z</i>): 456.26 [M + H]<sup>+</sup>. Anal. (C<sub>24</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub>S) C, H, N.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> In Vitro Assay for SIRT1 and SIRT2 Activities</h3><div class="NLM_p">The Fluor de Lys fluorescence assays were based on the method described in the BioMol product sheet using BioMol KI177 substrate for SIRT1 and KI179 substrate for SIRT2. Determined <i>K</i><sub>m</sub> for SIRT1 substrate was 58 μM and for SIRT2 substrate 198 μM.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">Briefly, assays were carried out using Fluor de Lys acetylated 40 μM SIRT1- or 138 μM SIRT2-peptide substrate (concentrations were 70% of <i>K</i><sub>m</sub> values), 500 μM NAD<sup>+</sup> (N6522, Sigma), recombinant GST-SIRT1/2-enzyme and SIRT assay buffer (HDAC assay buffer, KI143, supplemented with 1 mg/mL bovine serum albumin (BSA), A3803, Sigma). GST-SIRT1-enzyme and GST-SIRT2-enzyme were produced as described recently.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> The buffer, SIRT1/2-peptide substrate, NAD<sup>+</sup> and dimethyl sulfoxide (DMSO)/compounds in DMSO (2.5 μL in 50 μL total volume of reaction mixture; DMSO from Sigma, D2650) for testing were preincubated for 5 min at rt. The reaction was started by adding the SIRT1- or SIRT2-enzyme. The reaction mixture was incubated for 1 h at 37 °C. After that Fluor de Lys developer (KI176) plus 2 mM nicotinamide in 50 μL were added and incubation was continued for 45 min at 37 °C. Fluorescence readings were obtained using the Victor 1420 Multilabel Counter (Wallac, Finland) with excitation wavelength 355 nm and emission 460 nm.</div><div class="NLM_p last">The IC<sub>50</sub> values were based on 9-point dose–response determination (2000 μM, 1000 μM, 100 μM, 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM and 0.0001 μM) where more necessary dose points were added between the critical concentrations depending on the compound. Each experiment was repeated at least three times and calculated using Graph Pad Prism Software version 4.03 ( 19922005 GraphPad Software, Inc.). The SIRT1 and SIRT2 assays differ in their active enzyme concentrations, and consequently, SIRT1 and SIRT2 IC<sub>50</sub> values cannot be directly compared.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> In Vitro Assay for HDAC Activities</h3><div class="NLM_p">The Fluor de Lys fluorescence assay was based on the method described in the product sheet for HDAC Fluorimetric Assay/Drug Discovery Kit of Enzo Life Sciences (BML-AK500).</div><div class="NLM_p">Briefly, assay was carried out using Fluor de Lys acetylated 50 μM HDAC-peptide substrate, human cervical cancer cell line (HeLa) nuclear extract dilution as recommended in the kit and 200 μM test compounds diluted in HDAC assay buffer. The reaction was started by adding the substrate as recommended in the kit protocol. The reaction mixture was incubated for 1 h at 37 °C. After that Fluor de Lys developer plus 1 μM nicotinamide was added and incubation was continued for 15 min at 25 °C. Fluorescence readings were obtained using the Victor 1420 Multilabel Counter (Wallac, Finland) with excitation wavelength 355 nm and emission 460 nm.</div><div class="NLM_p last">The experiment was repeated twice. Means and standard deviations were calculated using SPSS Software version 14.0 for Windows (IBM Corporation, USA).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cell Culture</h3><div class="NLM_p last">Clonetics normal human astrocytes (NHA) were purchased from Lonza (Basel, Switzerland). Cells were cultured in Dulbecco’s modified Eagle medium (DMEM) (Sigma, St. Louis, MO, USA) with the astrocyte growth medium (AGM) supplement (Lonza, Basel, Switzerland), 10% fetal bovine serum (Lonza), 100 units/mL penicillin (Lonza), 100 μg/mL streptomycin (Lonza), and 2 mM glutamine (Lonza). Human retinal pigment epithelial cells (ARPE-19) were obtained from American Type Culture Collection (ATCC). The cells were grown in DMEM/Nut MIX F-12 medium (Lonza) including 10% fetal bovine serum (Hyclone, Logan, UT, USA), 100 units/mL penicillin, 100 μg/mL streptomycin, and 2 mM glutamine. SH-SY5Y neuroblastomas (DSMZ, Braunschweig, Germany) were cultured in 50% DMEM–50% optimized modified Eagle medium (OPTI-MEM) (Gibco, Rockville, MD, USA) containing 5% fetal bovine serum, 100 units/mL penicillin (Lonza), 100 μg/mL streptomycin (Lonza), and 2 mM glutamine (Lonza). All cell types were plated to 12-well plates (Nunc, Roskilde, Denmark) at density 10<sup>5</sup> cells/well, and the experiments were initiated after 24 h. Test compounds and etoposide (Sigma, St. Louis, MO, USA) were added at the same time and incubated for 5 h before harvesting.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Western Blotting</h3><div class="NLM_p last">For the Western blot analysis, the cells were lysed into the M-PER Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Waltham, MA, USA). Before estimation of protein levels with the DC protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) the lysates were centrifuged at 16000<i>g</i> for 20 min. Equal amounts of total protein were electrophoretically separated in 4–12% SDS–PAGE gel (Invitrogen, Carlsbad, CA, USA). Subsequently, proteins were transferred onto Hybond-ECL nitrocellulose transfer membrane (Amersham, GE Healthcare, London, U.K.) using electroblotting (Trans-Blot Cell wet blotting apparatus, Bio-Rad Laboratories, Hercules, CA, USA). The specific protein was detected with rabbit monoclonal acetyl-p53 (K382) antibody (Abcam, Cambridge, U.K.). Actin (H-196, sc-7210, Santa Cruz, CA, USA) was used as loading control. The staining of specific proteins was carried out using horseradish peroxidase (HRP)-linked secondary antibody (donkey-anti-rabbit, NA934, GE Healthcare, London, U.K.) and chemiluminescent substrate (Immobilon Western Chemiluminescent HRP Substrate, Millipore, Billerica, MA, USA). Filters were exposed to a medical X-ray film (SuperRX-film, Fujifilm Corporation, Tokyo, Japan), developed with Kodak X-OMAT 2000 developing machine (Eastman Kodak Company, Rochester, NY, USA) and scanned with the Epson Perfection V750 Pro scanner (Epson America Inc., Long Beach, CA, USA) using Jasc Paint Shop Pro 8 software (Jasc Software Inc., Eden Prairie, MN, USA). Images were processed with the use of UN-SCAN-IT gel software (Silk Scientific Corporation, Orem, UT, USA).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Lactate Dehydrogenase Assay</h3><div class="NLM_p last">Lactate dehydrogenase (LDH) leakage from the cells to medium was used as a marker for cytotoxicity. LDH was measured from cell culture medium with the cytotoxicity kit obtained from Promega (G1780).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/jm200590k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental procedures for the syntheses and NMR spectra for the compounds <b>4</b>–<b>24</b> and <b>26</b>–<b>30</b>, ESI-MS results, elemental analysis data and additional docking pose figures. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200590k/suppl_file/jm200590k_si_001.pdf">jm200590k_si_001.pdf (3.62 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200590k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heikki S. Salo</span> - <span class="hlFld-Affiliation affiliation">†School of Pharmacy and §Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#276f424e4c4c4e0974464b486752424109414e"><span class="__cf_email__" data-cfemail="1b537e7270707235487a77745b6e7e7d357d72">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tero Huhtiniemi</span> - <span class="hlFld-Affiliation affiliation">†School of Pharmacy and §Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiina Suuronen</span> - <span class="hlFld-Affiliation affiliation">†School of Pharmacy and §Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antti Poso</span> - <span class="hlFld-Affiliation affiliation">†School of Pharmacy and §Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antero Salminen</span> - <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jukka Leppänen</span> - <span class="hlFld-Affiliation affiliation">†School of Pharmacy and §Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elina Jarho</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maija Lahtela-Kakkonen</span> - <span class="hlFld-Affiliation affiliation">†School of Pharmacy and §Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Gothenburg, Sweden</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. Kristina Luthman for helpful discussions during this work and M.Sc. Marko Lehtonen, Tanja Bruijn, Miia Reponen, Tiina Koivunen and Anneleena Holopainen for their skillfull assistance. We thank the Graduate School of Drug Discovery, Academy of Finland (Grants 127062 and 132780), Orion Farmos Research Foundation, Finnish Cultural Foundation, Emil Aaltonen Foundation and the Saastamoinen Foundation for financial support. We thank Biocenter Kuopio for the facilities and the CSC-IT center of Science Limited for providing software licenses for the Shcrödinger software package. This work is part of COST Action TD09056: “Epigenetics: Bench to Bedside”.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> Abbreviations Used</h2><tr><td class="NLM_term">SIRT1–7</td><td class="NLM_def"><p class="first last">human silent information regulator type 1–7</p></td></tr><tr><td class="NLM_term">Sir2Tm</td><td class="NLM_def"><p class="first last">silent information regulator 2 <i>Thermotoga maritima</i></p></td></tr><tr><td class="NLM_term">NAD+</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">cbz</td><td class="NLM_def"><p class="first last">carbonyloxybenzyl</p></td></tr><tr><td class="NLM_term">fmoc</td><td class="NLM_def"><p class="first last">9-fluorenylmethoxycarbonyl</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid phase peptide synthesis</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure activity relationship</p></td></tr><tr><td class="NLM_term">rmsd</td><td class="NLM_def"><p class="first last">root-mean-square deviation</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">SH-SY5Y</td><td class="NLM_def"><p class="first last">human derived neuroblastoma cell line</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione-<i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium</p></td></tr><tr><td class="NLM_term">AGM</td><td class="NLM_def"><p class="first last">astrocyte growth medium</p></td></tr><tr><td class="NLM_term">OPTI-MEM</td><td class="NLM_def"><p class="first last">optimized modified Eagle medium</p></td></tr><tr><td class="NLM_term">SDS–PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrogenase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Haigis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span> </span><span class="NLM_article-title">Mammalian sirtuins: biological insights and disease relevance</span> <span class="citation_source-journal">Annu. Rev. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1146%2Fannurev.pathol.4.110807.092250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20078221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFekt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=253-295&author=M.+C.+Haigisauthor=D.+A.+Sinclair&title=Mammalian+sirtuins%3A+biological+insights+and+disease+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian sirtuins: biological insights and disease relevance</span></div><div class="casAuthors">Haigis, Marcia C.; Sinclair, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">253-295</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Aging is accompanied by a decline in the healthy function of multiple organ systems, leading to increased incidence and mortality from diseases such as type II diabetes mellitus, neurodegenerative diseases, cancer, and cardiovascular disease.  Historically, researchers have focused on investigating individual pathways in isolated organs as a strategy to identify the root cause of a disease, with hopes of designing better drugs.  Studies of aging in yeast led to the discovery of a family of conserved enzymes known as the sirtuins, which affect multiple pathways that increase the life span and the overall health of organisms.  Since the discovery of the first known mammalian sirtuin, SIRT1, 10 years ago, there were major advances in our understanding of the enzymol. of sirtuins, their regulation, and their ability to broadly improve mammalian physiol. and health span.  This review summarizes and discusses the advances of the past decade and the challenges that will confront the field in the coming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6CJDwZ1VNd7Vg90H21EOLACvtfcHk0liRZHKaVy1DGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFekt7c%253D&md5=0fd55200789fb122f51e11106c60ec05</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pathol.4.110807.092250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pathol.4.110807.092250%26sid%3Dliteratum%253Aachs%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26atitle%3DMammalian%2520sirtuins%253A%2520biological%2520insights%2520and%2520disease%2520relevance%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%26date%3D2010%26volume%3D5%26spage%3D253%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lavu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P. D.</span><span> </span><span class="NLM_article-title">Sirtuins—novel therapeutic targets to treat age-associated diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=841-853&author=S.+Lavuauthor=O.+Bossauthor=P.+J.+Elliottauthor=P.+D.+Lambert&title=Sirtuins%E2%80%94novel+therapeutic+targets+to+treat+age-associated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavu%26aufirst%3DS.%26aulast%3DBoss%26aufirst%3DO.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DLambert%26aufirst%3DP.%2BD.%26atitle%3DSirtuins%25E2%2580%2594novel%2520therapeutic%2520targets%2520to%2520treat%2520age-associated%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D841%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Milne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galonek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israelian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iffland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medvedik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirousek, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, C. H.</span><span> </span><span class="NLM_article-title">Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1038%2Fnature06261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18046409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKmtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=712-716&author=J.+C.+Milneauthor=P.+D.+Lambertauthor=S.+Schenkauthor=D.+P.+Carneyauthor=J.+J.+Smithauthor=D.+J.+Gagneauthor=L.+Jinauthor=O.+Bossauthor=R.+B.+Perniauthor=C.+B.+Vuauthor=J.+E.+Bemisauthor=R.+Xieauthor=J.+S.+Dischauthor=P.+Y.+Ngauthor=J.+J.+Nunesauthor=A.+V.+Lynchauthor=H.+Yangauthor=H.+Galonekauthor=K.+Israelianauthor=W.+Choyauthor=A.+Ifflandauthor=S.+Lavuauthor=O.+Medvedikauthor=D.+A.+Sinclairauthor=J.+M.+Olefskyauthor=M.+R.+Jirousekauthor=P.+J.+Elliottauthor=C.+H.+Westphal&title=Small+molecule+activators+of+SIRT1+as+therapeutics+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes</span></div><div class="casAuthors">Milne, Jill C.; Lambert, Philip D.; Schenk, Simon; Carney, David P.; Smith, Jesse J.; Gagne, David J.; Jin, Lei; Boss, Olivier; Perni, Robert B.; Vu, Chi B.; Bemis, Jean E.; Xie, Roger; Disch, Jeremy S.; Ng, Pui Yee; Nunes, Joseph J.; Lynch, Amy V.; Yang, Hongying; Galonek, Heidi; Israelian, Kristine; Choy, Wendy; Iffland, Andre; Lavu, Siva; Medvedik, Oliver; Sinclair, David A.; Olefsky, Jerrold M.; Jirousek, Michael R.; Elliott, Peter J.; Westphal, Christoph H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7170</span>),
    <span class="NLM_cas:pages">712-716</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of aging such as type 2 diabetes.  SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity.  Resveratrol, a polyphenolic SIRT1 activator, mimics the antiaging effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival.  Here the authors describe the identification and characterization of small mol. activators of SIRT1 that are structurally unrelated to, and 1000-fold more potent than, resveratrol.  These compds. bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis const. for acetylated substrates.  In diet-induced obese and genetically obese mice, these compds. improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity.  In Zucker fa/fa rats, hyperinsulinemic-euglycemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver.  Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of aging such as type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtZUMUqn50MbVg90H21EOLACvtfcHk0liRZHKaVy1DGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKmtbrM&md5=8343b182d3596cbd8eb175c8b9cdcace</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature06261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06261%26sid%3Dliteratum%253Aachs%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26aulast%3DLambert%26aufirst%3DP.%2BD.%26aulast%3DSchenk%26aufirst%3DS.%26aulast%3DCarney%26aufirst%3DD.%2BP.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DGagne%26aufirst%3DD.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DBoss%26aufirst%3DO.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DDisch%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DA.%2BV.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGalonek%26aufirst%3DH.%26aulast%3DIsraelian%26aufirst%3DK.%26aulast%3DChoy%26aufirst%3DW.%26aulast%3DIffland%26aufirst%3DA.%26aulast%3DLavu%26aufirst%3DS.%26aulast%3DMedvedik%26aufirst%3DO.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DWestphal%26aufirst%3DC.%2BH.%26atitle%3DSmall%2520molecule%2520activators%2520of%2520SIRT1%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D712%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Biological and potential therapeutic roles of sirtuin deacetylases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4018</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1007%2Fs00018-008-8357-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18820996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCgs7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=4000-4018&author=D.+M.+Taylorauthor=M.+M.+Maxwellauthor=R.+Luthi-Carterauthor=A.+G.+Kazantsev&title=Biological+and+potential+therapeutic+roles+of+sirtuin+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Biological and Potential Therapeutic Roles of Sirtuin Deacetylases</span></div><div class="casAuthors">Taylor, D. M.; Maxwell, M. M.; Luthi-Carter, R.; Kazantsev, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4000-4018</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Sirtuins comprise a unique class of NAD (NAD+)-dependent deacetylases that target multiple protein substrates to execute diverse biol. functions.  These enzymes are key regulators of clin. important cellular and organismal processes, including metab., cell division and aging.  The desire to understand the important determinants of human health and lifespan has resulted in a firestorm of work on the seven mammalian sirtuins in less than a decade.  The implication of sirtuins in medically important areas such as diabetes, cancer, cardiovascular dysfunction and neurodegenerative disease has further catapulted them to a prominent status as potential targets for nutritional and therapeutic development.  Here, we present a review of published results on sirtuin biol. and its relevance to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzJ78zj4tWQrVg90H21EOLACvtfcHk0lgClTxPhyVyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCgs7bJ&md5=f72dd55ed976ba98b4a7ff607e0d0977</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8357-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8357-y%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DBiological%2520and%2520potential%2520therapeutic%2520roles%2520of%2520sirtuin%2520deacetylases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D4000%26epage%3D4018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Peck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fruscia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span> </span><span class="NLM_article-title">SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1158%2F1535-7163.MCT-09-0971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20371709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=844-855&author=B.+Peckauthor=C.+Y.+Chenauthor=K.+K.+Hoauthor=P.+Di+Frusciaauthor=S.+S.+Myattauthor=R.+C.+Coombesauthor=M.+J.+Fuchterauthor=C.+D.+Hsiaoauthor=E.+W.+Lam&title=SIRT+inhibitors+induce+cell+death+and+p53+acetylation+through+targeting+both+SIRT1+and+SIRT2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2</span></div><div class="casAuthors">Peck, Barrie; Chen, Chun-Yuan; Ho, Ka-Kei; Di Fruscia, Paolo; Myatt, Stephen S.; Coombes, R. Charles; Fuchter, Matthew J.; Hsiao, Chwan-Deng; Lam, Eric W.-F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">844-855</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SIRT proteins play an important role in the survival and drug resistance of tumor cells, esp. during chemotherapy.  In this study, we investigated the potency, specificity, and cellular targets of three SIRT inhibitors, Sirtinol, Salermide, and EX527.  Cell proliferative and cell cycle analyses showed that Sirtinol and Salermide, but not EX527, were effective in inducing cell death at concns. of 50 μmol/L or over in MCF-7 cells.  Instead, EX527 caused cell cycle arrest at G1 at comparable concns.  In vitro SIRT assays using a p53 peptide substrate showed that all three compds. are potent SIRT1/2 inhibitors, with EX527 having the highest inhibitory activity for SIRT1.  Computational docking anal. showed that Sirtinol and Salermide have high degrees of selectivity for SIRT1/2, whereas EX527 has high specificity for SIRT1 but not SIRT2.  Consistently, Sirtinol and Salermide, but not EX527, treatment resulted in the in vivo acetylation of the SIRT1/2 target p53 and SIRT2 target tubulin in MCF-7 cells, suggesting that EX527 is ineffective in inhibiting SIRT2 and that p53 mediates the cytotoxic function of Sirtinol and Salermide.  Studies using breast carcinoma cell lines and p53-deficient mouse fibroblasts confirmed that p53 is essential for the Sirtinol and Salermide-induced apoptosis.  Further, we showed using small interfering RNA that silencing both SIRTs, but not SIRT1 and SIRT2 individually, can induce cell death in MCF-7 cells.  Together, our results identify the specificity and cellular targets of these novel inhibitors and suggest that SIRT inhibitors require combined targeting of both SIRT1 and SIRT2 to induce p53 acetylation and cell death.  Mol Cancer Ther; 9(4); 844-55.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOOb1TBGW47Vg90H21EOLACvtfcHk0lgClTxPhyVyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D&md5=d2cf2c3adb9d6218c94ad143011082bd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0971%26sid%3Dliteratum%253Aachs%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DHo%26aufirst%3DK.%2BK.%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DMyatt%26aufirst%3DS.%2BS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DHsiao%26aufirst%3DC.%2BD.%26aulast%3DLam%26aufirst%3DE.%2BW.%26atitle%3DSIRT%2520inhibitors%2520induce%2520cell%2520death%2520and%2520p53%2520acetylation%2520through%2520targeting%2520both%2520SIRT1%2520and%2520SIRT2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D844%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Neugebauer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Inhibitors of NAD+ dependent histone deacetylases (sirtuins)</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.2174%2F138161208783885380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18336301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=562-573&author=R.+C.+Neugebauerauthor=W.+Sipplauthor=M.+Jung&title=Inhibitors+of+NAD%2B+dependent+histone+deacetylases+%28sirtuins%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of NAD+ dependent histone deacetylases (sirtuins)</span></div><div class="casAuthors">Neugebauer, Robert C.; Sippl, Wolfgang; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">562-573</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes that deacetylate acetyl lysines in histones and various non-histone proteins.  Three classes of histone deacetylases have been described in humans: class I, II and IV were shown to be zinc dependent amidohydrolases and eleven subtypes are known today (HDAC1-11).  Class III enzymes depend in their catalysis on NAD+ with the subsequent formation of nicotinamide and O-acetyl-ADP ribose.  Based on the homol. to the yeast histone deacetylase Sir2p the NAD+-dependent deacetylases have been termed sirtuins and seven members (SIRT1-7) have been described in humans.  Whereas class I and II HDACs have been identified as valid anticancer targets and clin. studies of their inhibitors as new anticancer agents are under way much less is known about the consequences of class III histone deacetylase inhibition.  Sirtuins have been linked to aging and overexpression of sirtuins leads to a prolonged lifespan in yeast.  Lately, sirtuin activity has been tied to the pathogenesis of HIV, cancer and neurodegenerative disease.  In the last two years several reports of new sirtuin inhibitors have emerged.  Addnl., sirtuin activators have been identified and have been implicated as potential drugs for the ameloriation of metabolic diseases.  Thus, the field of sirtuin biol. can be investigated with these new tools which will allow in turn to assess the therapeutic potential of those compds.  We will present an overview over sirtuins and their available inhibitors and activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg2Jg1EtHcurVg90H21EOLACvtfcHk0lgClTxPhyVyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVGksbs%253D&md5=942d69f31f9035a5eb97032fa9fec2eb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161208783885380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208783885380%26sid%3Dliteratum%253Aachs%26aulast%3DNeugebauer%26aufirst%3DR.%2BC.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520NAD%252B%2520dependent%2520histone%2520deacetylases%2520%2528sirtuins%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D562%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altucci, L.</span><span> </span><span class="NLM_article-title">Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1016%2Fj.biocel.2008.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18790076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=199-213&author=A.+Maiauthor=L.+Altucci&title=Epi-drugs+to+fight+cancer%3A+from+chemistry+to+cancer+treatment%2C+the+road+ahead"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead</span></div><div class="casAuthors">Mai, Antonello; Altucci, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-213</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In addn. to genetic events, a variety of epigenetic events were widely reported to contribute to the onset of many diseases including cancer.  DNA methylation and histone modifications (such as acetylation, methylation, sumoylation, and phosphorylation) involving chromatin remodelling are among the most studied epigenetic mechanisms for regulation of gene expression leading, when altered, to some diseases.  Epigenetic therapy tries to reverse the aberrations followed to the disruption of the balance of the epigenetic signalling ways through the use of both natural compds. and synthetic mols., active on specific epi-targets.  Such epi-drugs are, for example, inhibitors of DNA methyltransferases, histone deacetylases, histone acetyltransferases, histone methyltransferases, and histone demethylases.  In this review we will focus on the chem. aspects of such mols., joined to their effective (or potential) application in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop4CbZIUDH4LVg90H21EOLACvtfcHk0lgClTxPhyVyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu7zI&md5=0571583c8adf6a41ee44c893f71c5c94</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26atitle%3DEpi-drugs%2520to%2520fight%2520cancer%253A%2520from%2520chemistry%2520to%2520cancer%2520treatment%252C%2520the%2520road%2520ahead%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Guarani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potente, M.</span><span> </span><span class="NLM_article-title">SIRT1—a metabolic sensor that controls blood vessel growth</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1016%2Fj.coph.2010.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20149740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs12ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=139-145&author=V.+Guaraniauthor=M.+Potente&title=SIRT1%E2%80%94a+metabolic+sensor+that+controls+blood+vessel+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT1 - a metabolic sensor that controls blood vessel growth</span></div><div class="casAuthors">Guarani, Virginia; Potente, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-145</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Blood vessels deliver nutrients and O2 to cells and tissues in the body.  When blood supply is insufficient, new vessels form to meet the metabolic tissue requirements.  Several studies have examd. the cellular and mol. principles of blood vessel formation, yet little is known about how vessels sense and integrate environmental signals originating from nutrient- and O2-deprived tissues to achieve functional vascular patterning.  NAD-dependent deacetylase SIRT1 mediates adaptation to environmental stresses by adjusting cellular responses to the energetic state of the cell and recent studies highlight important functions of SIRT1 in regulating vascular growth, shape, and function.  Here, the authors review the emerging role of SIRT1 as a metabolic sensor coupling energy and oxygen homeostasis to the growth and function of the vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocH5np7vWFTrVg90H21EOLACvtfcHk0lhS9OcO9kLzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs12ntbo%253D&md5=a79ee52ce95a66b3d4b515e8517f7c47</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DGuarani%26aufirst%3DV.%26aulast%3DPotente%26aufirst%3DM.%26atitle%3DSIRT1%25E2%2580%2594a%2520metabolic%2520sensor%2520that%2520controls%2520blood%2520vessel%2520growth%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Alcain, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalba, J. M.</span><span> </span><span class="NLM_article-title">Sirtuin inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1517%2F13543770902755111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=19441904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=283-294&author=F.+J.+Alcainauthor=J.+M.+Villalba&title=Sirtuin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin inhibitors</span></div><div class="casAuthors">Alcain, Francisco J.; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The sirtuin family of deacetylase enzymes comprises seven proteins (SIRT1-7) that are dependent on NAD+ for their activity.  Three proteins are located in the nucleus, three in the mitochondria and only one is predominantly cytoplasmic.  Caloric restriction and oxidative stress generally up-regulate their expression.  SIRT1, the ortholog of yeast Sir2, is the mammalian sirtuin that has been most extensively studied to date.  Among other targets, SIRT1 down-regulates the activity of the nuclear transcription factor p53, being this related with an increase in lifespan and cell survival assocd. to stress resistance.  Objective: Because sirtuin modulation could have beneficial effects on several human diseases, there is a growing interest in the discovery and development of small mols. that modify its activity.  This review will be focused on sirtuin inhibitors.  Conclusions: Several specific inhibitors of SIRT1 have been described.  These compds. could be mainly useful for the treatment of cancers by increasing p53 activity that stops the formation of tumors and induces apoptosis.  A p53-independent massive induction of apoptosis has been also described for one inhibitor.  In addn., a potent and selective SIRT2 inhibitor that ameliorates the α-synuclein fibril formation in Parkinson disease has been proposed to treat this kind of neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0LxRE1oL__LVg90H21EOLACvtfcHk0lhS9OcO9kLzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslWlurc%253D&md5=d6a31fb4a3cd0aa829a52d97999ffee8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F13543770902755111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902755111%26sid%3Dliteratum%253Aachs%26aulast%3DAlcain%26aufirst%3DF.%2BJ.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DSirtuin%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D283%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffitt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokce, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7927</span><span class="NLM_x">–</span> <span class="NLM_lpage">7932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1073%2Fpnas.1002924107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20378838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7927-7932&author=R.+Luthi-Carterauthor=D.+M.+Taylorauthor=J.+Pallosauthor=E.+Lambertauthor=A.+Amoreauthor=A.+Parkerauthor=H.+Moffittauthor=D.+L.+Smithauthor=H.+Runneauthor=O.+Gokceauthor=A.+Kuhnauthor=Z.+Xiangauthor=M.+M.+Maxwellauthor=S.+A.+Reevesauthor=G.+P.+Batesauthor=C.+Neriauthor=L.+M.+Thompsonauthor=J.+L.+Marshauthor=A.+G.+Kazantsev&title=SIRT2+inhibition+achieves+neuroprotection+by+decreasing+sterol+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span></div><div class="casAuthors">Luthi-Carter, Ruth; Taylor, David M.; Pallos, Judit; Lambert, Emmanuel; Amore, Allison; Parker, Alex; Moffitt, Hilary; Smith, Donna L.; Runne, Heike; Gokce, Ozgun; Kuhn, Alexandre; Xiang, Zhongmin; Maxwell, Michele M.; Reeves, Steven A.; Bates, Gillian P.; Neri, Christian; Thompson, Leslie M.; Marsh, J. Lawrence; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7927-7932, S7927/1-S7927/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Huntington's disease (HD), an incurable neurodegenerative disorder, has a complex pathogenesis including protein aggregation and the dysregulation of neuronal transcription and metab.  Here, we demonstrate that inhibition of sirtuin 2 (SIRT2) achieves neuroprotection in cellular and invertebrate models of HD.  Genetic or pharmacol. inhibition of SIRT2 in a striatal neuron model of HD resulted in gene expression changes including significant down-regulation of RNAs responsible for sterol biosynthesis.  Whereas mutant huntingtin fragments increased sterols in neuronal cells, SIRT2 inhibition reduced sterol levels via decreased nuclear trafficking of SREBP-2.  Importantly, manipulation of sterol biosynthesis at the transcriptional level mimicked SIRT2 inhibition, demonstrating that the metabolic effects of SIRT2 inhibition are sufficient to diminish mutant huntingtin toxicity.  These data identify SIRT2 inhibition as a promising avenue for HD therapy and elucidate a unique mechanism of SIRT2-inhibitor-mediated neuroprotection.  Furthermore, the ascertainment of SIRT2's role in regulating cellular metab. demonstrates a central function shared with other sirtuin proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl8YT_ra15oLVg90H21EOLACvtfcHk0lhS9OcO9kLzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D&md5=8b4798da04f14888acbcd64d1670d503</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002924107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002924107%26sid%3Dliteratum%253Aachs%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DPallos%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DE.%26aulast%3DAmore%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DMoffitt%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRunne%26aufirst%3DH.%26aulast%3DGokce%26aufirst%3DO.%26aulast%3DKuhn%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DReeves%26aufirst%3DS.%2BA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DNeri%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DMarsh%26aufirst%3DJ.%2BL.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSIRT2%2520inhibition%2520achieves%2520neuroprotection%2520by%2520decreasing%2520sterol%2520biosynthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D7927%26epage%3D7932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathearn, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Fatkins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnot, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span> </span><span class="NLM_article-title">Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3651</span><span class="NLM_x">–</span> <span class="NLM_lpage">3656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3651-3656&author=D.+G.+Fatkinsauthor=A.+D.+Monnotauthor=W.+Zheng&title=Nepsilon-thioacetyl-lysine%3A+a+multi-facet+functional+probe+for+enzymatic+protein+lysine+Nepsilon-deacetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFatkins%26aufirst%3DD.%2BG.%26aulast%3DMonnot%26aufirst%3DA.%2BD.%26aulast%3DZheng%26aufirst%3DW.%26atitle%3DNepsilon-thioacetyl-lysine%253A%2520a%2520multi-facet%2520functional%2520probe%2520for%2520enzymatic%2520protein%2520lysine%2520Nepsilon-deacetylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3651%26epage%3D3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Fatkins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span> </span><span class="NLM_article-title">Substituting N-thioacetyl-lysine for N-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD-dependent protein deacetylases</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.3390%2Fijms9010001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=19325715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1eltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1-11&author=D.+G.+Fatkinsauthor=W.+Zheng&title=Substituting+N-thioacetyl-lysine+for+N-acetyl-lysine+in+peptide+substrates+as+a+general+approach+to+inhibiting+human+NAD-dependent+protein+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Substituting Nε-thioacetyl-lysine for Nε-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD+-dependent protein deacetylases</span></div><div class="casAuthors">Fatkins, David G.; Zheng, Weiping</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">Inhibitors of human NAD+-dependent protein deacetylases possess great value for deciphering the biol. of these enzymes and as potential therapeutics for metabolic and age-related diseases and cancer.  In the current study, we have exptl. demonstrated that, the potent inhibition we obtained previously for one of these enzymes (i.e. sirtuin type 1 (SIRT1)) by simply replacing Nε-thioacetyl-lysine for Nε-acetyl-lysine in its peptide substrate, represented a general and efficient strategy to develop potent and selective inhibitors of human NAD+-dependent protein deacetylase enzymes.  Indeed, by using this simple inhibition strategy, potent (low-micromolar) and selective (≤40-fold) SIRT2 and SIRT3 inhibitors, which were either comparable or superior to currently existing inhibitors, have also been quickly identified in the current study.  These inhibitors could be used as chem. biol. tools or as lead compds. for further focused structure-activity optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzCcE-RRm9S7Vg90H21EOLACvtfcHk0lgcCNJeHxb6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1eltb0%253D&md5=e529577e63c20c549304713b0da68c59</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fijms9010001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms9010001%26sid%3Dliteratum%253Aachs%26aulast%3DFatkins%26aufirst%3DD.%2BG.%26aulast%3DZheng%26aufirst%3DW.%26atitle%3DSubstituting%2520N-thioacetyl-lysine%2520for%2520N-acetyl-lysine%2520in%2520peptide%2520substrates%2520as%2520a%2520general%2520approach%2520to%2520inhibiting%2520human%2520NAD-dependent%2520protein%2520deacetylases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2008%26volume%3D9%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">37256</span><span class="NLM_x">–</span> <span class="NLM_lpage">37265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1074%2Fjbc.M707878200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=17951578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVamurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=37256-37265&author=B.+C.+Smithauthor=J.+M.+Denu&title=Acetyl-lysine+analog+peptides+as+mechanistic+probes+of+protein+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Acetyl-lysine Analog Peptides as Mechanistic Probes of Protein Deacetylases</span></div><div class="casAuthors">Smith, Brian C.; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">37256-37265</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Class III histone deacetylases (Sir2 or sirtuins) catalyze the NAD+-dependent conversion of acetyl-lysine residues to nicotinamide, 2'-O-acetyl-ADP-ribose (OAADPr), and deacetylated lysine.  Class I and II HDACs utilize a different deacetylation mechanism, utilizing an active site zinc to direct hydrolysis of acetyl-lysine residues to lysine and acetate.  Here, using ten acetyl-lysine analog peptides, we have probed the substrate binding pockets of sirtuins and investigated the catalytic differences among sirtuins and class I and II deacetylases.  For the sirtuin Hst2, acetyl-lysine analog peptide binding correlated with the hydrophobic substituent parameter π with a slope of -0.35 from a plot of log Kd vs. π.  Interestingly, propionyl- and butyryl-lysine peptides were found to bind tighter to Hst2 compared with acetyl-lysine peptide and showed measurable rates of catalysis with Hst2, Sirt1, Sirt2, and Sirt3, suggesting propionyl- and butyryl-lysine proteins may be sirtuin substrates in vivo.  Unique among the acetyl-lysine analog peptides examd., homocitrulline peptide produced ADP-ribose instead of the corresponding OAADPr analog.  The electron-withdrawing nature of each acetyl analog had a profound impact on the deacylation rate between deacetylase classes.  The rate of catalysis with the acetyl-lysine analog peptides varied over five orders of magnitude with the class III deacetylase Hst2, revealing a linear free energy relationship with a slope of -1.57 when plotted vs. the Taft const., σ*.  HDAC8, a class I deacetylase, displayed the opposite trend with a slope of +0.79.  These results are applicable toward the development of selective substrates and other mechanistic probes of protein deacetylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAtaU7ZQLTgbVg90H21EOLACvtfcHk0lgcCNJeHxb6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVamurjP&md5=a7dbda2619674194d7b60ec6e727d604</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707878200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707878200%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DAcetyl-lysine%2520analog%2520peptides%2520as%2520mechanistic%2520probes%2520of%2520protein%2520deacetylases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D37256%26epage%3D37265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5670</span><span class="NLM_x">–</span> <span class="NLM_lpage">5672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5670-5672&author=T.+Suzukiauthor=T.+Asabaauthor=E.+Imaiauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=N.+Miyata&title=Identification+of+a+cell-active+non-peptide+sirtuin+inhibitor+containing+N-thioacetyl+lysine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DAsaba%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DE.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520a%2520cell-active%2520non-peptide%2520sirtuin%2520inhibitor%2520containing%2520N-thioacetyl%2520lysine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5670%26epage%3D5672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kiviranta, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tervonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E. M.</span><span> </span><span class="NLM_article-title">N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801401k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2153-2156&author=P.+H.+Kivirantaauthor=T.+Suuronenauthor=E.+A.+A.+Wall%C3%A9nauthor=J.+Lepp%C3%A4nenauthor=J.+Tervonenauthor=S.+Kyrylenkoauthor=A.+Salminenauthor=A.+Posoauthor=E.+M.+Jarho&title=N%28epsilon%29-thioacetyl-lysine-containing+tri-%2C+tetra-%2C+and+pentapeptides+as+SIRT1+and+SIRT2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm801401k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801401k%26sid%3Dliteratum%253Aachs%26aulast%3DKiviranta%26aufirst%3DP.%2BH.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DTervonen%26aufirst%3DJ.%26aulast%3DKyrylenko%26aufirst%3DS.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DJarho%26aufirst%3DE.%2BM.%26atitle%3DN%2528epsilon%2529-thioacetyl-lysine-containing%2520tri-%252C%2520tetra-%252C%2520and%2520pentapeptides%2520as%2520SIRT1%2520and%2520SIRT2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2153%26epage%3D2156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Huhtiniemi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruijn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jääskeläinen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E.</span><span> </span><span class="NLM_article-title">N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5616</span><span class="NLM_x">–</span> <span class="NLM_lpage">5625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5616-5625&author=T.+Huhtiniemiauthor=T.+Suuronenauthor=M.+Lahtela-Kakkonenauthor=T.+Bruijnauthor=S.+J%C3%A4%C3%A4skel%C3%A4inenauthor=A.+Posoauthor=A.+Salminenauthor=J.+Lepp%C3%A4nenauthor=E.+Jarho&title=N%28epsilon%29-Modified+lysine+containing+inhibitors+for+SIRT1+and+SIRT2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuhtiniemi%26aufirst%3DT.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DBruijn%26aufirst%3DT.%26aulast%3DJ%25C3%25A4%25C3%25A4skel%25C3%25A4inen%26aufirst%3DS.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DJarho%26aufirst%3DE.%26atitle%3DN%2528epsilon%2529-Modified%2520lysine%2520containing%2520inhibitors%2520for%2520SIRT1%2520and%2520SIRT2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5616%26epage%3D5625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">14478</span><span class="NLM_x">–</span> <span class="NLM_lpage">14486</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7013294" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlaktbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=14478-14486&author=B.+C.+Smithauthor=J.+M.+Denu&title=Mechanism-based+inhibition+of+Sir2+deacetylases+by+thioacetyl-lysine+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inhibition of Sir2 Deacetylases by Thioacetyl-Lysine Peptide</span></div><div class="casAuthors">Smith, Brian C.; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">14478-14486</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sir2 protein deacetylases (or sirtuins) catalyze NAD+-dependent conversion of ε-amino-acetylated lysine residues to deacetylated lysine, nicotinamide, and 2'-O-acetyl-ADP-ribose.  Small-mol. modulation of sirtuin activity might treat age-assocd. diseases, such as type II diabetes, obesity, and neurodegenerative disorders.  Here, we have evaluated the mechanisms of sirtuin inhibition of histone peptides contg. thioacetyl or mono-, di-, and trifluoroacetyl groups at the ε-amino of lysine.  Although all substituted peptides yielded inhibition of the deacetylation reaction, the thioacetyl-lysine peptide exhibited exceptionally potent inhibition of sirtuins Sirt1, Sirt2, Sirt3, and Hst2.  Using Hst2 as a representative sirtuin, the trifluoroacetyl-lysine peptide displayed competitive inhibition with acetyl-lysine substrate and yielded an inhibition const. (Kis) of 4.8 μM, similar to its Kd value of 3.3 μM.  In contrast, inhibition by thioacetyl-lysine peptide yielded an inhibition const. (Kis) of 0.017 μM, 280-fold lower than its Kd value of 4.7 μM.  Examn. of thioacetyl-lysine peptide as an alternative sirtuin substrate revealed conserved prodn. of deacetylated peptide and 1'-SH-2'-O-acetyl-ADP-ribose.  Pre-steady-state and steady-state anal. of the thioacetyl-lysine peptide showed rapid nicotinamide formation (4.5 s-1) but slow overall turnover (0.0024 s-1), indicating that the reaction stalled at an intermediate after nicotinamide formation.  Mass spectral anal. yielded a novel species (m/z 1754.3) that is consistent with an ADP-ribose-peptidyl adduct (1'-S-alkylamidate) as the stalled intermediate.  Addnl. expts. involving solvent isotope effects, general base mutational anal., and d. functional calcns. are consistent with impaired 2'-hydroxyl attack on the ADP-ribose-peptidyl intermediate.  These results have implications for the development of mechanism-based inhibitors of Sir2 deacetylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq32NwFjRpaYrVg90H21EOLACvtfcHk0lg9389A0pKr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlaktbvO&md5=9056742159164b461b495f9c5ff3d8cf</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi7013294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7013294%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DMechanism-based%2520inhibition%2520of%2520Sir2%2520deacetylases%2520by%2520thioacetyl-lysine%2520peptide%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D14478%26epage%3D14486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">5802</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja070162w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=5802-5803&author=B.+C.+Smithauthor=J.+M.+Denu&title=Sir2+deacetylases+exhibit+nucleophilic+participation+of+acetyl-lysine+in+NAD%2B+cleavage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja070162w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja070162w%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DSir2%2520deacetylases%2520exhibit%2520nucleophilic%2520participation%2520of%2520acetyl-lysine%2520in%2520NAD%252B%2520cleavage%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D5802%26epage%3D5803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McGregor, D. P.</span><span> </span><span class="NLM_article-title">Discovering and improving novel peptide therapeutics</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1016%2Fj.coph.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18602024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=616-619&author=D.+P.+McGregor&title=Discovering+and+improving+novel+peptide+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering and improving novel peptide therapeutics</span></div><div class="casAuthors">McGregor, Duncan Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">616-619</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peptides have a no. of advantages over small mols. in terms of specificity and affinity for targets, and over antibodies in terms of size.  However, sensitivity to serum and tissue proteases coupled with short serum half-life has resulted in few recombinant library derived peptides, making the transition from lead to drug on the market.  Recently, a series of technologies have been developed to address both these issues: selection methodologies addressing protease resistance have been developed that when combined with methods such as pegylation antibody Fc attachment and binding to serum albumin look likely to finally turn therapeutic peptides into a widely accepted drug class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3f9m8QDMxWbVg90H21EOLACvtfcHk0lj4MuAk9Pzd-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLjM&md5=d80dfe343f1fd49d2943ea05e3a86f52</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcGregor%26aufirst%3DD.%2BP.%26atitle%3DDiscovering%2520and%2520improving%2520novel%2520peptide%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D616%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Asaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">6989</span><span class="NLM_x">–</span> <span class="NLM_lpage">6996</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja807083y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6989-6996&author=T.+Asabaauthor=T.+Suzukiauthor=R.+Uedaauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=N.+Miyata&title=Inhibition+of+human+sirtuins+by+in+situ+generation+of+an+acetylated+lysine-ADP-ribose+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja807083y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja807083y%26sid%3Dliteratum%253Aachs%26aulast%3DAsaba%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520human%2520sirtuins%2520by%2520in%2520situ%2520generation%2520of%2520an%2520acetylated%2520lysine-ADP-ribose%2520conjugate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D6989%26epage%3D6996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Huhtiniemi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittekindt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span> </span><span class="NLM_article-title">Comparative and pharmacophore model for deacetylase SIRT1</span> <span class="citation_source-journal">J. Comput.-Aided. Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=589-599&author=T.+Huhtiniemiauthor=C.+Wittekindtauthor=T.+Laitinenauthor=J.+Lepp%C3%A4nenauthor=A.+Salminenauthor=A.+Posoauthor=M.+Lahtela-Kakkonen&title=Comparative+and+pharmacophore+model+for+deacetylase+SIRT1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuhtiniemi%26aufirst%3DT.%26aulast%3DWittekindt%26aufirst%3DC.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26atitle%3DComparative%2520and%2520pharmacophore%2520model%2520for%2520deacetylase%2520SIRT1%26jtitle%3DJ.%2520Comput.-Aided.%2520Mol.%2520Des.%26date%3D2006%26volume%3D20%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the histone deacetylase SIRT2</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1038%2F89668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=11427894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=621-625&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=N.+P.+Pavletich&title=Structure+of+the+histone+deacetylase+SIRT2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the histone deacetylase SIRT2</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres, and ribosomal gene clusters, and plays a crit. role in the detn. of life span in yeast and Caenorhabditis elegans.  Here, the 1.7 Å crystal structure of the 323-amino-acid catalytic core of human SIRT2, a homolog of yeast Sir2, revealed an NAD-binding domain, which was a variant of the Rossmann fold, and a smaller domain composed of a helical module and a Zn-binding module.  A conserved large groove at the interface of the 2 domains was the likely site of catalysis based on mutagenesis.  Intersecting this large groove, there was a pocket formed by the helical module.  The pocket was lined with hydrophobic residues conserved within each of the 5 Sir2 classes, suggesting that it is a class-specific protein-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNi1R8KPeQ7Vg90H21EOLACvtfcHk0lj4MuAk9Pzd-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D&md5=6d305c420bff2690da780fc23938c22f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F89668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89668%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520histone%2520deacetylase%2520SIRT2%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D621%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirousek, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Crystal structures of human SIRT3 displaying substrate-induced conformational changes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">24394</span><span class="NLM_x">–</span> <span class="NLM_lpage">24405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=24394-24405&author=L.+Jinauthor=W.+Weiauthor=Y.+Jiangauthor=H.+Pengauthor=J.+Caiauthor=C.+Maoauthor=H.+Daiauthor=W.+Choyauthor=J.+E.+Bemisauthor=M.+R.+Jirousekauthor=J.+C.+Milneauthor=C.+H.+Westphalauthor=R.+B.+Perni&title=Crystal+structures+of+human+SIRT3+displaying+substrate-induced+conformational+changes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DChoy%26aufirst%3DW.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26aulast%3DWestphal%26aufirst%3DC.%2BH.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DCrystal%2520structures%2520of%2520human%2520SIRT3%2520displaying%2520substrate-induced%2520conformational%2520changes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D24394%26epage%3D24405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cosgrove, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bever, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avalos, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">The structural basis of sirtuin substrate affinity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">7511</span><span class="NLM_x">–</span> <span class="NLM_lpage">7521</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0526332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=7511-7521&author=M.+S.+Cosgroveauthor=K.+Beverauthor=J.+L.+Avalosauthor=S.+Muhammadauthor=X.+Zhangauthor=C.+Wolberger&title=The+structural+basis+of+sirtuin+substrate+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi0526332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0526332%26sid%3Dliteratum%253Aachs%26aulast%3DCosgrove%26aufirst%3DM.%2BS.%26aulast%3DBever%26aufirst%3DK.%26aulast%3DAvalos%26aufirst%3DJ.%2BL.%26aulast%3DMuhammad%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DThe%2520structural%2520basis%2520of%2520sirtuin%2520substrate%2520affinity%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D7511%26epage%3D7521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span> <span class="citation_source-book">MOE (The Molecular Operating Environment)</span>, Version 2008.10 and 2009.10; software available from <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>, <span class="NLM_publisher-loc">1010 Sherbrooke Street West, Suite 910, Montreal, Canada H3A 2R7</span>. <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28The+Molecular+Operating+Environment%29%2C+Version+2008.10+and+2009.10%3B+software+available+from+Chemical+Computing+Group+Inc.%2C+1010+Sherbrooke+Street+West%2C+Suite+910%2C+Montreal%2C+Canada+H3A+2R7.+http%3A%2F%2Fwww.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMOE%2520%2528The%2520Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Solomon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasupuleti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, L. J.</span><span> </span><span class="NLM_article-title">Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1128%2FMCB.26.1.28-38.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=16354677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslaqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=28-38&author=J.+M.+Solomonauthor=R.+Pasupuletiauthor=L.+Xuauthor=T.+McDonaghauthor=R.+Curtisauthor=P.+S.+DiStefanoauthor=L.+J.+Huber&title=Inhibition+of+SIRT1+catalytic+activity+increases+p53+acetylation+but+does+not+alter+cell+survival+following+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage</span></div><div class="casAuthors">Solomon, Jonathan M.; Pasupuleti, Rao; Xu, Lei; McDonagh, Thomas; Curtis, Rory; DiStefano, Peter S.; Huber, L. Julie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-38</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human SIRT1 is an enzyme that deacetylates the p53 tumor suppressor protein and has been suggested to modulate p53-dependent functions including DNA damage-induced cell death.  In this report, we used EX-527, a novel, potent, and specific small-mol. inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage.  Treatment with EX-527 dramatically increased acetylation at lysine 382 of p53 after different types of DNA damage in primary human mammary epithelial cells and several cell lines.  Significantly, inhibition of SIRT1 catalytic activity by EX-527 had no effect on cell growth, viability, or p53-controlled gene expression in cells treated with etoposide.  Acetyl-p53 was also increased by the histone deacetylase (HDAC) class I/II inhibitor trichostatin A (TSA).  EX-527 and TSA acted synergistically to increase acetyl-p53 levels, confirming that p53 acetylation is regulated by both SIRT1 and HDACs.  While TSA alone reduced cell survival after DNA damage, the combination of EX-527 and TSA had no further effect on cell viability and growth.  These results show that, although SIRT1 deacetylates p53, this does not play a role in cell survival following DNA damage in certain cell lines and primary human mammary epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8llXW_ws_q7Vg90H21EOLACvtfcHk0liHYh48hMjjHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslaqsLs%253D&md5=bb10711590ed785b57bbad6dcde66911</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.1.28-38.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.1.28-38.2006%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DJ.%2BM.%26aulast%3DPasupuleti%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMcDonagh%26aufirst%3DT.%26aulast%3DCurtis%26aufirst%3DR.%26aulast%3DDiStefano%26aufirst%3DP.%2BS.%26aulast%3DHuber%26aufirst%3DL.%2BJ.%26atitle%3DInhibition%2520of%2520SIRT1%2520catalytic%2520activity%2520increases%2520p53%2520acetylation%2520but%2520does%2520not%2520alter%2520cell%2520survival%2520following%2520DNA%2520damage%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D28%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span> <span class="citation_source-book">LigPrep</span>, version 2.3; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span> <span class="citation_source-book">Epik</span>, version 2.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DEpik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span> <span class="citation_source-book">CombiGlide</span>, version 2.5; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CombiGlide%2C+version+2.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DCombiGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span> <span class="citation_source-book">Glide</span>, version 5.5; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span> <span class="citation_source-book">Schrödinger Suite 2009 Protein Preparation Wizard, Epik version 2.0; Impact version 5.5; Prime version 2.1</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2009+Protein+Preparation+Wizard%2C+Epik+version+2.0%3B+Impact+version+5.5%3B+Prime+version+2.1%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Suite%25202009%2520Protein%2520Preparation%2520Wizard%252C%2520Epik%2520version%25202.0%253B%2520Impact%2520version%25205.5%253B%2520Prime%2520version%25202.1%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kerwin, S. M.</span><span> </span><span class="NLM_article-title">ChemBioOffice Ultra 2010 suite</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">2466</span><span class="NLM_x">–</span> <span class="NLM_lpage">2467</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja1005306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=2466-2467&author=S.+M.+Kerwin&title=ChemBioOffice+Ultra+2010+suite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja1005306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja1005306%26sid%3Dliteratum%253Aachs%26aulast%3DKerwin%26aufirst%3DS.%2BM.%26atitle%3DChemBioOffice%2520Ultra%25202010%2520suite%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D2466%26epage%3D2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span> <span class="citation_source-book">Discovery Studio Modeling Environment</span>, Release 2.5; <span class="NLM_publisher-name">Accelrys Software Inc.</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discovery+Studio+Modeling+Environment%2C+Release+2.5%3B+Accelrys+Software+Inc.%3A+San+Diego%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDiscovery%2520Studio%2520Modeling%2520Environment%26pub%3DAccelrys%2520Software%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span> </span><span class="NLM_article-title">The Universal Protein Resource (UniProt) in 2010</span>.  <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">D142</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Universal+Protein+Resource+%28UniProt%29+in+2010.+Nucleic+Acids+Res.+2010%2C+38%2C+D142%E2%80%93148."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520Universal%2520Protein%2520Resource%2520%2528UniProt%2529%2520in%25202010%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2010%26volume%3D38%26spage%3DD142%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Larkin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackshields, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGettigan, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWilliam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span> </span><span class="NLM_article-title">Clustal W and Clustal X</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2947</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=2947-2948&author=M.+A.+Larkinauthor=G.+Blackshieldsauthor=N.+P.+Brownauthor=R.+Chennaauthor=P.+A.+McGettiganauthor=H.+McWilliamauthor=F.+Valentinauthor=I.+M.+Wallaceauthor=A.+Wilmauthor=R.+Lopezauthor=J.+D.+Thompsonauthor=T.+J.+Gibsonauthor=D.+G.+Higgins&title=Clustal+W+and+Clustal+X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DM.%2BA.%26aulast%3DBlackshields%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DN.%2BP.%26aulast%3DChenna%26aufirst%3DR.%26aulast%3DMcGettigan%26aufirst%3DP.%2BA.%26aulast%3DMcWilliam%26aufirst%3DH.%26aulast%3DValentin%26aufirst%3DF.%26aulast%3DWallace%26aufirst%3DI.%2BM.%26aulast%3DWilm%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26atitle%3DClustal%2520W%2520and%2520Clustal%2520X%26jtitle%3DBioinformatics%26date%3D2007%26volume%3D23%26spage%3D2947%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Waterhouse, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clamp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, G. J.</span><span> </span><span class="NLM_article-title">Jalview Version 2—a multiple sequence alignment editor and analysis workbench</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1189</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=1189-1191&author=A.+M.+Waterhouseauthor=J.+B.+Procterauthor=D.+M.+Martinauthor=M.+Clampauthor=G.+J.+Barton&title=Jalview+Version+2%E2%80%94a+multiple+sequence+alignment+editor+and+analysis+workbench"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DA.%2BM.%26aulast%3DProcter%26aufirst%3DJ.%2BB.%26aulast%3DMartin%26aufirst%3DD.%2BM.%26aulast%3DClamp%26aufirst%3DM.%26aulast%3DBarton%26aufirst%3DG.%2BJ.%26atitle%3DJalview%2520Version%25202%25E2%2580%2594a%2520multiple%2520sequence%2520alignment%2520editor%2520and%2520analysis%2520workbench%26jtitle%3DBioinformatics%26date%3D2009%26volume%3D25%26spage%3D1189%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span> <span class="citation_source-book">rmsd.py version 1.14.2.6, Maestro version 9.1</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=rmsd.py+version+1.14.2.6%2C+Maestro+version+9.1%3B+Schrodinger%2C+LLC%3A+New+York%2C+NY%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3Drmsd.py%2520version%25201.14.2.6%252C%2520Maestro%2520version%25209.1%26pub%3DSchrodinger%252C%2520LLC%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Tervo, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niskanen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyrönen, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span> </span><span class="NLM_article-title">An in silico approach to discovering novel inhibitors of human sirtuin type 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6292</span><span class="NLM_x">–</span> <span class="NLM_lpage">6298</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049933m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6292-6298&author=A.+J.+Tervoauthor=S.+Kyrylenkoauthor=P.+Niskanenauthor=A.+Salminenauthor=J.+Lepp%C3%A4nenauthor=T.+H.+Nyr%C3%B6nenauthor=T.+J%C3%A4rvinenauthor=A.+Poso&title=An+in+silico+approach+to+discovering+novel+inhibitors+of+human+sirtuin+type+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm049933m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049933m%26sid%3Dliteratum%253Aachs%26aulast%3DTervo%26aufirst%3DA.%2BJ.%26aulast%3DKyrylenko%26aufirst%3DS.%26aulast%3DNiskanen%26aufirst%3DP.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DNyr%25C3%25B6nen%26aufirst%3DT.%2BH.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DPoso%26aufirst%3DA.%26atitle%3DAn%2520in%2520silico%2520approach%2520to%2520discovering%2520novel%2520inhibitors%2520of%2520human%2520sirtuin%2520type%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6292%26epage%3D6298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kiviranta, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuusisto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tervo, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span> </span><span class="NLM_article-title">N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2448</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2448-2451&author=P.+H.+Kivirantaauthor=J.+Lepp%C3%A4nenauthor=V.+M.+Rinneauthor=T.+Suuronenauthor=O.+Kyrylenkoauthor=S.+Kyrylenkoauthor=E.+Kuusistoauthor=A.+J.+Tervoauthor=T.+J%C3%A4rvinenauthor=A.+Salminenauthor=A.+Posoauthor=E.+A.+A.+Wall%C3%A9n&title=N-%283-%284-Hydroxyphenyl%29-propenoyl%29-amino+acid+tryptamides+as+SIRT2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiviranta%26aufirst%3DP.%2BH.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DRinne%26aufirst%3DV.%2BM.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DKyrylenko%26aufirst%3DO.%26aulast%3DKyrylenko%26aufirst%3DS.%26aulast%3DKuusisto%26aufirst%3DE.%26aulast%3DTervo%26aufirst%3DA.%2BJ.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26atitle%3DN-%25283-%25284-Hydroxyphenyl%2529-propenoyl%2529-amino%2520acid%2520tryptamides%2520as%2520SIRT2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2448%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chunpu Li, Sha-Sha Hu, Lisheng Yang, Min Wang, Jian-Dong Long, Bing Wang, Haozhen Han, Haoran Zhu, Sen Zhao, Jing-Gen Liu, Dongxiang Liu, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-Benzylidene-2-phenyl-1,3-dioxane-4,6-diones as Highly Potent and Selective SIRT1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 397-403. <a href="https://doi.org/10.1021/acsmedchemlett.0c00559" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00559%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5-Benzylidene-2-phenyl-1%25252C3-dioxane-4%25252C6-diones%252Bas%252BHighly%252BPotent%252Band%252BSelective%252BSIRT1%252BInhibitors%26aulast%3DLi%26aufirst%3DChunpu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D18102020%26date%3D22022021%26date%3D01032021%26volume%3D12%26issue%3D3%26spage%3D397%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Sundriyal</span>, <span class="hlFld-ContribAuthor ">Sébastien  Moniot</span>, <span class="hlFld-ContribAuthor ">Zimam  Mahmud</span>, <span class="hlFld-ContribAuthor ">Shang  Yao</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Reynolds</span>, <span class="hlFld-ContribAuthor ">David T.  Dexter</span>, <span class="hlFld-ContribAuthor ">Michael J. E.  Sternberg</span>, <span class="hlFld-ContribAuthor ">Eric W.-F.  Lam</span>, <span class="hlFld-ContribAuthor ">Clemens  Steegborn</span>, and <span class="hlFld-ContribAuthor ">Matthew J.  Fuchter</span>  . </span><span class="cited-content_cbyCitation_article-title">Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1928-1945. <a href="https://doi.org/10.1021/acs.jmedchem.6b01690" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01690%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThienopyrimidinone%252BBased%252BSirtuin-2%252B%252528SIRT2%252529-Selective%252BInhibitors%252BBind%252Bin%252Bthe%252BLigand%252BInduced%252BSelectivity%252BPocket%26aulast%3DSundriyal%26aufirst%3DSandeep%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D17112016%26date%3D15022017%26date%3D09032017%26date%3D30012017%26volume%3D60%26issue%3D5%26spage%3D1928%26epage%3D1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Qiu</span>, <span class="hlFld-ContribAuthor ">Lixin  Gao</span>, <span class="hlFld-ContribAuthor ">Jixing  Tang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Guo</span>, <span class="hlFld-ContribAuthor ">Shunying  Liu</span>, <span class="hlFld-ContribAuthor ">Liping  Yang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, and <span class="hlFld-ContribAuthor ">Wenhao  Hu</span>  . </span><span class="cited-content_cbyCitation_article-title">Regio- and Diastereoselective Construction of α-Hydroxy-δ-amino Ester Derivatives via 1,4-Conjugate Addition of β,γ-Unsaturated N-Sulfonylimines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (9)
                                     , 4142-4147. <a href="https://doi.org/10.1021/jo500176g" title="DOI URL">https://doi.org/10.1021/jo500176g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo500176g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo500176g%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegio-%252Band%252BDiastereoselective%252BConstruction%252Bof%252B%2525CE%2525B1-Hydroxy-%2525CE%2525B4-amino%252BEster%252BDerivatives%252Bvia%252B1%25252C4-Conjugate%252BAddition%252Bof%252B%2525CE%2525B2%25252C%2525CE%2525B3-Unsaturated%252BN-Sulfonylimines%26aulast%3DQiu%26aufirst%3DLin%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30012014%26date%3D15042014%26date%3D02052014%26date%3D01042014%26volume%3D79%26issue%3D9%26spage%3D4142%26epage%3D4147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Mellini</span>, <span class="hlFld-ContribAuthor ">Tarja  Kokkola</span>, <span class="hlFld-ContribAuthor ">Tiina  Suuronen</span>, <span class="hlFld-ContribAuthor ">Heikki S.  Salo</span>, <span class="hlFld-ContribAuthor ">Laura  Tolvanen</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>, and <span class="hlFld-ContribAuthor ">Elina M.  Jarho</span>  . </span><span class="cited-content_cbyCitation_article-title">Screen of Pseudopeptidic Inhibitors of Human Sirtuins 1–3: Two Lead Compounds with Antiproliferative Effects in Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6681-6695. <a href="https://doi.org/10.1021/jm400438k" title="DOI URL">https://doi.org/10.1021/jm400438k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400438k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400438k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScreen%252Bof%252BPseudopeptidic%252BInhibitors%252Bof%252BHuman%252BSirtuins%252B1%2525E2%252580%2525933%25253A%252BTwo%252BLead%252BCompounds%252Bwith%252BAntiproliferative%252BEffects%252Bin%252BCancer%252BCells%26aulast%3DMellini%26aufirst%3DPaolo%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26032013%26date%3D22082013%26date%3D12092013%26date%3D08082013%26volume%3D56%26issue%3D17%26spage%3D6681%26epage%3D6695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Tamer M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Simon M.  Vogel</span>, and <span class="hlFld-ContribAuthor ">Frank M.  Boeckler</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0 – A Public Library of Challenging Docking Benchmark Sets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (6)
                                     , 1447-1462. <a href="https://doi.org/10.1021/ci400115b" title="DOI URL">https://doi.org/10.1021/ci400115b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400115b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400115b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Band%252BOptimization%252Bof%252BVirtual%252BScreening%252BWorkflows%252Bwith%252BDEKOIS%252B2.0%252B%2525E2%252580%252593%252BA%252BPublic%252BLibrary%252Bof%252BChallenging%252BDocking%252BBenchmark%252BSets%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19022013%26date%3D12062013%26date%3D24062013%26date%3D25052013%26volume%3D53%26issue%3D6%26spage%3D1447%26epage%3D1462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy S.  Disch</span>, <span class="hlFld-ContribAuthor ">Ghotas  Evindar</span>, <span class="hlFld-ContribAuthor ">Cynthia H.  Chiu</span>, <span class="hlFld-ContribAuthor ">Charles A.  Blum</span>, <span class="hlFld-ContribAuthor ">Han  Dai</span>, <span class="hlFld-ContribAuthor ">Lei  Jin</span>, <span class="hlFld-ContribAuthor ">Eli  Schuman</span>, <span class="hlFld-ContribAuthor ">Kenneth E.  Lind</span>, <span class="hlFld-ContribAuthor ">Svetlana L.  Belyanskaya</span>, <span class="hlFld-ContribAuthor ">Jianghe  Deng</span>, <span class="hlFld-ContribAuthor ">Frank  Coppo</span>, <span class="hlFld-ContribAuthor ">Leah  Aquilani</span>, <span class="hlFld-ContribAuthor ">Todd L.  Graybill</span>, <span class="hlFld-ContribAuthor ">John W.  Cuozzo</span>, <span class="hlFld-ContribAuthor ">Siva  Lavu</span>, <span class="hlFld-ContribAuthor ">Cheney  Mao</span>, <span class="hlFld-ContribAuthor ">George P.  Vlasuk</span>, and <span class="hlFld-ContribAuthor ">Robert B.  Perni</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (9)
                                     , 3666-3679. <a href="https://doi.org/10.1021/jm400204k" title="DOI URL">https://doi.org/10.1021/jm400204k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400204k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400204k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BThieno%25255B3%25252C2-d%25255Dpyrimidine-6-carboxamides%252Bas%252BPotent%252BInhibitors%252Bof%252BSIRT1%25252C%252BSIRT2%25252C%252Band%252BSIRT3%26aulast%3DDisch%26aufirst%3DJeremy%2BS.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D07022013%26date%3D29042013%26date%3D09052013%26date%3D09042013%26volume%3D56%26issue%3D9%26spage%3D3666%26epage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piia  Kokkonen</span>, <span class="hlFld-ContribAuthor ">Minna  Rahnasto-Rilla</span>, <span class="hlFld-ContribAuthor ">Päivi H.  Kiviranta</span>, <span class="hlFld-ContribAuthor ">Tero  Huhtiniemi</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Elina  Jarho</span>, and <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>  . </span><span class="cited-content_cbyCitation_article-title">Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (12)
                                     , 969-974. <a href="https://doi.org/10.1021/ml300139n" title="DOI URL">https://doi.org/10.1021/ml300139n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300139n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300139n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPeptides%252Band%252BPseudopeptides%252Bas%252BSIRT6%252BDeacetylation%252BInhibitors%26aulast%3DKokkonen%26aufirst%3DPiia%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D04062012%26date%3D23102012%26date%3D26102012%26date%3D13122012%26date%3D23102012%26volume%3D3%26issue%3D12%26spage%3D969%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas S.  Madsen</span> and <span class="hlFld-ContribAuthor ">Christian A.  Olsen</span>  . </span><span class="cited-content_cbyCitation_article-title">Substrates for Efficient Fluorometric Screening Employing the NAD-Dependent Sirtuin 5 Lysine Deacylase (KDAC) Enzyme. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (11)
                                     , 5582-5590. <a href="https://doi.org/10.1021/jm300526r" title="DOI URL">https://doi.org/10.1021/jm300526r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300526r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300526r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstrates%252Bfor%252BEfficient%252BFluorometric%252BScreening%252BEmploying%252Bthe%252BNAD-Dependent%252BSirtuin%252B5%252BLysine%252BDeacylase%252B%252528KDAC%252529%252BEnzyme%26aulast%3DMadsen%26aufirst%3DAndreas%2BS.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D13042012%26date%3D24052012%26date%3D14062012%26date%3D15052012%26volume%3D55%26issue%3D11%26spage%3D5582%26epage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Cruz-Vicente</span>, <span class="hlFld-ContribAuthor ">Luís A.  Passarinha</span>, <span class="hlFld-ContribAuthor ">Samuel  Silvestre</span>, <span class="hlFld-ContribAuthor ">Eugenia  Gallardo</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (8)
                                     , 2193. <a href="https://doi.org/10.3390/molecules26082193" title="DOI URL">https://doi.org/10.3390/molecules26082193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26082193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26082193%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BDevelopments%252Bin%252BNew%252BTherapeutic%252BAgents%252Bagainst%252BAlzheimer%252Band%252BParkinson%252BDiseases%25253A%252BIn-Silico%252BApproaches%26aulast%3DCruz-Vicente%26aufirst%3DPedro%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D8%26spage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Wenbo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging roles of SIRT6 in human diseases and its modulators. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (2)
                                     , 1089-1137. <a href="https://doi.org/10.1002/med.21753" title="DOI URL">https://doi.org/10.1002/med.21753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21753%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEmerging%252Broles%252Bof%252BSIRT6%252Bin%252Bhuman%252Bdiseases%252Band%252Bits%252Bmodulators%26aulast%3DLiu%26aufirst%3DGang%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D2%26spage%3D1089%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonam  Sinha</span>, <span class="hlFld-ContribAuthor ">Sonal  Sharma</span>, <span class="hlFld-ContribAuthor ">Jaykant  Vora</span>, <span class="hlFld-ContribAuthor ">Neeta  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of sirtuins in breast cancer metastasis and multidrug resistance: Implication for novel therapeutic strategies targeting sirtuins. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>158 </em>, 104880. <a href="https://doi.org/10.1016/j.phrs.2020.104880" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.104880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.104880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.104880%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DEmerging%252Brole%252Bof%252Bsirtuins%252Bin%252Bbreast%252Bcancer%252Bmetastasis%252Band%252Bmultidrug%252Bresistance%25253A%252BImplication%252Bfor%252Bnovel%252Btherapeutic%252Bstrategies%252Btargeting%252Bsirtuins%26aulast%3DSinha%26aufirst%3DSonam%26date%3D2020%26volume%3D158%26spage%3D104880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuins as Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 185-200. <a href="https://doi.org/10.1002/9783527809257.ch8" title="DOI URL">https://doi.org/10.1002/9783527809257.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527809257.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527809257.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DSirtuins%252Bas%252BDrug%252BTargets%26aulast%3DZwergel%26aufirst%3DClemens%26date%3D2019%26date%3D2019%26spage%3D185%26epage%3D200%26pub%3DWiley%26atitle%3DEpigenetic%252BDrug%252BDiscovery%26aulast%3DSippl%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26volume%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minna  Rahnasto-Rilla</span>, <span class="hlFld-ContribAuthor ">Jonna  Tyni</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin Inhibitors and Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 55-92. <a href="https://doi.org/10.1007/7355_2019_70" title="DOI URL">https://doi.org/10.1007/7355_2019_70</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_70%26sid%3Dliteratum%253Aachs%26atitle%3DSirtuin%252BInhibitors%252Band%252BActivators%26aulast%3DRahnasto-Rilla%26aufirst%3DMinna%26date%3D2019%26date%3D2019%26spage%3D55%26epage%3D92%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin E.  Bonomi</span>, <span class="hlFld-ContribAuthor ">Maxwell  Laws</span>, <span class="hlFld-ContribAuthor ">Vadim  Popov</span>, <span class="hlFld-ContribAuthor ">Swatabdi  Kamal</span>, <span class="hlFld-ContribAuthor ">Shreya  Potukutchi</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Shavrin</span>, <span class="hlFld-ContribAuthor ">Xin  Lu</span>, <span class="hlFld-ContribAuthor ">Nashaat  Turkman</span>, <span class="hlFld-ContribAuthor ">Ren-Shyan  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  Mangner</span>, <span class="hlFld-ContribAuthor ">Juri G.  Gelovani</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Substrate Radiotracer for Molecular Imaging of SIRT2 Expression and Activity with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2018,</strong> <em>20 </em>
                                    (4)
                                     , 594-604. <a href="https://doi.org/10.1007/s11307-017-1149-8" title="DOI URL">https://doi.org/10.1007/s11307-017-1149-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-017-1149-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-017-1149-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DA%252BNovel%252BSubstrate%252BRadiotracer%252Bfor%252BMolecular%252BImaging%252Bof%252BSIRT2%252BExpression%252Band%252BActivity%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DBonomi%26aufirst%3DRobin%2BE.%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D4%26spage%3D594%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Schiedel</span>, <span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Tobias  Rumpf</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>. </span><span class="cited-content_cbyCitation_article-title">The Current State of NAD
              +
              -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (1)
                                     , 147-200. <a href="https://doi.org/10.1002/med.21436" title="DOI URL">https://doi.org/10.1002/med.21436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21436%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252BCurrent%252BState%252Bof%252BNAD%252B%25252B%252B-Dependent%252BHistone%252BDeacetylases%252B%252528Sirtuins%252529%252Bas%252BNovel%252BTherapeutic%252BTargets%26aulast%3DSchiedel%26aufirst%3DMatthias%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D1%26spage%3D147%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nima  Rajabi</span>, <span class="hlFld-ContribAuthor ">Iacopo  Galleano</span>, <span class="hlFld-ContribAuthor ">Andreas S.  Madsen</span>, <span class="hlFld-ContribAuthor ">Christian A.  Olsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Sirtuins: Substrate Specificity and Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 25-69. <a href="https://doi.org/10.1016/bs.pmbts.2017.11.003" title="DOI URL">https://doi.org/10.1016/bs.pmbts.2017.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmbts.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmbts.2017.11.003%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BSirtuins%25253A%252BSubstrate%252BSpecificity%252Band%252BInhibitor%252BDesign%26aulast%3DRajabi%26aufirst%3DNima%26date%3D2018%26spage%3D25%26epage%3D69%26pub%3DElsevier%26atitle%3DSirtuins%252Bin%252BHealth%252Band%252BDisease%26date%3D2018%26volume%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanhong  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Liu</span>, <span class="hlFld-ContribAuthor ">Di  Chen</span>, <span class="hlFld-ContribAuthor ">Lingling  Yan</span>, <span class="hlFld-ContribAuthor ">Weiping  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2017,</strong> <em>38 </em>
                                    (5)
                                     , 459-472. <a href="https://doi.org/10.1016/j.tips.2017.01.009" title="DOI URL">https://doi.org/10.1016/j.tips.2017.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2017.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2017.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DSirtuin%252BInhibition%25253A%252BStrategies%25252C%252BInhibitors%25252C%252Band%252BTherapeutic%252BPotential%26aulast%3DJiang%26aufirst%3DYanhong%26date%3D2017%26volume%3D38%26issue%3D5%26spage%3D459%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Carafa</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Mariantonietta  Forgione</span>, <span class="hlFld-ContribAuthor ">Francesca  Cuomo</span>, <span class="hlFld-ContribAuthor ">Enrica  Serretiello</span>, <span class="hlFld-ContribAuthor ">Gebremedhin Solomon  Hailu</span>, <span class="hlFld-ContribAuthor ">Elina  Jarho</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin functions and modulation: from chemistry to the clinic. </span><span class="cited-content_cbyCitation_journal-name">Clinical Epigenetics</span><span> <strong>2016,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13148-016-0224-3" title="DOI URL">https://doi.org/10.1186/s13148-016-0224-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13148-016-0224-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13148-016-0224-3%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Epigenetics%26atitle%3DSirtuin%252Bfunctions%252Band%252Bmodulation%25253A%252Bfrom%252Bchemistry%252Bto%252Bthe%252Bclinic%26aulast%3DCarafa%26aufirst%3DVincenzo%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunan  Sun</span>, <span class="hlFld-ContribAuthor ">Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Hongmei  Zhu</span>, <span class="hlFld-ContribAuthor ">Siu-wai  Leung</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep19312" title="DOI URL">https://doi.org/10.1038/srep19312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep19312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep19312%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DLigand-based%252Bvirtual%252Bscreening%252Band%252Binductive%252Blearning%252Bfor%252Bidentification%252Bof%252BSIRT1%252Binhibitors%252Bin%252Bnatural%252Bproducts%26aulast%3DSun%26aufirst%3DYunan%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Berin  Karaman</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Computational Studies of Sirtuin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 297-325. <a href="https://doi.org/10.1016/B978-0-12-802808-7.00011-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-802808-7.00011-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802808-7.00011-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802808-7.00011-3%26sid%3Dliteratum%253Aachs%26atitle%3DStructure-Based%252BDesign%252Band%252BComputational%252BStudies%252Bof%252BSirtuin%252BInhibitors%26aulast%3DKaraman%26aufirst%3DBerin%26date%3D2016%26spage%3D297%26epage%3D325%26pub%3DElsevier%26atitle%3DEpi-Informatics%26date%3D2016%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piia  Kokkonen</span>, <span class="hlFld-ContribAuthor ">Minna  Rahnasto-Rilla</span>, <span class="hlFld-ContribAuthor ">Paolo  Mellini</span>, <span class="hlFld-ContribAuthor ">Elina  Jarho</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>, <span class="hlFld-ContribAuthor ">Tarja  Kokkola</span>. </span><span class="cited-content_cbyCitation_article-title">Studying SIRT6 regulation using H3K56 based substrate and small molecules. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2014,</strong> <em>63 </em>, 71-76. <a href="https://doi.org/10.1016/j.ejps.2014.06.015" title="DOI URL">https://doi.org/10.1016/j.ejps.2014.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2014.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2014.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DStudying%252BSIRT6%252Bregulation%252Busing%252BH3K56%252Bbased%252Bsubstrate%252Band%252Bsmall%252Bmolecules%26aulast%3DKokkonen%26aufirst%3DPiia%26date%3D2014%26volume%3D63%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piia  Kokkonen</span>, <span class="hlFld-ContribAuthor ">Paolo  Mellini</span>, <span class="hlFld-ContribAuthor ">Olli  Nyrhilä</span>, <span class="hlFld-ContribAuthor ">Minna  Rahnasto-Rilla</span>, <span class="hlFld-ContribAuthor ">Tiina  Suuronen</span>, <span class="hlFld-ContribAuthor ">Päivi  Kiviranta</span>, <span class="hlFld-ContribAuthor ">Tero  Huhtiniemi</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Elina  Jarho</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative insights for the design of substrate-based SIRT1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2014,</strong> <em>59 </em>, 12-19. <a href="https://doi.org/10.1016/j.ejps.2014.04.003" title="DOI URL">https://doi.org/10.1016/j.ejps.2014.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2014.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DQuantitative%252Binsights%252Bfor%252Bthe%252Bdesign%252Bof%252Bsubstrate-based%252BSIRT1%252Binhibitors%26aulast%3DKokkonen%26aufirst%3DPiia%26date%3D2014%26volume%3D59%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarja  Kokkola</span>, <span class="hlFld-ContribAuthor ">Tiina  Suuronen</span>, <span class="hlFld-ContribAuthor ">Ferdinand  Molnár</span>, <span class="hlFld-ContribAuthor ">Juha  Määttä</span>, <span class="hlFld-ContribAuthor ">Antero  Salminen</span>, <span class="hlFld-ContribAuthor ">Elina M.  Jarho</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>. </span><span class="cited-content_cbyCitation_article-title">AROS has a context-dependent effect on SIRT1. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2014,</strong> <em>588 </em>
                                    (9)
                                     , 1523-1528. <a href="https://doi.org/10.1016/j.febslet.2014.03.020" title="DOI URL">https://doi.org/10.1016/j.febslet.2014.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.febslet.2014.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.febslet.2014.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DAROS%252Bhas%252Ba%252Bcontext-dependent%252Beffect%252Bon%252BSIRT1%26aulast%3DKokkola%26aufirst%3DTarja%26date%3D2014%26date%3D2014%26volume%3D588%26issue%3D9%26spage%3D1523%26epage%3D1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago  Silva</span>, <span class="hlFld-ContribAuthor ">Joana  Reis</span>, <span class="hlFld-ContribAuthor ">José  Teixeira</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2014,</strong> <em>15 </em>, 116-145. <a href="https://doi.org/10.1016/j.arr.2014.03.008" title="DOI URL">https://doi.org/10.1016/j.arr.2014.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2014.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DAlzheimer%252527s%252Bdisease%25252C%252Benzyme%252Btargets%252Band%252Bdrug%252Bdiscovery%252Bstruggles%25253A%252BFrom%252Bnatural%252Bproducts%252Bto%252Bdrug%252Bprototypes%26aulast%3DSilva%26aufirst%3DTiago%26date%3D2014%26volume%3D15%26spage%3D116%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Hu</span>, <span class="hlFld-ContribAuthor ">Hui  Jing</span>, <span class="hlFld-ContribAuthor ">Hening  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (8)
                                     , 945-966. <a href="https://doi.org/10.4155/fmc.14.44" title="DOI URL">https://doi.org/10.4155/fmc.14.44</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.44%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSirtuin%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DHu%26aufirst%3DJing%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D945%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mike  Schutkowski</span>, <span class="hlFld-ContribAuthor ">Frank  Fischer</span>, <span class="hlFld-ContribAuthor ">Claudia  Roessler</span>, <span class="hlFld-ContribAuthor ">Clemens  Steegborn</span>. </span><span class="cited-content_cbyCitation_article-title">New assays and approaches for discovery and design of Sirtuin modulators. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , 183-199. <a href="https://doi.org/10.1517/17460441.2014.875526" title="DOI URL">https://doi.org/10.1517/17460441.2014.875526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2014.875526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2014.875526%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNew%252Bassays%252Band%252Bapproaches%252Bfor%252Bdiscovery%252Band%252Bdesign%252Bof%252BSirtuin%252Bmodulators%26aulast%3DSchutkowski%26aufirst%3DMike%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D183%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song  Song</span>, <span class="hlFld-ContribAuthor ">Shou-Fei  Zhu</span>, <span class="hlFld-ContribAuthor ">Liu-Yang  Pu</span>, <span class="hlFld-ContribAuthor ">Qi-Lin  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Iridium-Catalyzed Enantioselective Hydrogenation of Unsaturated Heterocyclic Acids. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2013,</strong> <em>125 </em>
                                    (23)
                                     , 6188-6191. <a href="https://doi.org/10.1002/ange.201301341" title="DOI URL">https://doi.org/10.1002/ange.201301341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201301341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201301341%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DIridium-Catalyzed%252BEnantioselective%252BHydrogenation%252Bof%252BUnsaturated%252BHeterocyclic%252BAcids%26aulast%3DSong%26aufirst%3DSong%26date%3D2013%26date%3D2013%26volume%3D125%26issue%3D23%26spage%3D6188%26epage%3D6191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song  Song</span>, <span class="hlFld-ContribAuthor ">Shou-Fei  Zhu</span>, <span class="hlFld-ContribAuthor ">Liu-Yang  Pu</span>, <span class="hlFld-ContribAuthor ">Qi-Lin  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Iridium-Catalyzed Enantioselective Hydrogenation of Unsaturated Heterocyclic Acids. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2013,</strong> <em>52 </em>
                                    (23)
                                     , 6072-6075. <a href="https://doi.org/10.1002/anie.201301341" title="DOI URL">https://doi.org/10.1002/anie.201301341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201301341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201301341%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DIridium-Catalyzed%252BEnantioselective%252BHydrogenation%252Bof%252BUnsaturated%252BHeterocyclic%252BAcids%26aulast%3DSong%26aufirst%3DSong%26date%3D2013%26date%3D2013%26volume%3D52%26issue%3D23%26spage%3D6072%26epage%3D6075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heikki S.  Salo</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Elina  Jarho</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel SIRT3 inhibitor scaffolds by virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 2990-2995. <a href="https://doi.org/10.1016/j.bmcl.2013.03.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnovel%252BSIRT3%252Binhibitor%252Bscaffolds%252Bby%252Bvirtual%252Bscreening%26aulast%3DSalo%26aufirst%3DHeikki%2BS.%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D2990%26epage%3D2995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica L.  Feldman</span>, <span class="hlFld-ContribAuthor ">Kristin E.  Dittenhafer-Reed</span>, <span class="hlFld-ContribAuthor ">John M.  Denu</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin Catalysis and Regulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2012,</strong> <em>287 </em>
                                    (51)
                                     , 42419-42427. <a href="https://doi.org/10.1074/jbc.R112.378877" title="DOI URL">https://doi.org/10.1074/jbc.R112.378877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.R112.378877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.R112.378877%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DSirtuin%252BCatalysis%252Band%252BRegulation%26aulast%3DFeldman%26aufirst%3DJessica%2BL.%26date%3D2012%26volume%3D287%26issue%3D51%26spage%3D42419%26epage%3D42427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soo Hyuk  Choi</span>, <span class="hlFld-ContribAuthor ">Luisa  Quinti</span>, <span class="hlFld-ContribAuthor ">Aleksey G.  Kazantsev</span>, <span class="hlFld-ContribAuthor ">Richard B.  Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">3-(N-Arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (8)
                                     , 2789-2793. <a href="https://doi.org/10.1016/j.bmcl.2012.02.089" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.02.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.02.089%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3-%252528N-Arylsulfamoyl%252529benzamides%25252C%252Binhibitors%252Bof%252Bhuman%252Bsirtuin%252Btype%252B2%252B%252528SIRT2%252529%26aulast%3DChoi%26aufirst%3DSoo%2BHyuk%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2789%26epage%3D2793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <i>N</i><sup>ε</sup>-Thioacetyllysine containing sirtuin inhibitors with various peptide sequences.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 9-fluorenylmethyl chloroformate, 0 °C to rt, 4 h; (b) solid phase peptide synthesis with Fmoc strategy [(coupling) appropriate carboxylic acid, TBTU, DIPEA, DFM, rt, 1 h; (Fmoc deprotection) 20% piperidine/DMF; (cleavage as –COOH) 1 M NaOH (aq) /dioxane (2:6), rt, 1 h, filtration, 3 M HCl (aq) or (cleavage as –COOCH<sub>3</sub>) DIPEA/MeOH/DMF (1:5:5), heat at reflux, overnight]; (c) 8 M methylamine in EtOH, 100 °C, 20 min; (d) 10% Pd on charcoal, MeOH, rt, overnight; (e) ethyl dithioacetate, EtOH/10% (w/v) Na<sub>2</sub>CO<sub>3</sub> (aq) (3:1), rt, 12–48 h; (f) appropriate amine, TBTU, DMF/pyridine (1:1), 0 °C to rt, 1–2 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of (a) SIRT3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and (b) Sir2Tm (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d">2h2d</a>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> showing the substrate binding site around the acetylated lysine. (c) The sequence homology of SIRT1–3 and Sir2Tm in the binding site area.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The binding hypothesis represented with wire spheres for pseudopeptidic inhibitors. (a) The molecular structure (green carbon atoms) represents the binding mode of the peptide cocrystallized with SIRT3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr">3glr</a>). (b) The key hydrogen bonds formed by the acetylated lysine in the SIRT3 (blue and magenta spheres). (c) N-Terminal modification from the virtual database screening that forms a hydrogen bond to Leu298 (blue sphere) and fills a cavity surrounded by residues Pro297, Leu298, Phe302 and Leu303 (green sphere). (d, e) Possibility for aromatic interactions found from the virtual database screening (orange spheres).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The docking poses of the pseudopeptides. The interactions were predicted with the Ligand Interactions tool available in MOE.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (a) The docking poses of compounds <b>18</b> and <b>24</b> showed binding to the crevice between Pro297 and Pro326, positioning of the <i>tert</i>-butyl groups in a pocket surrounded by residues Pro297, Leu298, Gln300, Phe302 and Leu303 and hydrogen bonding to Leu298. (b) The docking poses of compounds <b>20</b> (cyan) and <b>21</b> (green). (c) The docking poses of compounds <b>22</b> (orange) and <b>23</b> (cyan) compared to compound <b>21</b> (green). Compound <b>23</b> was hydrogen bonded to Gly295. (d) The docking pose of compound <b>30</b> showing aromatic interactions with Phe294 and hydrogen bonding to Glu325. The best ranked pose (green) had the N-terminal amide in the <i>cis</i>-form while the second ranked pose (cyan) had the N-terminal amide in the <i>trans</i>-form. However, the poses of the C-terminal fragment were identical. (e) The docking poses of compounds <b>25</b> (green) and <b>27</b> (cyan) placed the cyclohexyl and phenyl moieties in the same location. (f) The docking poses of compounds <b>25</b> (green), <b>28</b> (cyan) and <b>29</b> (dark cyan) with the overlaid phenyl moieties. The hydrogen bond acceptors hydroxyl and fluorine are toward the backbone amine of Glu325.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/medium/jm-2011-00590k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of SIRT1 activity increases p53 acetylation after DNA damage. (A) Effect of 10 μM compound <b>30</b> on p53 acetylation after 100 μM etoposide (eto) treatment for 5 h in three different cell lines. (B) Effect of 10 μM compound <b>20</b> and 10 or 100 μM compound <b>24</b> on p53 acetylation after 100 μM etoposide treatment for 5 h in SH-SY5Y cells. + present; – absent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200590k/production/images/large/jm-2011-00590k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200590k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Haigis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span> </span><span class="NLM_article-title">Mammalian sirtuins: biological insights and disease relevance</span> <span class="citation_source-journal">Annu. Rev. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1146%2Fannurev.pathol.4.110807.092250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20078221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFekt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=253-295&author=M.+C.+Haigisauthor=D.+A.+Sinclair&title=Mammalian+sirtuins%3A+biological+insights+and+disease+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian sirtuins: biological insights and disease relevance</span></div><div class="casAuthors">Haigis, Marcia C.; Sinclair, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">253-295</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Aging is accompanied by a decline in the healthy function of multiple organ systems, leading to increased incidence and mortality from diseases such as type II diabetes mellitus, neurodegenerative diseases, cancer, and cardiovascular disease.  Historically, researchers have focused on investigating individual pathways in isolated organs as a strategy to identify the root cause of a disease, with hopes of designing better drugs.  Studies of aging in yeast led to the discovery of a family of conserved enzymes known as the sirtuins, which affect multiple pathways that increase the life span and the overall health of organisms.  Since the discovery of the first known mammalian sirtuin, SIRT1, 10 years ago, there were major advances in our understanding of the enzymol. of sirtuins, their regulation, and their ability to broadly improve mammalian physiol. and health span.  This review summarizes and discusses the advances of the past decade and the challenges that will confront the field in the coming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6CJDwZ1VNd7Vg90H21EOLACvtfcHk0lgy_nYBZ2FUpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFekt7c%253D&md5=0fd55200789fb122f51e11106c60ec05</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pathol.4.110807.092250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pathol.4.110807.092250%26sid%3Dliteratum%253Aachs%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26atitle%3DMammalian%2520sirtuins%253A%2520biological%2520insights%2520and%2520disease%2520relevance%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%26date%3D2010%26volume%3D5%26spage%3D253%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lavu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P. D.</span><span> </span><span class="NLM_article-title">Sirtuins—novel therapeutic targets to treat age-associated diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=841-853&author=S.+Lavuauthor=O.+Bossauthor=P.+J.+Elliottauthor=P.+D.+Lambert&title=Sirtuins%E2%80%94novel+therapeutic+targets+to+treat+age-associated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavu%26aufirst%3DS.%26aulast%3DBoss%26aufirst%3DO.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DLambert%26aufirst%3DP.%2BD.%26atitle%3DSirtuins%25E2%2580%2594novel%2520therapeutic%2520targets%2520to%2520treat%2520age-associated%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D841%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Milne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galonek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israelian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iffland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medvedik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirousek, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, C. H.</span><span> </span><span class="NLM_article-title">Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1038%2Fnature06261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18046409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKmtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=712-716&author=J.+C.+Milneauthor=P.+D.+Lambertauthor=S.+Schenkauthor=D.+P.+Carneyauthor=J.+J.+Smithauthor=D.+J.+Gagneauthor=L.+Jinauthor=O.+Bossauthor=R.+B.+Perniauthor=C.+B.+Vuauthor=J.+E.+Bemisauthor=R.+Xieauthor=J.+S.+Dischauthor=P.+Y.+Ngauthor=J.+J.+Nunesauthor=A.+V.+Lynchauthor=H.+Yangauthor=H.+Galonekauthor=K.+Israelianauthor=W.+Choyauthor=A.+Ifflandauthor=S.+Lavuauthor=O.+Medvedikauthor=D.+A.+Sinclairauthor=J.+M.+Olefskyauthor=M.+R.+Jirousekauthor=P.+J.+Elliottauthor=C.+H.+Westphal&title=Small+molecule+activators+of+SIRT1+as+therapeutics+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes</span></div><div class="casAuthors">Milne, Jill C.; Lambert, Philip D.; Schenk, Simon; Carney, David P.; Smith, Jesse J.; Gagne, David J.; Jin, Lei; Boss, Olivier; Perni, Robert B.; Vu, Chi B.; Bemis, Jean E.; Xie, Roger; Disch, Jeremy S.; Ng, Pui Yee; Nunes, Joseph J.; Lynch, Amy V.; Yang, Hongying; Galonek, Heidi; Israelian, Kristine; Choy, Wendy; Iffland, Andre; Lavu, Siva; Medvedik, Oliver; Sinclair, David A.; Olefsky, Jerrold M.; Jirousek, Michael R.; Elliott, Peter J.; Westphal, Christoph H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7170</span>),
    <span class="NLM_cas:pages">712-716</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of aging such as type 2 diabetes.  SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity.  Resveratrol, a polyphenolic SIRT1 activator, mimics the antiaging effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival.  Here the authors describe the identification and characterization of small mol. activators of SIRT1 that are structurally unrelated to, and 1000-fold more potent than, resveratrol.  These compds. bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis const. for acetylated substrates.  In diet-induced obese and genetically obese mice, these compds. improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity.  In Zucker fa/fa rats, hyperinsulinemic-euglycemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver.  Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of aging such as type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtZUMUqn50MbVg90H21EOLACvtfcHk0lgy_nYBZ2FUpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKmtbrM&md5=8343b182d3596cbd8eb175c8b9cdcace</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature06261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06261%26sid%3Dliteratum%253Aachs%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26aulast%3DLambert%26aufirst%3DP.%2BD.%26aulast%3DSchenk%26aufirst%3DS.%26aulast%3DCarney%26aufirst%3DD.%2BP.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DGagne%26aufirst%3DD.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DBoss%26aufirst%3DO.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DDisch%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DA.%2BV.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGalonek%26aufirst%3DH.%26aulast%3DIsraelian%26aufirst%3DK.%26aulast%3DChoy%26aufirst%3DW.%26aulast%3DIffland%26aufirst%3DA.%26aulast%3DLavu%26aufirst%3DS.%26aulast%3DMedvedik%26aufirst%3DO.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DWestphal%26aufirst%3DC.%2BH.%26atitle%3DSmall%2520molecule%2520activators%2520of%2520SIRT1%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D712%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Biological and potential therapeutic roles of sirtuin deacetylases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4018</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1007%2Fs00018-008-8357-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18820996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCgs7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=4000-4018&author=D.+M.+Taylorauthor=M.+M.+Maxwellauthor=R.+Luthi-Carterauthor=A.+G.+Kazantsev&title=Biological+and+potential+therapeutic+roles+of+sirtuin+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Biological and Potential Therapeutic Roles of Sirtuin Deacetylases</span></div><div class="casAuthors">Taylor, D. M.; Maxwell, M. M.; Luthi-Carter, R.; Kazantsev, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4000-4018</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Sirtuins comprise a unique class of NAD (NAD+)-dependent deacetylases that target multiple protein substrates to execute diverse biol. functions.  These enzymes are key regulators of clin. important cellular and organismal processes, including metab., cell division and aging.  The desire to understand the important determinants of human health and lifespan has resulted in a firestorm of work on the seven mammalian sirtuins in less than a decade.  The implication of sirtuins in medically important areas such as diabetes, cancer, cardiovascular dysfunction and neurodegenerative disease has further catapulted them to a prominent status as potential targets for nutritional and therapeutic development.  Here, we present a review of published results on sirtuin biol. and its relevance to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzJ78zj4tWQrVg90H21EOLACvtfcHk0li5tgx6UxkonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCgs7bJ&md5=f72dd55ed976ba98b4a7ff607e0d0977</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8357-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8357-y%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DBiological%2520and%2520potential%2520therapeutic%2520roles%2520of%2520sirtuin%2520deacetylases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D4000%26epage%3D4018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Peck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fruscia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span> </span><span class="NLM_article-title">SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1158%2F1535-7163.MCT-09-0971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20371709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=844-855&author=B.+Peckauthor=C.+Y.+Chenauthor=K.+K.+Hoauthor=P.+Di+Frusciaauthor=S.+S.+Myattauthor=R.+C.+Coombesauthor=M.+J.+Fuchterauthor=C.+D.+Hsiaoauthor=E.+W.+Lam&title=SIRT+inhibitors+induce+cell+death+and+p53+acetylation+through+targeting+both+SIRT1+and+SIRT2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2</span></div><div class="casAuthors">Peck, Barrie; Chen, Chun-Yuan; Ho, Ka-Kei; Di Fruscia, Paolo; Myatt, Stephen S.; Coombes, R. Charles; Fuchter, Matthew J.; Hsiao, Chwan-Deng; Lam, Eric W.-F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">844-855</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SIRT proteins play an important role in the survival and drug resistance of tumor cells, esp. during chemotherapy.  In this study, we investigated the potency, specificity, and cellular targets of three SIRT inhibitors, Sirtinol, Salermide, and EX527.  Cell proliferative and cell cycle analyses showed that Sirtinol and Salermide, but not EX527, were effective in inducing cell death at concns. of 50 μmol/L or over in MCF-7 cells.  Instead, EX527 caused cell cycle arrest at G1 at comparable concns.  In vitro SIRT assays using a p53 peptide substrate showed that all three compds. are potent SIRT1/2 inhibitors, with EX527 having the highest inhibitory activity for SIRT1.  Computational docking anal. showed that Sirtinol and Salermide have high degrees of selectivity for SIRT1/2, whereas EX527 has high specificity for SIRT1 but not SIRT2.  Consistently, Sirtinol and Salermide, but not EX527, treatment resulted in the in vivo acetylation of the SIRT1/2 target p53 and SIRT2 target tubulin in MCF-7 cells, suggesting that EX527 is ineffective in inhibiting SIRT2 and that p53 mediates the cytotoxic function of Sirtinol and Salermide.  Studies using breast carcinoma cell lines and p53-deficient mouse fibroblasts confirmed that p53 is essential for the Sirtinol and Salermide-induced apoptosis.  Further, we showed using small interfering RNA that silencing both SIRTs, but not SIRT1 and SIRT2 individually, can induce cell death in MCF-7 cells.  Together, our results identify the specificity and cellular targets of these novel inhibitors and suggest that SIRT inhibitors require combined targeting of both SIRT1 and SIRT2 to induce p53 acetylation and cell death.  Mol Cancer Ther; 9(4); 844-55.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOOb1TBGW47Vg90H21EOLACvtfcHk0li5tgx6UxkonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D&md5=d2cf2c3adb9d6218c94ad143011082bd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0971%26sid%3Dliteratum%253Aachs%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DHo%26aufirst%3DK.%2BK.%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DMyatt%26aufirst%3DS.%2BS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DHsiao%26aufirst%3DC.%2BD.%26aulast%3DLam%26aufirst%3DE.%2BW.%26atitle%3DSIRT%2520inhibitors%2520induce%2520cell%2520death%2520and%2520p53%2520acetylation%2520through%2520targeting%2520both%2520SIRT1%2520and%2520SIRT2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D844%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Neugebauer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Inhibitors of NAD+ dependent histone deacetylases (sirtuins)</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.2174%2F138161208783885380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18336301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=562-573&author=R.+C.+Neugebauerauthor=W.+Sipplauthor=M.+Jung&title=Inhibitors+of+NAD%2B+dependent+histone+deacetylases+%28sirtuins%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of NAD+ dependent histone deacetylases (sirtuins)</span></div><div class="casAuthors">Neugebauer, Robert C.; Sippl, Wolfgang; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">562-573</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes that deacetylate acetyl lysines in histones and various non-histone proteins.  Three classes of histone deacetylases have been described in humans: class I, II and IV were shown to be zinc dependent amidohydrolases and eleven subtypes are known today (HDAC1-11).  Class III enzymes depend in their catalysis on NAD+ with the subsequent formation of nicotinamide and O-acetyl-ADP ribose.  Based on the homol. to the yeast histone deacetylase Sir2p the NAD+-dependent deacetylases have been termed sirtuins and seven members (SIRT1-7) have been described in humans.  Whereas class I and II HDACs have been identified as valid anticancer targets and clin. studies of their inhibitors as new anticancer agents are under way much less is known about the consequences of class III histone deacetylase inhibition.  Sirtuins have been linked to aging and overexpression of sirtuins leads to a prolonged lifespan in yeast.  Lately, sirtuin activity has been tied to the pathogenesis of HIV, cancer and neurodegenerative disease.  In the last two years several reports of new sirtuin inhibitors have emerged.  Addnl., sirtuin activators have been identified and have been implicated as potential drugs for the ameloriation of metabolic diseases.  Thus, the field of sirtuin biol. can be investigated with these new tools which will allow in turn to assess the therapeutic potential of those compds.  We will present an overview over sirtuins and their available inhibitors and activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg2Jg1EtHcurVg90H21EOLACvtfcHk0li5tgx6UxkonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVGksbs%253D&md5=942d69f31f9035a5eb97032fa9fec2eb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161208783885380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208783885380%26sid%3Dliteratum%253Aachs%26aulast%3DNeugebauer%26aufirst%3DR.%2BC.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520NAD%252B%2520dependent%2520histone%2520deacetylases%2520%2528sirtuins%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D562%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altucci, L.</span><span> </span><span class="NLM_article-title">Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1016%2Fj.biocel.2008.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18790076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=199-213&author=A.+Maiauthor=L.+Altucci&title=Epi-drugs+to+fight+cancer%3A+from+chemistry+to+cancer+treatment%2C+the+road+ahead"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead</span></div><div class="casAuthors">Mai, Antonello; Altucci, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-213</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In addn. to genetic events, a variety of epigenetic events were widely reported to contribute to the onset of many diseases including cancer.  DNA methylation and histone modifications (such as acetylation, methylation, sumoylation, and phosphorylation) involving chromatin remodelling are among the most studied epigenetic mechanisms for regulation of gene expression leading, when altered, to some diseases.  Epigenetic therapy tries to reverse the aberrations followed to the disruption of the balance of the epigenetic signalling ways through the use of both natural compds. and synthetic mols., active on specific epi-targets.  Such epi-drugs are, for example, inhibitors of DNA methyltransferases, histone deacetylases, histone acetyltransferases, histone methyltransferases, and histone demethylases.  In this review we will focus on the chem. aspects of such mols., joined to their effective (or potential) application in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop4CbZIUDH4LVg90H21EOLACvtfcHk0ljCs2Wugub-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu7zI&md5=0571583c8adf6a41ee44c893f71c5c94</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26atitle%3DEpi-drugs%2520to%2520fight%2520cancer%253A%2520from%2520chemistry%2520to%2520cancer%2520treatment%252C%2520the%2520road%2520ahead%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Guarani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potente, M.</span><span> </span><span class="NLM_article-title">SIRT1—a metabolic sensor that controls blood vessel growth</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1016%2Fj.coph.2010.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20149740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs12ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=139-145&author=V.+Guaraniauthor=M.+Potente&title=SIRT1%E2%80%94a+metabolic+sensor+that+controls+blood+vessel+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT1 - a metabolic sensor that controls blood vessel growth</span></div><div class="casAuthors">Guarani, Virginia; Potente, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-145</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Blood vessels deliver nutrients and O2 to cells and tissues in the body.  When blood supply is insufficient, new vessels form to meet the metabolic tissue requirements.  Several studies have examd. the cellular and mol. principles of blood vessel formation, yet little is known about how vessels sense and integrate environmental signals originating from nutrient- and O2-deprived tissues to achieve functional vascular patterning.  NAD-dependent deacetylase SIRT1 mediates adaptation to environmental stresses by adjusting cellular responses to the energetic state of the cell and recent studies highlight important functions of SIRT1 in regulating vascular growth, shape, and function.  Here, the authors review the emerging role of SIRT1 as a metabolic sensor coupling energy and oxygen homeostasis to the growth and function of the vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocH5np7vWFTrVg90H21EOLACvtfcHk0ljCs2Wugub-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs12ntbo%253D&md5=a79ee52ce95a66b3d4b515e8517f7c47</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DGuarani%26aufirst%3DV.%26aulast%3DPotente%26aufirst%3DM.%26atitle%3DSIRT1%25E2%2580%2594a%2520metabolic%2520sensor%2520that%2520controls%2520blood%2520vessel%2520growth%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Alcain, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalba, J. M.</span><span> </span><span class="NLM_article-title">Sirtuin inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1517%2F13543770902755111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=19441904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=283-294&author=F.+J.+Alcainauthor=J.+M.+Villalba&title=Sirtuin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin inhibitors</span></div><div class="casAuthors">Alcain, Francisco J.; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The sirtuin family of deacetylase enzymes comprises seven proteins (SIRT1-7) that are dependent on NAD+ for their activity.  Three proteins are located in the nucleus, three in the mitochondria and only one is predominantly cytoplasmic.  Caloric restriction and oxidative stress generally up-regulate their expression.  SIRT1, the ortholog of yeast Sir2, is the mammalian sirtuin that has been most extensively studied to date.  Among other targets, SIRT1 down-regulates the activity of the nuclear transcription factor p53, being this related with an increase in lifespan and cell survival assocd. to stress resistance.  Objective: Because sirtuin modulation could have beneficial effects on several human diseases, there is a growing interest in the discovery and development of small mols. that modify its activity.  This review will be focused on sirtuin inhibitors.  Conclusions: Several specific inhibitors of SIRT1 have been described.  These compds. could be mainly useful for the treatment of cancers by increasing p53 activity that stops the formation of tumors and induces apoptosis.  A p53-independent massive induction of apoptosis has been also described for one inhibitor.  In addn., a potent and selective SIRT2 inhibitor that ameliorates the α-synuclein fibril formation in Parkinson disease has been proposed to treat this kind of neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0LxRE1oL__LVg90H21EOLACvtfcHk0ljCs2Wugub-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslWlurc%253D&md5=d6a31fb4a3cd0aa829a52d97999ffee8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F13543770902755111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902755111%26sid%3Dliteratum%253Aachs%26aulast%3DAlcain%26aufirst%3DF.%2BJ.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DSirtuin%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D283%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffitt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokce, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7927</span><span class="NLM_x">–</span> <span class="NLM_lpage">7932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1073%2Fpnas.1002924107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=20378838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7927-7932&author=R.+Luthi-Carterauthor=D.+M.+Taylorauthor=J.+Pallosauthor=E.+Lambertauthor=A.+Amoreauthor=A.+Parkerauthor=H.+Moffittauthor=D.+L.+Smithauthor=H.+Runneauthor=O.+Gokceauthor=A.+Kuhnauthor=Z.+Xiangauthor=M.+M.+Maxwellauthor=S.+A.+Reevesauthor=G.+P.+Batesauthor=C.+Neriauthor=L.+M.+Thompsonauthor=J.+L.+Marshauthor=A.+G.+Kazantsev&title=SIRT2+inhibition+achieves+neuroprotection+by+decreasing+sterol+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span></div><div class="casAuthors">Luthi-Carter, Ruth; Taylor, David M.; Pallos, Judit; Lambert, Emmanuel; Amore, Allison; Parker, Alex; Moffitt, Hilary; Smith, Donna L.; Runne, Heike; Gokce, Ozgun; Kuhn, Alexandre; Xiang, Zhongmin; Maxwell, Michele M.; Reeves, Steven A.; Bates, Gillian P.; Neri, Christian; Thompson, Leslie M.; Marsh, J. Lawrence; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7927-7932, S7927/1-S7927/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Huntington's disease (HD), an incurable neurodegenerative disorder, has a complex pathogenesis including protein aggregation and the dysregulation of neuronal transcription and metab.  Here, we demonstrate that inhibition of sirtuin 2 (SIRT2) achieves neuroprotection in cellular and invertebrate models of HD.  Genetic or pharmacol. inhibition of SIRT2 in a striatal neuron model of HD resulted in gene expression changes including significant down-regulation of RNAs responsible for sterol biosynthesis.  Whereas mutant huntingtin fragments increased sterols in neuronal cells, SIRT2 inhibition reduced sterol levels via decreased nuclear trafficking of SREBP-2.  Importantly, manipulation of sterol biosynthesis at the transcriptional level mimicked SIRT2 inhibition, demonstrating that the metabolic effects of SIRT2 inhibition are sufficient to diminish mutant huntingtin toxicity.  These data identify SIRT2 inhibition as a promising avenue for HD therapy and elucidate a unique mechanism of SIRT2-inhibitor-mediated neuroprotection.  Furthermore, the ascertainment of SIRT2's role in regulating cellular metab. demonstrates a central function shared with other sirtuin proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl8YT_ra15oLVg90H21EOLACvtfcHk0ljuxkNp5RK8Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D&md5=8b4798da04f14888acbcd64d1670d503</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002924107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002924107%26sid%3Dliteratum%253Aachs%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DPallos%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DE.%26aulast%3DAmore%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DMoffitt%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRunne%26aufirst%3DH.%26aulast%3DGokce%26aufirst%3DO.%26aulast%3DKuhn%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DReeves%26aufirst%3DS.%2BA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DNeri%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DMarsh%26aufirst%3DJ.%2BL.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSIRT2%2520inhibition%2520achieves%2520neuroprotection%2520by%2520decreasing%2520sterol%2520biosynthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D7927%26epage%3D7932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathearn, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Fatkins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnot, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span> </span><span class="NLM_article-title">Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3651</span><span class="NLM_x">–</span> <span class="NLM_lpage">3656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3651-3656&author=D.+G.+Fatkinsauthor=A.+D.+Monnotauthor=W.+Zheng&title=Nepsilon-thioacetyl-lysine%3A+a+multi-facet+functional+probe+for+enzymatic+protein+lysine+Nepsilon-deacetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFatkins%26aufirst%3DD.%2BG.%26aulast%3DMonnot%26aufirst%3DA.%2BD.%26aulast%3DZheng%26aufirst%3DW.%26atitle%3DNepsilon-thioacetyl-lysine%253A%2520a%2520multi-facet%2520functional%2520probe%2520for%2520enzymatic%2520protein%2520lysine%2520Nepsilon-deacetylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3651%26epage%3D3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Fatkins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span> </span><span class="NLM_article-title">Substituting N-thioacetyl-lysine for N-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD-dependent protein deacetylases</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.3390%2Fijms9010001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=19325715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1eltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1-11&author=D.+G.+Fatkinsauthor=W.+Zheng&title=Substituting+N-thioacetyl-lysine+for+N-acetyl-lysine+in+peptide+substrates+as+a+general+approach+to+inhibiting+human+NAD-dependent+protein+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Substituting Nε-thioacetyl-lysine for Nε-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD+-dependent protein deacetylases</span></div><div class="casAuthors">Fatkins, David G.; Zheng, Weiping</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">Inhibitors of human NAD+-dependent protein deacetylases possess great value for deciphering the biol. of these enzymes and as potential therapeutics for metabolic and age-related diseases and cancer.  In the current study, we have exptl. demonstrated that, the potent inhibition we obtained previously for one of these enzymes (i.e. sirtuin type 1 (SIRT1)) by simply replacing Nε-thioacetyl-lysine for Nε-acetyl-lysine in its peptide substrate, represented a general and efficient strategy to develop potent and selective inhibitors of human NAD+-dependent protein deacetylase enzymes.  Indeed, by using this simple inhibition strategy, potent (low-micromolar) and selective (≤40-fold) SIRT2 and SIRT3 inhibitors, which were either comparable or superior to currently existing inhibitors, have also been quickly identified in the current study.  These inhibitors could be used as chem. biol. tools or as lead compds. for further focused structure-activity optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzCcE-RRm9S7Vg90H21EOLACvtfcHk0ljuxkNp5RK8Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1eltb0%253D&md5=e529577e63c20c549304713b0da68c59</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fijms9010001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms9010001%26sid%3Dliteratum%253Aachs%26aulast%3DFatkins%26aufirst%3DD.%2BG.%26aulast%3DZheng%26aufirst%3DW.%26atitle%3DSubstituting%2520N-thioacetyl-lysine%2520for%2520N-acetyl-lysine%2520in%2520peptide%2520substrates%2520as%2520a%2520general%2520approach%2520to%2520inhibiting%2520human%2520NAD-dependent%2520protein%2520deacetylases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2008%26volume%3D9%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">37256</span><span class="NLM_x">–</span> <span class="NLM_lpage">37265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1074%2Fjbc.M707878200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=17951578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVamurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=37256-37265&author=B.+C.+Smithauthor=J.+M.+Denu&title=Acetyl-lysine+analog+peptides+as+mechanistic+probes+of+protein+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Acetyl-lysine Analog Peptides as Mechanistic Probes of Protein Deacetylases</span></div><div class="casAuthors">Smith, Brian C.; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">37256-37265</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Class III histone deacetylases (Sir2 or sirtuins) catalyze the NAD+-dependent conversion of acetyl-lysine residues to nicotinamide, 2'-O-acetyl-ADP-ribose (OAADPr), and deacetylated lysine.  Class I and II HDACs utilize a different deacetylation mechanism, utilizing an active site zinc to direct hydrolysis of acetyl-lysine residues to lysine and acetate.  Here, using ten acetyl-lysine analog peptides, we have probed the substrate binding pockets of sirtuins and investigated the catalytic differences among sirtuins and class I and II deacetylases.  For the sirtuin Hst2, acetyl-lysine analog peptide binding correlated with the hydrophobic substituent parameter π with a slope of -0.35 from a plot of log Kd vs. π.  Interestingly, propionyl- and butyryl-lysine peptides were found to bind tighter to Hst2 compared with acetyl-lysine peptide and showed measurable rates of catalysis with Hst2, Sirt1, Sirt2, and Sirt3, suggesting propionyl- and butyryl-lysine proteins may be sirtuin substrates in vivo.  Unique among the acetyl-lysine analog peptides examd., homocitrulline peptide produced ADP-ribose instead of the corresponding OAADPr analog.  The electron-withdrawing nature of each acetyl analog had a profound impact on the deacylation rate between deacetylase classes.  The rate of catalysis with the acetyl-lysine analog peptides varied over five orders of magnitude with the class III deacetylase Hst2, revealing a linear free energy relationship with a slope of -1.57 when plotted vs. the Taft const., σ*.  HDAC8, a class I deacetylase, displayed the opposite trend with a slope of +0.79.  These results are applicable toward the development of selective substrates and other mechanistic probes of protein deacetylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAtaU7ZQLTgbVg90H21EOLACvtfcHk0lhuiVcEXGD-AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVamurjP&md5=a7dbda2619674194d7b60ec6e727d604</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707878200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707878200%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DAcetyl-lysine%2520analog%2520peptides%2520as%2520mechanistic%2520probes%2520of%2520protein%2520deacetylases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D37256%26epage%3D37265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5670</span><span class="NLM_x">–</span> <span class="NLM_lpage">5672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5670-5672&author=T.+Suzukiauthor=T.+Asabaauthor=E.+Imaiauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=N.+Miyata&title=Identification+of+a+cell-active+non-peptide+sirtuin+inhibitor+containing+N-thioacetyl+lysine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DAsaba%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DE.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520a%2520cell-active%2520non-peptide%2520sirtuin%2520inhibitor%2520containing%2520N-thioacetyl%2520lysine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5670%26epage%3D5672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kiviranta, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tervonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E. M.</span><span> </span><span class="NLM_article-title">N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801401k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2153-2156&author=P.+H.+Kivirantaauthor=T.+Suuronenauthor=E.+A.+A.+Wall%C3%A9nauthor=J.+Lepp%C3%A4nenauthor=J.+Tervonenauthor=S.+Kyrylenkoauthor=A.+Salminenauthor=A.+Posoauthor=E.+M.+Jarho&title=N%28epsilon%29-thioacetyl-lysine-containing+tri-%2C+tetra-%2C+and+pentapeptides+as+SIRT1+and+SIRT2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm801401k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801401k%26sid%3Dliteratum%253Aachs%26aulast%3DKiviranta%26aufirst%3DP.%2BH.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DTervonen%26aufirst%3DJ.%26aulast%3DKyrylenko%26aufirst%3DS.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DJarho%26aufirst%3DE.%2BM.%26atitle%3DN%2528epsilon%2529-thioacetyl-lysine-containing%2520tri-%252C%2520tetra-%252C%2520and%2520pentapeptides%2520as%2520SIRT1%2520and%2520SIRT2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2153%26epage%3D2156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Huhtiniemi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruijn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jääskeläinen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E.</span><span> </span><span class="NLM_article-title">N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5616</span><span class="NLM_x">–</span> <span class="NLM_lpage">5625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5616-5625&author=T.+Huhtiniemiauthor=T.+Suuronenauthor=M.+Lahtela-Kakkonenauthor=T.+Bruijnauthor=S.+J%C3%A4%C3%A4skel%C3%A4inenauthor=A.+Posoauthor=A.+Salminenauthor=J.+Lepp%C3%A4nenauthor=E.+Jarho&title=N%28epsilon%29-Modified+lysine+containing+inhibitors+for+SIRT1+and+SIRT2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuhtiniemi%26aufirst%3DT.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DBruijn%26aufirst%3DT.%26aulast%3DJ%25C3%25A4%25C3%25A4skel%25C3%25A4inen%26aufirst%3DS.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DJarho%26aufirst%3DE.%26atitle%3DN%2528epsilon%2529-Modified%2520lysine%2520containing%2520inhibitors%2520for%2520SIRT1%2520and%2520SIRT2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5616%26epage%3D5625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">14478</span><span class="NLM_x">–</span> <span class="NLM_lpage">14486</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7013294" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlaktbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=14478-14486&author=B.+C.+Smithauthor=J.+M.+Denu&title=Mechanism-based+inhibition+of+Sir2+deacetylases+by+thioacetyl-lysine+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inhibition of Sir2 Deacetylases by Thioacetyl-Lysine Peptide</span></div><div class="casAuthors">Smith, Brian C.; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">14478-14486</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sir2 protein deacetylases (or sirtuins) catalyze NAD+-dependent conversion of ε-amino-acetylated lysine residues to deacetylated lysine, nicotinamide, and 2'-O-acetyl-ADP-ribose.  Small-mol. modulation of sirtuin activity might treat age-assocd. diseases, such as type II diabetes, obesity, and neurodegenerative disorders.  Here, we have evaluated the mechanisms of sirtuin inhibition of histone peptides contg. thioacetyl or mono-, di-, and trifluoroacetyl groups at the ε-amino of lysine.  Although all substituted peptides yielded inhibition of the deacetylation reaction, the thioacetyl-lysine peptide exhibited exceptionally potent inhibition of sirtuins Sirt1, Sirt2, Sirt3, and Hst2.  Using Hst2 as a representative sirtuin, the trifluoroacetyl-lysine peptide displayed competitive inhibition with acetyl-lysine substrate and yielded an inhibition const. (Kis) of 4.8 μM, similar to its Kd value of 3.3 μM.  In contrast, inhibition by thioacetyl-lysine peptide yielded an inhibition const. (Kis) of 0.017 μM, 280-fold lower than its Kd value of 4.7 μM.  Examn. of thioacetyl-lysine peptide as an alternative sirtuin substrate revealed conserved prodn. of deacetylated peptide and 1'-SH-2'-O-acetyl-ADP-ribose.  Pre-steady-state and steady-state anal. of the thioacetyl-lysine peptide showed rapid nicotinamide formation (4.5 s-1) but slow overall turnover (0.0024 s-1), indicating that the reaction stalled at an intermediate after nicotinamide formation.  Mass spectral anal. yielded a novel species (m/z 1754.3) that is consistent with an ADP-ribose-peptidyl adduct (1'-S-alkylamidate) as the stalled intermediate.  Addnl. expts. involving solvent isotope effects, general base mutational anal., and d. functional calcns. are consistent with impaired 2'-hydroxyl attack on the ADP-ribose-peptidyl intermediate.  These results have implications for the development of mechanism-based inhibitors of Sir2 deacetylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq32NwFjRpaYrVg90H21EOLACvtfcHk0lhuiVcEXGD-AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlaktbvO&md5=9056742159164b461b495f9c5ff3d8cf</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi7013294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7013294%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DMechanism-based%2520inhibition%2520of%2520Sir2%2520deacetylases%2520by%2520thioacetyl-lysine%2520peptide%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D14478%26epage%3D14486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">5802</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja070162w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=5802-5803&author=B.+C.+Smithauthor=J.+M.+Denu&title=Sir2+deacetylases+exhibit+nucleophilic+participation+of+acetyl-lysine+in+NAD%2B+cleavage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja070162w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja070162w%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DSir2%2520deacetylases%2520exhibit%2520nucleophilic%2520participation%2520of%2520acetyl-lysine%2520in%2520NAD%252B%2520cleavage%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D5802%26epage%3D5803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McGregor, D. P.</span><span> </span><span class="NLM_article-title">Discovering and improving novel peptide therapeutics</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1016%2Fj.coph.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=18602024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=616-619&author=D.+P.+McGregor&title=Discovering+and+improving+novel+peptide+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering and improving novel peptide therapeutics</span></div><div class="casAuthors">McGregor, Duncan Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">616-619</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peptides have a no. of advantages over small mols. in terms of specificity and affinity for targets, and over antibodies in terms of size.  However, sensitivity to serum and tissue proteases coupled with short serum half-life has resulted in few recombinant library derived peptides, making the transition from lead to drug on the market.  Recently, a series of technologies have been developed to address both these issues: selection methodologies addressing protease resistance have been developed that when combined with methods such as pegylation antibody Fc attachment and binding to serum albumin look likely to finally turn therapeutic peptides into a widely accepted drug class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3f9m8QDMxWbVg90H21EOLACvtfcHk0li9utRHAIEanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLjM&md5=d80dfe343f1fd49d2943ea05e3a86f52</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcGregor%26aufirst%3DD.%2BP.%26atitle%3DDiscovering%2520and%2520improving%2520novel%2520peptide%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D616%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Asaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">6989</span><span class="NLM_x">–</span> <span class="NLM_lpage">6996</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja807083y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6989-6996&author=T.+Asabaauthor=T.+Suzukiauthor=R.+Uedaauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=N.+Miyata&title=Inhibition+of+human+sirtuins+by+in+situ+generation+of+an+acetylated+lysine-ADP-ribose+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja807083y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja807083y%26sid%3Dliteratum%253Aachs%26aulast%3DAsaba%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520human%2520sirtuins%2520by%2520in%2520situ%2520generation%2520of%2520an%2520acetylated%2520lysine-ADP-ribose%2520conjugate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D6989%26epage%3D6996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Huhtiniemi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittekindt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span> </span><span class="NLM_article-title">Comparative and pharmacophore model for deacetylase SIRT1</span> <span class="citation_source-journal">J. Comput.-Aided. Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=589-599&author=T.+Huhtiniemiauthor=C.+Wittekindtauthor=T.+Laitinenauthor=J.+Lepp%C3%A4nenauthor=A.+Salminenauthor=A.+Posoauthor=M.+Lahtela-Kakkonen&title=Comparative+and+pharmacophore+model+for+deacetylase+SIRT1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuhtiniemi%26aufirst%3DT.%26aulast%3DWittekindt%26aufirst%3DC.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26atitle%3DComparative%2520and%2520pharmacophore%2520model%2520for%2520deacetylase%2520SIRT1%26jtitle%3DJ.%2520Comput.-Aided.%2520Mol.%2520Des.%26date%3D2006%26volume%3D20%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the histone deacetylase SIRT2</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1038%2F89668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=11427894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=621-625&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=N.+P.+Pavletich&title=Structure+of+the+histone+deacetylase+SIRT2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the histone deacetylase SIRT2</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres, and ribosomal gene clusters, and plays a crit. role in the detn. of life span in yeast and Caenorhabditis elegans.  Here, the 1.7 Å crystal structure of the 323-amino-acid catalytic core of human SIRT2, a homolog of yeast Sir2, revealed an NAD-binding domain, which was a variant of the Rossmann fold, and a smaller domain composed of a helical module and a Zn-binding module.  A conserved large groove at the interface of the 2 domains was the likely site of catalysis based on mutagenesis.  Intersecting this large groove, there was a pocket formed by the helical module.  The pocket was lined with hydrophobic residues conserved within each of the 5 Sir2 classes, suggesting that it is a class-specific protein-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNi1R8KPeQ7Vg90H21EOLACvtfcHk0li9utRHAIEanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D&md5=6d305c420bff2690da780fc23938c22f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F89668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89668%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520histone%2520deacetylase%2520SIRT2%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D621%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirousek, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Crystal structures of human SIRT3 displaying substrate-induced conformational changes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">24394</span><span class="NLM_x">–</span> <span class="NLM_lpage">24405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=24394-24405&author=L.+Jinauthor=W.+Weiauthor=Y.+Jiangauthor=H.+Pengauthor=J.+Caiauthor=C.+Maoauthor=H.+Daiauthor=W.+Choyauthor=J.+E.+Bemisauthor=M.+R.+Jirousekauthor=J.+C.+Milneauthor=C.+H.+Westphalauthor=R.+B.+Perni&title=Crystal+structures+of+human+SIRT3+displaying+substrate-induced+conformational+changes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DChoy%26aufirst%3DW.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26aulast%3DWestphal%26aufirst%3DC.%2BH.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DCrystal%2520structures%2520of%2520human%2520SIRT3%2520displaying%2520substrate-induced%2520conformational%2520changes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D24394%26epage%3D24405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cosgrove, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bever, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avalos, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">The structural basis of sirtuin substrate affinity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">7511</span><span class="NLM_x">–</span> <span class="NLM_lpage">7521</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0526332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=7511-7521&author=M.+S.+Cosgroveauthor=K.+Beverauthor=J.+L.+Avalosauthor=S.+Muhammadauthor=X.+Zhangauthor=C.+Wolberger&title=The+structural+basis+of+sirtuin+substrate+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi0526332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0526332%26sid%3Dliteratum%253Aachs%26aulast%3DCosgrove%26aufirst%3DM.%2BS.%26aulast%3DBever%26aufirst%3DK.%26aulast%3DAvalos%26aufirst%3DJ.%2BL.%26aulast%3DMuhammad%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DThe%2520structural%2520basis%2520of%2520sirtuin%2520substrate%2520affinity%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D7511%26epage%3D7521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span> <span class="citation_source-book">MOE (The Molecular Operating Environment)</span>, Version 2008.10 and 2009.10; software available from <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>, <span class="NLM_publisher-loc">1010 Sherbrooke Street West, Suite 910, Montreal, Canada H3A 2R7</span>. <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28The+Molecular+Operating+Environment%29%2C+Version+2008.10+and+2009.10%3B+software+available+from+Chemical+Computing+Group+Inc.%2C+1010+Sherbrooke+Street+West%2C+Suite+910%2C+Montreal%2C+Canada+H3A+2R7.+http%3A%2F%2Fwww.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMOE%2520%2528The%2520Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Solomon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasupuleti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, L. J.</span><span> </span><span class="NLM_article-title">Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200590k&amp;key=10.1128%2FMCB.26.1.28-38.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200590k&amp;key=16354677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200590k&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslaqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=28-38&author=J.+M.+Solomonauthor=R.+Pasupuletiauthor=L.+Xuauthor=T.+McDonaghauthor=R.+Curtisauthor=P.+S.+DiStefanoauthor=L.+J.+Huber&title=Inhibition+of+SIRT1+catalytic+activity+increases+p53+acetylation+but+does+not+alter+cell+survival+following+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage</span></div><div class="casAuthors">Solomon, Jonathan M.; Pasupuleti, Rao; Xu, Lei; McDonagh, Thomas; Curtis, Rory; DiStefano, Peter S.; Huber, L. Julie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-38</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human SIRT1 is an enzyme that deacetylates the p53 tumor suppressor protein and has been suggested to modulate p53-dependent functions including DNA damage-induced cell death.  In this report, we used EX-527, a novel, potent, and specific small-mol. inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage.  Treatment with EX-527 dramatically increased acetylation at lysine 382 of p53 after different types of DNA damage in primary human mammary epithelial cells and several cell lines.  Significantly, inhibition of SIRT1 catalytic activity by EX-527 had no effect on cell growth, viability, or p53-controlled gene expression in cells treated with etoposide.  Acetyl-p53 was also increased by the histone deacetylase (HDAC) class I/II inhibitor trichostatin A (TSA).  EX-527 and TSA acted synergistically to increase acetyl-p53 levels, confirming that p53 acetylation is regulated by both SIRT1 and HDACs.  While TSA alone reduced cell survival after DNA damage, the combination of EX-527 and TSA had no further effect on cell viability and growth.  These results show that, although SIRT1 deacetylates p53, this does not play a role in cell survival following DNA damage in certain cell lines and primary human mammary epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8llXW_ws_q7Vg90H21EOLACvtfcHk0liRX8syx0p8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslaqsLs%253D&md5=bb10711590ed785b57bbad6dcde66911</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.1.28-38.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.1.28-38.2006%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DJ.%2BM.%26aulast%3DPasupuleti%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMcDonagh%26aufirst%3DT.%26aulast%3DCurtis%26aufirst%3DR.%26aulast%3DDiStefano%26aufirst%3DP.%2BS.%26aulast%3DHuber%26aufirst%3DL.%2BJ.%26atitle%3DInhibition%2520of%2520SIRT1%2520catalytic%2520activity%2520increases%2520p53%2520acetylation%2520but%2520does%2520not%2520alter%2520cell%2520survival%2520following%2520DNA%2520damage%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D28%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span> <span class="citation_source-book">LigPrep</span>, version 2.3; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span> <span class="citation_source-book">Epik</span>, version 2.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DEpik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span> <span class="citation_source-book">CombiGlide</span>, version 2.5; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CombiGlide%2C+version+2.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DCombiGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span> <span class="citation_source-book">Glide</span>, version 5.5; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span> <span class="citation_source-book">Schrödinger Suite 2009 Protein Preparation Wizard, Epik version 2.0; Impact version 5.5; Prime version 2.1</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2009+Protein+Preparation+Wizard%2C+Epik+version+2.0%3B+Impact+version+5.5%3B+Prime+version+2.1%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Suite%25202009%2520Protein%2520Preparation%2520Wizard%252C%2520Epik%2520version%25202.0%253B%2520Impact%2520version%25205.5%253B%2520Prime%2520version%25202.1%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kerwin, S. M.</span><span> </span><span class="NLM_article-title">ChemBioOffice Ultra 2010 suite</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">2466</span><span class="NLM_x">–</span> <span class="NLM_lpage">2467</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja1005306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=2466-2467&author=S.+M.+Kerwin&title=ChemBioOffice+Ultra+2010+suite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja1005306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja1005306%26sid%3Dliteratum%253Aachs%26aulast%3DKerwin%26aufirst%3DS.%2BM.%26atitle%3DChemBioOffice%2520Ultra%25202010%2520suite%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D2466%26epage%3D2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span> <span class="citation_source-book">Discovery Studio Modeling Environment</span>, Release 2.5; <span class="NLM_publisher-name">Accelrys Software Inc.</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discovery+Studio+Modeling+Environment%2C+Release+2.5%3B+Accelrys+Software+Inc.%3A+San+Diego%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDiscovery%2520Studio%2520Modeling%2520Environment%26pub%3DAccelrys%2520Software%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span> </span><span class="NLM_article-title">The Universal Protein Resource (UniProt) in 2010</span>.  <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">D142</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Universal+Protein+Resource+%28UniProt%29+in+2010.+Nucleic+Acids+Res.+2010%2C+38%2C+D142%E2%80%93148."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520Universal%2520Protein%2520Resource%2520%2528UniProt%2529%2520in%25202010%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2010%26volume%3D38%26spage%3DD142%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Larkin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackshields, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGettigan, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWilliam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span> </span><span class="NLM_article-title">Clustal W and Clustal X</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2947</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=2947-2948&author=M.+A.+Larkinauthor=G.+Blackshieldsauthor=N.+P.+Brownauthor=R.+Chennaauthor=P.+A.+McGettiganauthor=H.+McWilliamauthor=F.+Valentinauthor=I.+M.+Wallaceauthor=A.+Wilmauthor=R.+Lopezauthor=J.+D.+Thompsonauthor=T.+J.+Gibsonauthor=D.+G.+Higgins&title=Clustal+W+and+Clustal+X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DM.%2BA.%26aulast%3DBlackshields%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DN.%2BP.%26aulast%3DChenna%26aufirst%3DR.%26aulast%3DMcGettigan%26aufirst%3DP.%2BA.%26aulast%3DMcWilliam%26aufirst%3DH.%26aulast%3DValentin%26aufirst%3DF.%26aulast%3DWallace%26aufirst%3DI.%2BM.%26aulast%3DWilm%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26atitle%3DClustal%2520W%2520and%2520Clustal%2520X%26jtitle%3DBioinformatics%26date%3D2007%26volume%3D23%26spage%3D2947%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Waterhouse, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clamp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, G. J.</span><span> </span><span class="NLM_article-title">Jalview Version 2—a multiple sequence alignment editor and analysis workbench</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1189</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=1189-1191&author=A.+M.+Waterhouseauthor=J.+B.+Procterauthor=D.+M.+Martinauthor=M.+Clampauthor=G.+J.+Barton&title=Jalview+Version+2%E2%80%94a+multiple+sequence+alignment+editor+and+analysis+workbench"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DA.%2BM.%26aulast%3DProcter%26aufirst%3DJ.%2BB.%26aulast%3DMartin%26aufirst%3DD.%2BM.%26aulast%3DClamp%26aufirst%3DM.%26aulast%3DBarton%26aufirst%3DG.%2BJ.%26atitle%3DJalview%2520Version%25202%25E2%2580%2594a%2520multiple%2520sequence%2520alignment%2520editor%2520and%2520analysis%2520workbench%26jtitle%3DBioinformatics%26date%3D2009%26volume%3D25%26spage%3D1189%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span> <span class="citation_source-book">rmsd.py version 1.14.2.6, Maestro version 9.1</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=rmsd.py+version+1.14.2.6%2C+Maestro+version+9.1%3B+Schrodinger%2C+LLC%3A+New+York%2C+NY%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3Drmsd.py%2520version%25201.14.2.6%252C%2520Maestro%2520version%25209.1%26pub%3DSchrodinger%252C%2520LLC%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Tervo, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niskanen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyrönen, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span> </span><span class="NLM_article-title">An in silico approach to discovering novel inhibitors of human sirtuin type 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6292</span><span class="NLM_x">–</span> <span class="NLM_lpage">6298</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049933m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6292-6298&author=A.+J.+Tervoauthor=S.+Kyrylenkoauthor=P.+Niskanenauthor=A.+Salminenauthor=J.+Lepp%C3%A4nenauthor=T.+H.+Nyr%C3%B6nenauthor=T.+J%C3%A4rvinenauthor=A.+Poso&title=An+in+silico+approach+to+discovering+novel+inhibitors+of+human+sirtuin+type+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm049933m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049933m%26sid%3Dliteratum%253Aachs%26aulast%3DTervo%26aufirst%3DA.%2BJ.%26aulast%3DKyrylenko%26aufirst%3DS.%26aulast%3DNiskanen%26aufirst%3DP.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DNyr%25C3%25B6nen%26aufirst%3DT.%2BH.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DPoso%26aufirst%3DA.%26atitle%3DAn%2520in%2520silico%2520approach%2520to%2520discovering%2520novel%2520inhibitors%2520of%2520human%2520sirtuin%2520type%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6292%26epage%3D6298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kiviranta, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyrylenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuusisto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tervo, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span> </span><span class="NLM_article-title">N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2448</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2448-2451&author=P.+H.+Kivirantaauthor=J.+Lepp%C3%A4nenauthor=V.+M.+Rinneauthor=T.+Suuronenauthor=O.+Kyrylenkoauthor=S.+Kyrylenkoauthor=E.+Kuusistoauthor=A.+J.+Tervoauthor=T.+J%C3%A4rvinenauthor=A.+Salminenauthor=A.+Posoauthor=E.+A.+A.+Wall%C3%A9n&title=N-%283-%284-Hydroxyphenyl%29-propenoyl%29-amino+acid+tryptamides+as+SIRT2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiviranta%26aufirst%3DP.%2BH.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DRinne%26aufirst%3DV.%2BM.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DKyrylenko%26aufirst%3DO.%26aulast%3DKyrylenko%26aufirst%3DS.%26aulast%3DKuusisto%26aufirst%3DE.%26aulast%3DTervo%26aufirst%3DA.%2BJ.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26atitle%3DN-%25283-%25284-Hydroxyphenyl%2529-propenoyl%2529-amino%2520acid%2520tryptamides%2520as%2520SIRT2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2448%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr','PDB','3glr'); return false;">PDB: 3glr</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d','PDB','2h2d'); return false;">PDB: 2h2d</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gls" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gls','PDB','3gls'); return false;">PDB: 3gls</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glt" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glt','PDB','3glt'); return false;">PDB: 3glt</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glu" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glu','PDB','3glu'); return false;">PDB: 3glu</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f','PDB','1j8f'); return false;">PDB: 1j8f</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2f" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2f','PDB','2h2f'); return false;">PDB: 2h2f</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2g" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2g','PDB','2h2g'); return false;">PDB: 2h2g</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2h" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2h','PDB','2h2h'); return false;">PDB: 2h2h</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2i" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2i','PDB','2h2i'); return false;">PDB: 2h2i</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr.pdb" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3glr.pdb','PDB','3glr.pdb'); return false;">PDB: 3glr</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d.pdb" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2h2d.pdb','PDB','2h2d.pdb'); return false;">PDB: 2h2d</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/jm200590k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26853"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental procedures for the syntheses and NMR spectra for the compounds <b>4</b>–<b>24</b> and <b>26</b>–<b>30</b>, ESI-MS results, elemental analysis data and additional docking pose figures. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200590k/suppl_file/jm200590k_si_001.pdf">jm200590k_si_001.pdf (3.62 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200590k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm200590k%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-19%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200590k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679abaa198fa3c16","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
